Form 8-K
8-K — MFA FINANCIAL, INC.
Accession: 0001104659-26-114714
Filed: 2026-10-08
Period: 2026-10-02
CIK: 0001055160
SIC: 6798 (REAL ESTATE INVESTMENT TRUSTS)
Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item: Regulation FD Disclosure
Item: Financial Statements and Exhibits
Documents
8-K — tm2627083d1_8k.htm (Primary)
EX-10.1 — EXHIBIT 10.1 (tm2627083d1_ex10-1.htm)
EX-10.2 — EXHIBIT 10.2 (tm2627083d1_ex10-2.htm)
EX-10.3 — EXHIBIT 10.3 (tm2627083d1_ex10-3.htm)
EX-99.1 — EXHIBIT 99.1 (tm2627083d1_ex99-1.htm)
GRAPHIC (tm2627083d1_img001.jpg)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — FORM 8-K
8-K (Primary)
Filename: tm2627083d1_8k.htm · Sequence: 1
false
0001055160
0001055160
2026-10-02
2026-10-02
0001055160
us-gaap:CommonStockMember
2026-10-02
2026-10-02
0001055160
us-gaap:SeriesBPreferredStockMember
2026-10-02
2026-10-02
0001055160
us-gaap:SeriesCPreferredStockMember
2026-10-02
2026-10-02
0001055160
MFA:Senior8.875PercentNotesDue2029Member
2026-10-02
2026-10-02
0001055160
MFA:Senior9.000PercentNotesDue2029Member
2026-10-02
2026-10-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
October 2, 2026
MFA
FINANCIAL, INC.
(Exact name of registrant as specified in its
charter)
Maryland
1-13991
13-3974868
(State or other jurisdiction
(Commission File Number)
(IRS Employer
of incorporation
Identification No.)
or organization)
12
East 49th Street
11th
Floor – Suite 825
New York, New York
10017
(Address of principal executive offices)
(Zip Code)
Registrant's
telephone number, including area code: (212)
207-6400
Not Applicable
(Former name or former address, if changed
since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
¨
Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
Title
of each class:
Trading
Symbols:
Name
of each
exchange on which
registered:
Common
Stock, par value $0.01 per share
MFA
New
York Stock Exchange
7.50%
Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share
MFA/PB
New
York Stock Exchange
6.50%
Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, par value $0.01 per share
MFA/PC
New
York Stock Exchange
8.875%
Senior Notes due 2029
MFAN
New
York Stock Exchange
9.000%
Senior Notes due 2029
MFAO
New
York Stock Exchange
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02. Departure of Directors
or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b)
On October 8, 2026, MFA Financial, Inc. (“MFA” or the “Company”) announced that Craig L. Knutson, age
67, will be retiring as Chief Executive Officer of the Company effective June 30, 2027, after having served as MFA’s CEO or
Co-CEO since July 2017. Following his retirement, it is expected that Mr. Knutson will continue to serve on the Board
of Directors of the Company, subject to his election by the stockholders of MFA at the Company’s 2027 annual meeting of stockholders,
which is expected to be held in June 2027.
(c) and (d) On October 8, 2026,
MFA announced the appointment of Bryan Wulfsohn, age 43, as CEO of the Company, effective July 1, 2027, following the retirement
of Mr. Knutson. Mr. Wulfsohn, who joined MFA in 2010, has been the Company’s President since September 2024 and
its Chief Investment Officer or Co-Chief Investment Officer since 2019. In addition, on October 8, 2026, MFA announced that Mr. Wulfsohn
will become a member of its Board of Directors, effective January 1, 2027.
A copy of the press release announcing Mr. Knutson’s
retirement and Mr. Wulfsohn’s appointments is attached as Exhibit 99.1 to this Current Report on Form 8-K.
(e) Amendment No. 3 to Amended and
Restated Employment Agreement with Craig L. Knutson
In connection with Mr. Knutson’s
expected retirement, the Company and Mr. Knutson entered into Amendment No. 3, dated as of October 2, 2026 (the “Knutson
Amendment”), to the Amended and Restated Employment Agreement, entered into as of February 22, 2021, as previously amended
by amendments no. 1 and no. 2 thereto (as amended, the “Knutson A&R Employment Agreement”). Under the terms of the Knutson
A&R Employment Agreement as modified by the Knutson Amendment, for 2027 Mr. Knutson will be entitled to a grant of time-based
restricted stock units (“TRSUs”) with a grant date value of $843,000 and a grant of performance-based restricted stock units
(“PRSUs”) with a grant date value of $1,264,500 (which, in each case, reflects a 50% decrease from the grant date value of
the TRSU and PRSU awards made to Mr. Knutson in 2026). The Knutson Amendment also specifies Mr. Knutson’s retirement
date of June 30, 2027, and the Company’s agreement to nominate him to stand for election to its Board of Directors
at the Company’s 2027 annual meeting of stockholders. The Knutson Amendment does not alter the remaining operative terms of the
Knutson A&R Employment Agreement, including base salary, target bonus, payments in connection with certain terminations of employment
(including retirement) and restrictive covenants, which remain unchanged from those previously disclosed in filings made with the Securities
and Exchange Commission.
A copy of the Knutson Amendment is attached as Exhibit 10.1 to
this Current Report on Form 8-K. The above description of the principal terms of the Knutson Amendment is a summary only and is
qualified in its entirety by reference to Exhibit 10.1, which is incorporated by reference herein.
-2-
Amended and Restated Employment Agreement with Bryan Wulfsohn;
and Employment Agreement with Michael C. Roper
On October 2, 2026, the Company entered into (i) an amended and
restated employment agreement with Bryan Wulfsohn, President and Chief Investment Officer of the Company (the “Wulfsohn A&R
Employment Agreement”), and (ii) an employment agreement with Michael C. Roper, Senior Vice President and Chief Financial Officer
of the Company (the “Roper Employment Agreement” and together with the Wulfsohn A&R Employment Agreement, the “Employment
Agreements”). Set forth below is a summary of the principal terms and conditions of the Employment Agreements.
Term
Each of the Wulfsohn A&R Employment Agreement and the Roper Employment
Agreement has a term running through December 31, 2027, which automatically renews for an additional one-year period at the end
of the initial term and each year thereafter, unless either MFA or the executive gives the other party written notice of its or his intent
not to renew the term of at least 31 days prior to the end of the then current-term.
Base Salary
Under the terms of the Wulfsohn A&R Employment Agreement, Mr. Wulfsohn
is entitled to receive an annualized base salary of $700,000 for the year ending December 31, 2026 (which is unchanged from the
level previously disclosed for 2025), and effective January 1, 2027, he will be entitled to receive an annualized base salary of
$762,500. Mr. Wulfsohn’s 2027 base salary, as well as the target amount of his 2027 annual performance-based bonus and grant
date values of his 2027 equity awards, which are described below, are reflective of his position as President of the Company through
June 30, 2027, and his promotion to Chief Executive Officer of the Company as of July 1, 2027, following Mr. Knutson’s
retirement.
Under the terms of the Roper Employment Agreement, Mr. Roper
is entitled to receive an annualized base salary of $550,000 for the year ending December 31, 2026, and effective January 1,
2027, he will be entitled to receive an annualized base salary of $575,000. Generally, the base salary of each executive may be increased
by the Compensation Committee (the “Compensation Committee”) of the Board of Directors but not decreased unless in connection
with an overall reduction in base salaries for the Company’s senior executives.
Annual Performance-Based Bonus
During the term of the Employment Agreements each executive is eligible
to receive an annual performance-based bonus (the “Annual Bonus”) based on the performance of the Company and the applicable
executive during the 12-month period beginning December 1st and ending on November 30th of the next succeeding year (each 12-month
period being a performance period). Pursuant to the terms of the Wulfsohn A&R Employment Agreement, for the performance period that
began on December 1, 2025 (the 2026 performance period), Mr. Wulsohn’s target annual bonus (the “Overall Target
Bonus”) is $1,450,000, and for the performance period beginning on December 1, 2026 (the 2027 performance period), his Overall
Target Bonus will be $1,700,000. Pursuant to the terms of the Roper Employment Agreement, for the 2026 performance period (which commenced
prior to the execution of the Roper Employment Agreement), Mr. Roper has no Overall Target Bonus, and his Annual Bonus for such
performance period will be determined in the discretion of the Compensation Committee. For the 2027 performance period Mr. Roper’s
Overall Target Bonus will be $850,000. Generally, each executive’s Overall Target Bonus may be increased by the Compensation Committee
but not decreased unless in connection with an overall reduction in target bonuses for the Company’s senior executives.
-3-
The Employment Agreements provide that each executive’s Annual
Bonus is comprised of two components: (i) a portion of the Annual Bonus is payable based on the achievement of objective performance
goals established annually by the Compensation Committee (the “Formulaic Bonus”), and (ii) a portion of the Annual Bonus
is based on the executive’s individual performance and other factors determined annually by the Compensation Committee (the “IRM
Bonus”). (For Mr. Roper, this Annual Bonus structure will take effect beginning with the 2027 performance period.) For each
executive: (a) 75% of the Overall Target Bonus is allocated to the Formulaic Bonus, and (b) 25% of the Overall Target Bonus
is allocated to the IRM Bonus. The amount of the Annual Bonus ultimately paid to an executive for each performance period may range from
zero to 200% of his Overall Target Bonus. Each executive’s Annual Bonus shall be paid in the form of cash.
Formulaic Bonus. For each
performance period the target amount of the Formulaic Bonus (the “Target Formulaic Bonus”) for each executive is equal to
75% of his Overall Target Bonus. For the 2026 performance period Mr. Wulfsohn’s Target Formulaic Bonus is $1,087,500, and
for the 2027 performance period his Target Formulaic Bonus will be $1,275,000. For the 2027 performance period Mr. Roper’s
Target Formulaic Bonus will be $637,500. Each executive is eligible to receive from zero to 200% of his Target Formulaic Bonus. The actual
amount of the Formulaic Bonus to be paid to each executive is based on Company’s achievement of the objective measures determined
by the Compensation Committee for the applicable performance period relative to threshold, target, and maximum performance goals established
by the Compensation Committee for such performance period.
IRM Bonus. For each performance
period the target amount of the IRM Bonus (the “Target IRM Bonus”) for each executive is equal to 25% of his Overall Target
Bonus. For the 2026 performance period Mr. Wulfsohn’s Target IRM Bonus is $362,500, and for the 2027 performance period
his Target IRM Bonus will be $425,000. For the 2027 performance period Mr. Roper’s Target IRM Bonus will be $212,500. Each
executive is eligible to receive from zero to 200% of his Target IRM Bonus. The actual amount of the IRM Bonus to be paid to the executive
is determined by the Compensation Committee in its discretion based upon any factors it deems relevant and appropriate, including, without
limitation, the executive’s individual performance.
Equity Awards
Each of the Wulfsohn A&R Employment Agreement and the Roper Employment
Agreement provides that if the executive is employed by the Company on the applicable grant date, he is entitled to receive an annual
grant of restricted stock units, which will be comprised of TRSUs and PRSUs. The TRSUs and PRSUs are subject to the terms of the Company’s
Equity Compensation Plan, as may be amended, or any successor plan, and an applicable award agreement entered into between the executive
and the Company.
-4-
TRSUs. Under the terms
of the Wulfsohn A&R Employment Agreement, Mr. Wulfsohn will be entitled to receive an annual grant of TRSUs with an aggregate
grant date value of $1,160,000. Under the terms of the Roper Employment Agreement, Mr. Roper will be entitled to receive an annual
grant of TRSUs with an aggregate grant date value of $500,000. Under the Employment Agreements, the Compensation Committee may increase
or decrease the aggregate grant date value for any annual grant of TRSUs made in future years.
Except in certain circumstances described below in “Payments
and Other Benefits upon Termination of Employment,” each TRSU award will vest on the third December 31st to occur following
the date of grant, subject to the executive’s continued employment with the Company. Upon vesting, each executive will receive
one share of MFA common stock for each vested TRSU.
If dividends are paid on MFA common stock during the period in which
TRSUs are outstanding, each executive will be credited with an amount, per TRSU, equal to the amount of dividends declared and paid in
accordance with the terms and conditions of the applicable award agreement.
PRSUs. Under the terms
of the Wulfsohn A&R Employment Agreement, Mr. Wulfsohn will be entitled to receive an annual grant of PRSUs with an aggregate
grant date value (the “PRSU Grant Date Value”) of $1,740,000. Under the terms of the Roper Employment Agreement, Mr. Roper
will be entitled to receive an annual grant of PRSUs with an aggregate grant date value of $750,000. Under the Employment Agreements,
the Compensation Committee may increase or decrease the PRSU Grant Date Value for any annual grant of PRSUs made in future years.
A portion of each annual PRSU award will vest based on the Company’s
level of absolute total stockholder return (“TSR”) during the applicable three-year performance period and a portion will
vest based on the Company’s level of TSR during the applicable three-year performance period relative to the TSR during such period
of a peer group of companies designated by the Compensation Committee at the time of each grant. (The PRSUs that vest based on the Company’s
level of absolute TSR are hereinafter referred to as the “Absolute TSR PRSUs,” and the PRSUs that vest based on the Company’s
level of relative TSR are hereinafter referred to as the “Relative TSR PRSUs.”) Except in certain circumstances described
below in “Payments and Other Benefits upon Termination of Employment,” PRSUs will vest on the last day of the applicable
performance period, subject to the level of performance achieved and the executive’s continued employment with the Company.
Each annual grant of PRSUs provides for a target grant of Absolute
TSR PRSUs (the “Absolute TSR Target Award”) and a target grant of Relative TSR PRSUs (the “Relative TSR Target Award”).
For each executive, the Absolute TSR Target Award is a number of PRSUs equal to the quotient of (a) 50% of the executive’s
PRSU Grant Date Value divided by (b) the grant date fair value per unit of one Absolute TSR PRSU. Similarly, the Relative TSR Target
Award for each executive is a number of PRSUs equal to (a) 50% of the executive’s PRSU Grant Date Value divided by (b) the
grant date fair value per unit of one Relative TSR PRSU.
-5-
The actual number of Absolute TSR PRSUs that vest will be based on
the level of the Company’s cumulative total stockholder return (i.e., share price appreciation or depreciation, as the case may
be, plus dividends divided by initial share price) relative to an 8% per annum simple TSR for the three-year performance period beginning
on January 1 of the year of grant (e.g., the performance period for the PRSUs to be granted in 2027 will be January 1, 2027
through December 31, 2029). To determine the actual number of Absolute TSR PRSUs that will vest, the target number of each grant
of Absolute TSR PRSUs will be adjusted up or down at the end of the applicable three-year performance period based on the Company’s
cumulative TSR relative to an 8% per annum simple TSR objective from 0% of the target number (reflecting 0% per annum TSR during the
performance period) to 200% of the target number (reflecting 16% per annum (or higher) TSR during the performance period), with 100%
of the target number vesting if TSR of 8% per annum is achieved during the performance period.
The actual number of Relative TSR PRSUs that vest will be based on
the Company’s cumulative TSR during the applicable three-year performance period (beginning on January 1st of the year of
grant) as compared to the cumulative TSR of designated peer group companies for such performance period. To the extent that the Company’s
TSR rank is less than or equal to the 25th percentile when compared to the TSR of the members of the peer group, the executive will vest
in 0% of the target number of Relative TSR PRSUs awarded to him in respect of the applicable performance period. To the extent that the
Company’s TSR rank is in the 50th percentile, the executive will vest in 100% of the target number of Relative TSR PRSUs awarded
to him in respect of the applicable performance period. To the extent that the Company’s TSR rank is greater than or equal to the
80th percentile, the executive will vest in 200% of the target number of Relative TSR PRSUs awarded to him in respect of the applicable
performance period. To the extent that the Company’s TSR ranking falls in between the percentiles identified in the preceding sentences,
the number of Relative TSR PRSUs that vest will be interpolated. The terms of the Relative TSR PRSUs also provide that, regardless of
the Company’s TSR rank, in the event the Company has negative TSR for a performance period, the executive will not vest in more
than 100% of the target number of Relative TSR PRSUs awarded to him in respect of the applicable performance period.
Absolute TSR PRSUs and Relative TSR PRSUs that do not vest at the
end of the performance period will be forfeited. The executive will receive one share of MFA common stock for each Absolute TSR PRSU
and Relative TSR PRSU that vests, provided that the fair market value of the shares of MFA common stock delivered upon settlement
may not exceed 400% of the PRSU Grant Date Value of the PRSUs granted in respect of the completed performance period. Any PRSUs that
vest will be subject to an additional one-year deferral prior to settlement, subject to accelerated payout under certain circumstances.
Dividend equivalents will not be paid in respect of the PRSUs during
the performance period. Rather, dividend equivalents will accrue with respect to the PRSUs during the performance period, and to the
extent that the underlying PRSUs vest, an amount equal to the accrued dividend equivalents related to the vested PRSUs will be paid to
the executive in the form of additional shares of MFA common stock in accordance with the terms and conditions of the applicable award
agreement. Any dividend equivalents applicable to dividends declared and paid during the deferral period following vesting will generally
be paid in cash as and when dividends are declared. Accrued dividend equivalents will only be payable to the extent that the underlying
PRSUs vest.
-6-
Payments and Other Benefits upon Termination of Employment
The Employment Agreements provide for the payment of severance and
other benefits to each of Mr. Wulfsohn and Mr. Roper under various circumstances in which his employment with MFA is terminated.
Death or Disability. In
circumstances where termination of the executive’s employment is due to his death or disability (as such term is defined in each
of the Employment Agreements), the executive or his legal representative or estate, as the case may be, will be entitled to the following:
(i) aggregate cash severance (generally payable in lump sum in
the case of death and installments in the case of disability) equal to the sum of (A) his annual base salary and (B) his Overall
Target Bonus for the performance period in which the executive’s death or disability occurs;
(ii) any unpaid Annual Bonus for the Performance Period that
ended immediately preceding the executive’s termination;
(iii) in the case of disability only, reimbursement of health
insurance premiums for the executive and his eligible dependents for a period of 18 months following such termination; and
(iv) immediate vesting of all outstanding unvested equity-based
awards; provided, however, that performance-based equity awards will continue to vest in accordance with their respective
terms and conditions determined as though the executive remained actively employed through the end of the applicable performance period
(or if termination occurs within 24 months following a change of control, vesting will be based on the number of shares that vest based
on actual performance measured as of the date of the change of control).
Termination without Cause or Resignation
for Good Reason. In circumstances where Mr. Wulfsohn’s or Mr. Roper’s employment is terminated (a) by
MFA without cause (as such term is defined in each of the Employment Agreements), including a determination by the Company not to renew
the term of the executive’s employment agreement, or (b) by the executive for good reason (as such term is defined in each
of the Employment Agreements), except as described below with respect to a change of control, the executive will be entitled to the following:
(i) aggregate cash severance equal to the sum of (A) his
annual base salary and (B) his Overall Target Bonus for the performance period in which the notice of termination is provided, which
will be payable over the twelve-month period following termination; provided that, in the case of Mr. Wulfsohn only, following
his promotion to CEO, the cash severance amount payable will be equal to two times the sum of (X) his annual base salary and (Y) his
Overall Target Bonus for the performance period in which the notice of termination is provided, which will be payable over the 24-month
period following termination;
-7-
(ii) any unpaid Annual Bonus for the Performance Period that
ended immediately preceding the date on which notice of termination is provided;
(iii) a lump sum payment equal to a pro-rated Overall Target
Bonus for the year in which the notice of termination is provided;
(iv) reimbursement of health insurance premiums for the executive
and his eligible dependents for a period of 12 months following such termination; and
(v) immediate vesting of all outstanding unvested equity-based
awards; provided, however, that performance-based equity awards will continue to vest in accordance with their respective
terms and conditions determined as though the executive remained employed through the end of the applicable performance period.
Termination Related to Change in
Control. Each of the Employment Agreements provides that in the event the executive’s employment is terminated by the
Company other than for cause (including upon a determination by the Company not to renew the term of his Employment Agreement) or the
executive terminates his employment for good reason, in either case, during the 24-month period following a change in control of the
Company (or, in certain limited instances, within the three-month period preceding a change in control of the Company), he will be entitled
to the following (in lieu of the amounts described above): (i) a lump sum severance payment equal to two times the sum of (A) his
annual base salary and (B) the Overall Target Bonus for the performance period in which the notice of termination is provided; (ii) immediate
vesting of all outstanding unvested equity-based awards (which, for performance-based equity awards, will be based on actual performance
measured as of the date of the change in control, with the performance goals adjusted, as applicable, for the reduced performance period);
(iii) reimbursement of health insurance premiums for the executive and his eligible dependents for a period of 18 months following
such termination; (iv) a lump sum payment equal to a pro-rated Overall Target Bonus for the year in which the notice of termination
is provided; and (v) any unpaid Annual Bonus for the Performance Period that ended immediately preceding the date on which notice
of termination was provided.
Notice of Termination
Each executive must generally provide 90 days’ notice prior
to his resignation, and the Company generally must provide 90 days’ notice prior to terminating the executive, except in certain
circumstances. During this 90-day period after any such notice has been given, the executive will continue to receive base salary and
benefits but will be ineligible to receive an Annual Bonus for any Performance Period that was not completed as of the beginning of the
90-day period and will not be eligible to receive any further awards of TRSUs or PRSUs.
-8-
Other Terms and Provisions
In addition, each Employment Agreement provides that if any payments
or benefits provided to the executive would constitute excess parachute payments within the meaning of Section 280G of the Internal
Revenue Code of 1986, as amended (the “Code”), and would be subject to the excise tax imposed under Section 4999 of
the Code, the payments or benefits will be reduced by the amount required to avoid the excise tax, if such reduction would give the executive
a better after-tax result than if he received the full payments and benefits and paid the excise tax.
Each of the Employment Agreements also contains customary confidentiality,
non-disparagement, non-solicitation and non-competition covenants, as well as other terms customary for agreements applicable to senior
executives.
A copy of each of the Wulfsohn A&R Employment Agreement and the
Roper Employment Agreement is attached to this Current Report on Form 8-K as Exhibit 10.2 and Exhibit 10.3, respectively.
The above descriptions of the principal terms of the Wulfsohn A&R Employment Agreement and the Roper Employment Agreement are summaries
only and are qualified in their entirety by reference to the applicable exhibit, each of which is incorporated by reference herein.
Item 7.01. Regulation FD Disclosure
On October 8, 2026, MFA announced that Andrew
P. Kail, age 57, will join the Company as its Chief Investment Officer, effective January 1, 2027. Mr. Kail served most recently
as Managing Director, Head of Residential Lending, at Starwood Capital Group, a position he held from 2022 through earlier this year.
Prior thereto, he was Director of Business Development at Aspen Capital from 2019 to 2022. Earlier in his career Mr. Kail also held
senior leadership positions in mortgage finance with Fortress Investment Group, RBS Securities Inc. and Bear Stearns & Co., Inc.
A copy of the press release announcing Mr. Kail’s
appointment is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
Exhibit No.
Description
10.1
Amendment No. 3,
dated as of October 2, 2026, to Amended and Restated Employment Agreement, entered into as of February 22, 2021, by and
between the Company and Craig L. Knutson.
10.2
Amended and Restated
Employment Agreement, dated as of October 2, 2026, by and between the Company and Bryan Wulfsohn.
10.3
Employment Agreement,
dated as of October 2, 2026, by and between the Company and Michael C. Roper.
99.1
Press Release, dated
October 8, 2026, of MFA Financial Inc.
104
Cover Page Interactive Data File (formatted as
Inline XBRL).
-9-
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MFA FINANCIAL, INC.
(REGISTRANT)
By:
/s/ Harold E. Schwartz
Name:
Harold E. Schwartz
Title:
Senior Vice President and General Counsel
Date: October 8, 2026
-10-
EX-10.1 — EXHIBIT 10.1
EX-10.1
Filename: tm2627083d1_ex10-1.htm · Sequence: 2
Exhibit 10.1
EXECUTION COPY
AMENDMENT NO. 3 TO
EMPLOYMENT AGREEMENT
THIS AMENDMENT NO. 3 (the “Amendment”),
dated as of October 2, 2026, to the Amended and Restated Employment Agreement entered into as of February 22, 2021, as amended
by Amendment No. 1, dated as of May 3, 2022, and Amendment No. 2, dated as of February 21, 2024 (as amended, the “Employment
Agreement”), is made by and between MFA Financial, Inc. (“MFA” or the “Company”)
and Craig L. Knutson (the “Executive”).
WITNESSETH:
WHEREAS, MFA and the Executive desire to amend
the Employment Agreement.
NOW, THEREFORE, MFA and the Executive agree as
follows:
1. Subsection
(b) of Section 1 (Term of Employment) of the Employment Agreement is hereby deleted in its entirety and replaced with the following:
“(b) The
term of employment (the “Term of Employment”) under this Agreement shall commence on the Effective Date and continue
until June 30, 2027, or such earlier date as agreed to by the Company and the Executive (such date, the “Retirement Date”),
unless earlier terminated in accordance with Section 5 hereof. If the Retirement Date occurs during a Garden Leave (as defined below)
period, the Term of Employment shall continue through the end of such Garden Leave, unless, in the case of the Executive’s resignation
other than for Good Reason (as defined below), the Company elects, in its sole discretion, to terminate the Term of Employment on the
Retirement Date. Except as set forth in the preceding sentence, the Term of Employment shall not extend beyond the Retirement Date, and
the termination of the Executive’s employment on the Retirement Date shall not constitute a termination without Cause (as defined
below) or a termination for Good Reason.”
2. Subsection
(a) (Base Salary) of Section 3 (Compensation) of the Employment Agreement is hereby deleted in its entirety and replaced with
the following:
“During the Term of Employment, the Executive shall
be entitled to receive an annualized base salary (the “Base Salary”) of not less than $825,000.”
3. The
first sentence in subsection (d) (Retirement) of Section 5 (Termination of Employment) of the Employment Agreement is hereby
deleted in its entirety and replaced with the following:
“In the event the Executive’s employment terminates
(I) on the Retirement Date or (II) during the Term of Employment on account of the Executive’s voluntary resignation and,
in either event, no circumstance constituting Cause exists at the time of such termination, the termination shall constitute an Eligible
Retirement, and the Term of Employment shall terminate without further obligations to the Executive under this Agreement, except as provided
in this Section 5(d) and Section 5(g) below.”
-1-
4. The
following shall be added to the end of subsection (d) (Retirement) of Section 5 (Termination of Employment) of the Employment
Agreement:
“The Nominating and Corporate Governance Committee
(the “Nominating Committee”) of the Board of Directors shall recommend that the Board of Directors nominate, and the
Board of Directors shall nominate, the Executive to stand for election as a member of the Board of Directors at MFA’s 2027 Annual
Meeting of Stockholders (the “2027 Annual Meeting”); provided, however, that the Nominating Committee
shall have no obligation to recommend, and the Board of Directors shall have no obligation to nominate, the Executive for such election
to the Board of Directors in the event that the Executive’s employment is terminated for any reason or the Company shall have Cause
to terminate the Executive’s employment prior to the date of the 2027 Annual Meeting, and in such event the Executive shall, as
may be requested by the Company, take such actions and execute and deliver such documents as may be necessary or appropriate to withdraw
his nomination for election as a member of the Board of Directors.”
5. Subsection
(e) of Section 5 (Termination of Employment) of the Employment Agreement is hereby deleted in its entirety and replaced with
the following:
“(e) Termination
by the Company for Cause or Voluntary Termination by the Executive. In the event the Executive’s employment is terminated during
the Term of Employment (i) by the Company for Cause or (ii) by the Executive on his own initiative for other than a Good Reason
and other than due to the Executive’s Disability or pursuant to Section 5(d), the Executive shall be entitled only to the amounts
set forth in Section 5(h) below.”
6. The
first sentence in subsection (n) (Resignation from Positions) of Section 5 (Termination of Employment) of the Employment Agreement
is hereby deleted in its entirety and replaced with the following:
“In the event that the Executive’s employment
with the Company shall terminate for any reason or the Company shall have Cause to terminate the Executive’s employment prior to
or on the Retirement Date, the Executive shall, as may be requested by the Company, offer to resign from any position he then holds as
an officer, director or fiduciary of the Company or any Company-related entity. Notwithstanding the preceding sentence, the Executive
shall have no obligation to offer to resign from the Board of Directors of MFA in the event that (i) he shall be elected as a member
of the Board of Directors at the 2027 Annual Meeting except in such circumstance in which the Company shall have Cause to terminate
the Executive’s employment prior to or on the Retirement Date or (ii) the Retirement Date shall occur prior to the 2027 Annual
Meeting (in the case of (ii) the Executive may continue to serve as a member of the Board of Directors of MFA until the later of
(a) the expiration of the term ending at the 2027 Annual Meeting and (b) the expiration of the term for which he may be so elected
at the 2027 Annual Meeting).”
-2-
7. The
first sentence of Section 2 (Target Bonus) of Exhibit A (Annual Performance Bonus) of the Employment Agreement is hereby deleted
in its entirety and replaced with the following:
“For the Performance Period commencing on December 1,
2026, the Executive’s target annual cash bonus (the “Target Bonus”) shall be $2,020,000.”
8. The
second sentence of the first paragraph of Section 2 of Exhibit B (Summary of the Company’s Long Term Incentive Program)
of the Employment Agreement is hereby deleted in its entirety and replaced with the following:
“The TRSU Grant Date Value for the annual grant to
be made to the Executive in 2027 will be equal to $843,000.”
9. The
last sentence of the third paragraph of Section 3 of Exhibit B (Summary of the Company’s Long Term Incentive Program)
of the Employment Agreement is hereby deleted in its entirety and replaced with the following:
“The PRSU Grant Date Value for the annual grant to
be made to the Executive in 2027 will be equal to $1,264,500.”
10. Except
as hereinabove modified and amended, the Employment Agreement shall remain in full force and effect.
11. This
Amendment may be executed in any number of counterparts, each of which shall be an original, but all of which together shall constitute
one instrument.
[remainder of the page left intentionally
blank]
-3-
IN WITNESS WHEREOF, the parties have executed this
Amendment as of the day and year first written above.
MFA FINANCIAL, INC.
By:
/s/ Robin Josephs
Name:
Robin Josephs
Title:
Director and Chair, Compensation Committee
EXECUTIVE:
/s/ Craig L. Knutson
Craig L. Knutson
-4-
EX-10.2 — EXHIBIT 10.2
EX-10.2
Filename: tm2627083d1_ex10-2.htm · Sequence: 3
Exhibit 10.2
EXECUTION COPY
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
THIS AMENDED AND RESTATED
EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of the second day of October, 2026 (the “Effective
Date”), by and between MFA Financial, Inc. (“MFA”), and Bryan Wulfsohn (the “Executive”).
WITNESSETH:
WHEREAS, MFA and the Executive
entered into an employment agreement, amended and restated effective as of January 1, 2021 and further amended on May 3, 2022
(the “Former Employment Agreement”);
WHEREAS, MFA and the Executive
desire to enter into an amended and restated employment agreement that supersedes and replaces the Former Employment Agreement in all
respects as of the Effective Date and sets forth the terms of the Executive’s employment with MFA; and
WHEREAS, the Executive wishes
to continue serving MFA, and MFA wishes to secure the continued exclusive services of the Executive, under the terms and conditions described
in this Agreement, which will be legally binding on the date the Agreement is executed by the parties hereto.
NOW THEREFORE, in consideration
of the foregoing premises and the mutual agreements herein contained, the parties hereto agree as follows:
1. Term
of Employment.
(a) MFA
hereby employs the Executive, and the Executive hereby accepts employment with MFA, in the positions and with the duties and responsibilities
as set forth in Section 2 below for the Term of Employment, subject to the terms and conditions of this Agreement. Except as otherwise
provided in Section 3(b)(ii) below, as of the Effective Date of this Agreement, the Former Employment Agreement is terminated.
(b) The
term of employment (the “Term of Employment”) under this Agreement shall commence on the Effective Date and continue
until December 31, 2027 (the “Initial Term”); provided that, the Term of Employment shall automatically renew
for periods of one-year (each an “Extension Term”) unless either party gives the other party written notice 31 days
prior to the end of the Initial Term or any Extension Term, as applicable, that the Term of Employment shall not be further extended.
If the last day of the Initial Term or any Extension Term occurs during a Garden Leave Period, the Term of Employment shall continue through
the end of such Garden Leave Period. The Term of Employment may also be terminated in accordance with Section 5 hereof. The Company’s
failure to renew the Term of Employment at the end of the Initial Term or any Extension Term, as applicable, shall constitute termination
without Cause (as defined below). The Executive’s failure to renew the Term of Employment at the end of the Initial Term or any
Extension Term shall not, by itself, constitute a termination for Good Reason (as defined below).
2. Position;
Duties and Responsibilities.
(a) During
the period beginning on the Effective Date and ending on the CEO Retirement Date (as defined below), the Executive shall be employed as
President of MFA, reporting directly and solely to the Chief Executive Officer of MFA (the “Current CEO”). During the
period beginning on the CEO Retirement Date and for the remainder of the Term of Employment, the Executive shall be employed as the Chief
Executive Officer of MFA, reporting directly and solely to the Board of Directors of MFA (the “Board of Directors”).
With respect to each such role, the Executive shall have the authority, duties and day-to-day management responsibilities as are customarily
maintained and performed by persons holding such office at similarly situated mortgage REITs and such other duties as may be mutually
agreed upon between the Executive and the Current CEO or the Board of Directors, as applicable. For purposes of this Agreement, the “CEO
Retirement Date” refers to the date on which the Current CEO’s employment with MFA terminates, which is anticipated to
occur on or about July 1, 2027 and shall occur no later than December 31, 2027.
(b) During
the Term of Employment, the Executive shall, without additional compensation, also serve on the board of directors of, serve as an officer
of, and/or perform such executive and consulting services for, or on behalf of, such subsidiaries or affiliates of MFA as the Current
CEO or the Board of Directors, as applicable, may, from time to time, request. MFA and such subsidiaries and affiliates are hereinafter
referred to, collectively, as the “Company.” For purposes of this Agreement, the term “affiliate” shall
have the meaning ascribed thereto in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Act”).
(c) During
the Term of Employment, the Executive shall serve MFA faithfully, diligently and to the best of his ability and shall devote substantially
all of his business time and efforts to his employment and the performance of his duties under this Agreement. Nothing herein shall preclude
the Executive from engaging in charitable and community affairs and managing his personal, financial and legal affairs, so long as such
activities do not materially interfere with his carrying out his duties and responsibilities under this Agreement.
3. Compensation.
(a) Base
Salary. For the period beginning on the Effective Date and ending on December 31, 2026, the Executive shall be entitled to receive
an annualized base salary (the “Base Salary”) of $700,000, and effective as of January 1, 2027, the Executive
shall be entitled to receive a Base Salary of $762,500. The Compensation Committee of the Board of Directors (the “Compensation
Committee”) shall review the Executive’s Base Salary annually to determine whether increases or decreases are appropriate;
provided that, the Executive’s Base Salary may only be decreased if such decrease is part of an overall Company reduction of executive
base salaries and the applicable decrease (on a percentage basis) is substantially equivalent to that applicable to other senior executives
of MFA. For the avoidance of doubt, if the Executive’s annualized base salary is further increased during the Term of Employment,
such increased amount shall constitute the “Base Salary” for all purposes of this Agreement, and any decrease of such Base
Salary shall be subject to the proviso in the preceding sentence.
(b) Performance
Bonus.
2
(i) The
Executive shall be eligible to receive an annual bonus pursuant to the terms of this Agreement for the 12-month performance period beginning
December 1, 2026 and each subsequent December 1 during the Term of Employment (each, a “Performance Period”),
according to the terms set forth on the attached Exhibit A. The Compensation Committee shall make all determinations with
respect to the annual bonus in good faith and consistent with the attached Exhibit A.
(ii) For
the 12-month period beginning December 1, 2025, the Executive shall be eligible to receive an annual bonus pursuant to the terms
of the Former Employment Agreement. The Executive’s target annual bonus for such period is $1,450,000, and the Executive’s
annual bonus for such period shall be determined and paid in accordance with the terms of the Former Employment Agreement. In no event
shall such bonus be paid to the Executive later than March 15, 2027.
(c) Equity
Compensation. To the extent that the Executive is still employed by MFA and has not delivered or received a Notice of Termination
as of each applicable grant date, within the first five trading days of each calendar year during the Term of Employment, the Company
shall grant to the Executive a time-based restricted stock unit (“RSU”) award and a performance-based RSU award, each
of which shall be granted according to the terms set forth on the attached Exhibit B, the terms of the MFA Financial, Inc. Equity
Compensation Plan or any successor thereto (the “Equity Compensation Plan”) (which, for the avoidance of doubt, shall
not be inconsistent with the terms set forth on Exhibit B), and the terms set forth in the form time-based RSU award agreement and
the form performance-based RSU award agreement attached hereto as Exhibits C and D, respectively (the “Award Agreements”).
In the event of any inconsistency between the terms of this Agreement and the Award Agreements, the terms of the Award Agreements shall
govern. For the avoidance of doubt, each award granted to the Executive pursuant to the Equity Compensation Plan prior to the Effective
Date that is outstanding as of the Effective Date shall continue to be governed by the terms of the applicable award agreement, as amended
by Section 5(a)(iv), Section 5(b)(iii), Section 5(c)(v), and Section 5(f)(iii) of this Agreement.
(d) Stock
Ownership Requirements. All shares of MFA stock distributed to the Executive by the Company under this Agreement or otherwise shall
be subject to the stock ownership guidelines in effect for executives from time to time, as determined by the Board of Directors. Unless
the stock ownership guidelines provide otherwise, vested shares of equity grants cannot be transferred or sold during the Executive’s
employment by the Company unless and until the value of the Executive’s stock holdings in MFA (including shares of restricted stock
and RSUs (with any RSUs that vest based on performance valued at target)) exceeds four times the Executive’s Base Salary; and following
the termination of Executive’s employment with the Company, vested shares of equity grants may not be sold or transferred to the
extent the value of the Executive’s stock holdings does not exceed four times the Executive’s Base Salary as of the date of
the Executive’s termination of employment (provided, however, that this sentence shall no longer apply following the six-month anniversary
of the Executive’s termination of employment). Notwithstanding the foregoing, the restrictions of this subsection (d) shall
not prevent Executive from selling shares of MFA stock to satisfy income tax and employment tax obligations relating to the vesting and
settlement of the equity grants to which the shares relate.
3
4. Employee
Benefit Programs and Fringe Benefits. The Executive shall be entitled to at least 25 days in the aggregate of vacation and paid time
off for each calendar year during the Term of Employment and shall be entitled to participate in all executive incentive and employee
benefit programs of MFA now or hereafter made available to MFA’s senior executives or salaried employees generally, as such programs
may be in effect from time to time. The Executive shall be entitled to sick leave in accordance with applicable law and MFA policies.
MFA shall reimburse the Executive for any and all necessary, customary and usual business expenses incurred by Executive in connection
with his employment in accordance with applicable MFA policies.
5. Termination
of Employment.
(a) Termination
Due to Disability. If the Executive’s employment is terminated during the Term of Employment by reason of the Executive’s
Disability, the Executive’s Term of Employment shall terminate automatically without further obligations to the Executive under
this Agreement except as provided in Section 5(g) below. In addition, and if the requirements of Section 5(j) are
met:
(i) The
Executive shall receive cash payments in an aggregate amount equal to the sum of (A) Executive’s then current Base Salary
and (B) the Executive’s Target Bonus (as defined in Exhibit A) for the Performance Period in which a Notice of Termination
is delivered, with such amount to be paid in cash in equal ratable installments in accordance with applicable MFA payroll practices over
the 12 month period following such termination. Such installment payments shall commence as soon as possible (without undue delay), but
in any event within 60 days following the date of termination on account Disability, and the first payment shall include any unpaid installments
for the period prior to commencement. Notwithstanding the foregoing, in the event that the Executive’s employment is terminated
on account of Disability and such termination occurs within 24 months following a Change of Control (as defined below), in lieu of payment
in the form of installments, the sum of the amounts set forth in the preceding clauses (A) and (B) shall be paid in a lump
sum cash payment as soon as possible (without undue delay), but in any event within 60 days following the date of termination on account
of Disability.
(ii) The
Executive shall receive any unpaid Annual Bonus (as defined in Exhibit A) for the Performance Period (as defined in Exhibit A)
immediately preceding the Executive’s date of termination, which shall be paid at the time set forth in Exhibit A.
(iii) The
Company shall reimburse the Executive for 100% of the COBRA premiums incurred by the Executive for the Executive and his eligible dependents
under the Company’s health care plan during the 18 month period following the Executive’s termination of employment. Such
reimbursement shall be provided on the payroll date immediately following the date on which the Executive remits the applicable premium
payment and shall commence within 60 days after the termination date; provided that the first payment shall include any reimbursements
that would have otherwise been payable during the period beginning on the Executive’s termination date and ending on the date of
the first reimbursement payment. Reimbursement payments shall be treated as taxable compensation to the Executive to the extent required
by law.
4
(iv) All
of the Executive’s outstanding equity-based awards (e.g., restricted stock, phantom shares, RSUs and stock options) shall be treated
in accordance with the following (whether granted before or after the Effective Date) and paid at the time set forth in the applicable
award agreement:
(A) Except
as otherwise provided in (C) below, all unvested awards shall immediately vest.
(B) All
vested options shall remain exercisable until the earlier of (x) 90 days following the date of such termination or (y) the
date on which each such option would have expired had the Executive’s employment not terminated.
(C) Any
equity award that is subject to vesting based on the achievement of performance goals shall vest in accordance with the terms and conditions
applicable to such award, determined as though the Executive remained actively employed through the end of the applicable performance
period; for the avoidance of doubt, if a Change of Control occurs during the applicable performance period and the Executive’s
date of termination occurs following such Change of Control, the Executive’s award shall become vested with respect to a number
of shares determined based on actual performance measured as of the date of the Change of Control, provided that, to the extent equitable,
each applicable performance goal shall be adjusted to account for the reduced performance period as set forth in the applicable award
agreement.
(b) Termination
Due to Death. If the Executive’s employment is terminated during the Term of Employment by reason of the Executive’s
death, the Executive’s Term of Employment shall terminate automatically without further obligations to the Executive, his legal
representative or his estate, as the case may be, under this Agreement except as provided in Section 5(g) below. In addition:
(i) The
Executive’s legal representative or his estate, as the case may be, shall receive a lump sum cash payment equal to the sum of (A) Executive’s
then current Base Salary and (B) the Executive’s Target Bonus for the Performance Period in which the Executive’s death
occurs. Such payment shall be made as soon as possible (without undue delay), but in any event within 60 days following the date of the
Executive’s death.
5
(ii) The
Executive shall receive any unpaid Annual Bonus (as defined in Exhibit A) for the Performance Period (as defined in Exhibit A)
immediately preceding the Executive’s date of termination, which shall be paid at the time set forth in Exhibit A.
(iii) All
of the Executive’s outstanding equity-based awards (e.g., restricted stock, phantom shares, RSUs and stock options) shall be treated
in accordance with the following (whether granted before or after the Effective Date) and paid at the time set forth in the applicable
award agreement:
(A) Except
as otherwise provided in (C) below, all unvested awards shall immediately vest.
(B) All
vested options shall remain exercisable until the earlier of (x) 90 days following the date of such termination or (y) the
date on which each such option would have expired had the Executive’s employment not terminated.
(C) Any
equity award that is subject to vesting based on the achievement of performance goals shall vest in accordance with the terms and conditions
applicable to such award, determined as though the Executive remained actively employed through the end of the applicable performance
period; for the avoidance of doubt, if a Change of Control occurs during the applicable performance period and the Executive’s
date of termination occurs following such Change of Control, the Executive’s award shall become vested with respect to a number
of shares determined based on actual performance measured as of the date of the Change of Control, provided that, to the extent equitable,
each applicable performance goal shall be adjusted to account for the reduced performance period as set forth in the applicable award
agreement.
(c) Termination
By MFA Without Cause or By the Executive for Good Reason. In the event the Executive’s employment is terminated during the
Term of Employment by the Company without Cause or by the Executive for Good Reason (other than for Disability, as described in Section 5(a)),
the Executive’s Term of Employment shall terminate without further obligations to the Executive under this Agreement, except as
provided in Section 5(g) below. In addition and if the requirements of Section 5(j) are met:
(i) The
Executive shall be entitled to an amount (the “Severance Amount”) equal to two times the sum of (x) his then
current Base Salary, and (y) the Executive’s Target Bonus for the Performance Period in which a Notice of Termination is delivered
(such sum, the “Severance Sum”), with such amount to be paid in cash in equal ratable installments in accordance with
applicable MFA payroll practices over the 24 month period following the Executive’s termination (the “Severance Period”);
provided that, (A) if the Executive’s employment is terminated (I) prior to the CEO Retirement Date or (II) following
the CEO Retirement Date and the Executive is not the Chief Executive Officer of MFA at the time of such termination, then, the Severance
Amount shall be equal to one times the Severance Sum, and the Severance Period shall be the 12 month period following the Executive’s
termination of employment and (B) for purposes of this Section 5(c)(i) and Section 5(c)(ii), Base Salary and Target
Bonus shall be determined without regard to any changes giving rise to Good Reason pursuant to Section 6(g)(iv). The severance payments
shall commence within 60 days following the date of termination, and the first payment shall include any unpaid installments for the
period prior to commencement.
6
(ii) The
Executive shall receive a pro-rated portion of the Target Bonus, equal to the product of (A) the Target Bonus for the Performance
Period in which the Notice of Termination is provided, multiplied by (B) a fraction, the numerator of which is the number of days
during such Performance Period that the Executive is actively employed (excluding, for the avoidance of doubt and consistent with Section 5(e),
the Garden Leave Period), and the denominator of which is 365 (such payment, the “Pro-Rated Bonus”), which shall be
paid within 60 days following the Executive’s termination date.
(iii) The
Executive shall receive any unpaid Annual Bonus for the Performance Period immediately preceding the date on which the Notice of Termination
is provided (which, for the avoidance of doubt and consistent with Section 5(e) shall not include any Performance Period which
ends during the Garden Leave Period), which shall be paid at the time set forth in Exhibit A.
(iv) The
Company shall reimburse the Executive for 100% of the COBRA premiums incurred by the Executive for the Executive and his eligible dependents
under the Company’s health care plan during the 12 month period following the Executive’s termination of employment. Such
reimbursement shall be provided on the payroll date immediately following the date on which the Executive remits the applicable premium
payment and shall commence within 60 days after the termination date; provided that the first payment shall include any reimbursements
that would have otherwise been payable during the period beginning on the Executive’s termination date and ending on the date of
the first reimbursement payment. Reimbursement payments shall be treated as taxable compensation to the Executive to the extent required
by law.
(v) All
of the Executive’s outstanding equity-based awards (e.g., restricted stock, phantom shares, RSUs and stock options) shall be treated
in accordance with the following (whether granted before or after the Effective Date) and paid at the time set forth in the applicable
award agreement:
(A) Except
as otherwise provided in (C) below, all unvested awards shall immediately vest.
(B) All
vested options shall remain exercisable until the earlier of (I) 90 days following the date of such termination or (II) the
date on which each such option would have expired had the Executive’s employment not terminated.
7
(C) Any
equity award that is subject to vesting based on the achievement of performance goals shall vest in accordance with the terms and conditions
applicable to such award, determined as though the Executive remained actively employed through the end of the applicable performance
period. For the avoidance of doubt, nothing in this Section 5(c)(v)(C) requires vesting of any equity award if and to the extent
that the applicable performance goals are not achieved as of the end of the applicable performance period.
For the avoidance of doubt, a termination of
the Executive’s employment pursuant to this Section 5(c), Section 5(d), Section 5(f) or Section 5(k) below
shall not be a breach of this Agreement and does not relieve either party of its/his other obligations hereunder.
(d) Termination
by the Company for Cause or Voluntary Termination by the Executive. In the event the Executive’s employment is terminated during
the Term of Employment (i) by the Company for Cause, (ii) by the Executive on his own initiative for other than a Good Reason
and other than due to the Executive’s Disability, or (iii) due to the Executive’s failure to renew this Agreement at
the end of the Initial Term or any Extension Term, the Executive shall be entitled only to the amounts set forth in Section 5(g) below.
Notwithstanding any provision of this Agreement, if the Executive’s employment terminates pursuant to the preceding clause (ii),
the Executive’s last day of employment shall be the 90th day following the Company’s receipt of Notice of Termination by
the Executive.
(e) Garden
Leave. The Executive shall provide a Notice of Termination to the Company 90 days prior to any termination of the Executive’s
employment (whether for Good Reason or without Good Reason) during the Term of Employment, other than a termination during the period
described in Section 5(f), and the Company shall provide a Notice of Termination to the Executive 90 days prior to any termination
of the Executive’s employment without Cause during the Term of Employment, other than a termination during the period described
in Section 5(f). During this 90-day notice period (the “Garden Leave Period”), the Executive shall (i) continue
to be an employee of MFA and shall make himself available to provide such services directed by the Company that are reasonably consistent
with the Executive’s status as a senior executive of the Company and (ii) continue to be paid his Base Salary and to be eligible
to participate in the Company’s benefits programs, but shall not be eligible to: (A) earn any Annual Bonus with respect to
a Performance Period that ends on or after the date on which Notice of Termination is provided, (B) receive a Pro-Rated Bonus for
any portion of the Garden Leave Period, or (C) receive any award of RSUs during any Garden Leave Period. For the avoidance of doubt,
the preceding sentence shall not impair the Executive’s right to receive a Pro-Rated Bonus for any period of active employment
pursuant to Section 5(c)(ii) and Section 5(f)(ii). During the Garden Leave Period, the Company may require the Executive
to resign from any position with the Company and/or remove any or all of the Executive’s duties or responsibilities, which shall
not constitute Good Reason or otherwise be a violation of this Agreement. The Executive agrees that he will not commence employment with
any entity during or in connection with the commencement of the Garden Leave Period. During the Garden Leave Period, the Executive shall
take all steps reasonably requested by the Company to effect a successful transition of client and customer relationships to the person
or persons designated by the Company. For the avoidance of doubt, the Garden Leave Period shall not exceed 90 days.
8
(f) Termination
Related to Change of Control. In the event of the termination of the Executive’s employment during the Term of Employment
by the Company other than for Cause (and other than for Disability, as described in Section 5(a)) or by the Executive for Good Reason,
in either case within 24 months following a Change of Control, or within three months prior to a Change of Control if such termination
is initiated by, at the request or suggestion of, or with the agreement of, the counterparty to the Change of Control, the Executive’s
Term of Employment shall terminate without further obligations to the Executive under this Agreement, except as provided in Section 5(g) below.
In addition and if the requirements of Section 5(j) are met:
(i) MFA
shall immediately pay to Executive in a lump sum, but in all events within 60 days following the date of termination, an amount in cash
equal to two times the sum of (A) the Executive’s then current Base Salary and (B) the Executive’s Target Bonus
for the Performance Period in which a Notice of Termination is delivered, provided that, for purposes of this Section 5(f)(i) and
Section 5(f)(ii), Base Salary and Target Bonus shall be determined without regard to any reductions giving rise to Good Reason pursuant
to Section 6(g)(iv) or Section 6(g)(v);
(ii) The
Executive shall receive a Pro-Rated Bonus, which shall be paid within 60 days following the Executive’s termination date;
(iii) (A) All
of the Executive’s outstanding equity-based awards (e.g., restricted stock, phantom shares, RSUs and stock options), whether granted
before or after the Effective Date, shall immediately vest in full and shall be paid at the time set forth in the applicable award agreement;
and (B) any such options shall remain exercisable until the earlier of (I) 90 days following the date of such termination or
(II) the date on which each such option would have expired had the Executive’s employment not terminated; provided that, in
the case of any such award which is subject to vesting based on the achievement of performance goals, such award shall become vested
with respect to a number of shares determined based on actual performance measured as of the date of the Change of Control; provided
further that, to the extent equitable, each applicable performance goal shall be adjusted to account for the reduced performance period
as set forth in the applicable award agreement;
(iv) The
Company shall reimburse the Executive for 100% of the COBRA premiums incurred by the Executive for the Executive and his eligible dependents
under the Company’s health care plan during the 18 month period following the Executive’s termination of employment. Such
reimbursement shall be provided on the payroll date immediately following the date on which the Executive remits the applicable premium
payment and shall commence within 60 days after the termination date; provided that, the first payment shall include any reimbursements
that would have otherwise been payable during the period beginning on the Executive’s termination date and ending on the date of
the first reimbursement payment. Reimbursement payments shall be treated as taxable compensation to the Executive to the extent required
by law; and
9
(v) The
Executive shall receive any unpaid Annual Bonus for the Performance Period immediately preceding the Executive’s date of termination,
which shall be paid at the time set forth in Exhibit A.
For the avoidance of doubt, if the Executive
is eligible to receive payments and benefits pursuant to this Section 5(f), he shall not be eligible to receive any payments and
benefits pursuant to Section 5(a), 5(b) or 5(c).
(g) Other
Payments. Upon the termination of the Executive’s employment during the Term of Employment, in addition to the amounts payable
under any Section above and any accrued but unpaid Base Salary, the Executive shall be entitled to receive the following:
(i) any
vested deferred compensation (including any interest accrued on or appreciation in value of such deferred amounts) in accordance with
the applicable plan documents;
(ii) reimbursement
for reasonable business expenses incurred but not yet reimbursed by the Company; and
(iii) any
other vested benefits to which the Executive or his legal representative may be entitled under all applicable plans and programs of the
Company, as provided in Section 4 above.
(h) Payments
Subject to Section 409A and Other Applicable Law.
(i) This
Agreement and all payments hereunder (including payments pursuant to this Section 5) are intended to comply with or be exempt from
Section 409A of the Code and applicable Treasury regulations thereunder; provided that, MFA shall have no liability for any taxes
or penalties incurred by the Executive pursuant to Section 409A. Notwithstanding anything herein to the contrary, the Executive
shall not be entitled to any payment pursuant to this Section 5 prior to the earliest date permitted under Section 409A of
the Code, and applicable Treasury regulations thereunder. To the extent any payment pursuant to this Section 5 is required to be
delayed six months pursuant to the special rules of Section 409A of the Code related to “specified employees,”
each affected payment shall be delayed until six months after the Executive’s termination of employment, and, unless provided otherwise,
with the first such payment being a lump sum equal to the aggregate payments the Executive would have received during such six-month
period if no payment delay had been imposed. Any payments or distributions delayed in accordance with the prior sentence shall be paid
to the Executive on the first day of the seventh month following the Executive’s termination of employment. If the Executive dies
during the postponement period prior to payment, the amounts delayed shall be paid within 60 days after the date of the Executive’s
death.
10
(ii) Notwithstanding
any other provision contained herein, to the extent any payments or distributions due to the Executive upon termination of his employment
under this Agreement are subject to Section 409A of the Code, a termination of the Executive’s employment shall be interpreted
in a manner that is consistent with the definition of a “separation from service” under Section 409A of the Code and
the applicable Treasury regulations thereunder. Notwithstanding anything elsewhere to the contrary, the Executive shall have
no duties following any termination of his employment with MFA that are inconsistent with his having a “separation from service”
for purposes of Section 409A of the Code and any regulations thereunder.
(iii) With
respect to the lump sum amounts payable in connection with a Change of Control set forth in Section 5(a)(i) and Section 5(f)(i),
such amounts shall be paid in installments as described in Section 5(a)(i) and Section 5(c)(i) as though a Change
of Control had not occurred, if such Change of Control does not constitute a “change in control event” for purposes of Section 409A
of the Code or if otherwise required by Section 409A of the Code. The provisions of this Section 5 shall not amend the payment
timing of any equity award outstanding as of the Effective Date, as determined in accordance with the terms of the applicable award agreement.
(iv) In
the case of any amounts that are payable to the Executive under this Agreement in the form of installment payments, the Executive’s
right to receive such payments shall be treated as a right to receive a series of separate payments under Treas. Reg. §1.409A-2(b)(2)(iii).
(v) Notwithstanding
anything herein to the contrary, in the event that the reimbursements provided pursuant to Section 5(a)(iii), Section 5(c)(iv),
or Section 5(f)(iv) would subject the Executive or the Company to adverse tax consequences under Section 105(h) of
the Code or any tax penalties, then the parties shall enter into an economically consistent arrangement that does not cause either party
to incur such adverse tax consequences or penalties.
(i) No
Mitigation; No Offset. In the event of any termination of the Executive’s employment under this Agreement, he shall be under
no obligation to seek other employment or otherwise in any way to mitigate the amount of any payment provided for in this Section 5,
and there shall be no offset against amounts due him under this Agreement on account of any remuneration attributable to any subsequent
employment that he may obtain.
11
(j) Release.
The Company’s obligation to make any payment or provide any benefit pursuant to this Section 5 (other than pursuant to Sections
5(b) and 5(g) above) shall be contingent upon, and is the consideration for, (i) the Executive executing and delivering
to the Company, within 60 days after termination of his employment, a general release (the “Release”), substantially
in the form annexed hereto as Exhibit E (with any revisions necessary to comply with applicable law as reasonably determined
by counsel to MFA and provided in writing to the Executive within five business days after the date of the termination of his employment),
and (ii) such release becoming irrevocable in accordance with its terms within 60 days after termination of employment. In
the event that any payment or benefit is subject to Section 409A of the Code and the 60-day period referred to in the immediately
preceding sentence spans two calendar years, any such payments or benefits required to be made hereunder during such 60-day period shall
be made in the second calendar year, the first payment of which shall include all payments that would otherwise have been made prior
thereto.
(k) Change
in Status following an Externalization Event. Notwithstanding anything in this Section 5 to the contrary, in the event that
the circumstances described in clauses (i) or (ii) below occur, then for purposes of this Agreement, the Executive’s
termination of employment shall not constitute a termination by the Company without Cause or a termination by the Executive for Good
Reason, and the Executive shall only be entitled to the amounts set forth in Section 5(g). For the avoidance of doubt, in the event
that the circumstances described in clauses (i) or (ii) below occur, the Executive shall not be eligible to receive the payments
and benefits described in Section 5(c) or Section 5(f).
(i) In
connection with the Executive’s termination of employment, MFA is managed by an external manager pursuant to a management and advisory
contract and such external manager has provided the Executive with an offer of employment (A) on economic terms that are at least
substantially equivalent in form and economic substance (and not in the aggregate) to those provided to the Executive immediately prior
to such termination of employment, and (B) on other terms that would not be deemed to trigger “Good Reason” under the
definition provided herein (an offer of employment that meets the requirements of (A) and (B), a “Qualifying Offer”);
or
(ii) A
Change of Control occurs and immediately following such Change of Control, MFA is managed by an external manager pursuant to a management
and advisory contract and such external manager has provided the Executive with a Qualifying Offer.
(l) Parachute
Payments.
(i) Notwithstanding
any other provisions of this Agreement to the contrary, in the event that it shall be determined that any payment or distribution in
the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of the Executive, whether
paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the “Payments”),
would constitute an “excess parachute payment” within the meaning of Section 280G of the Code (after taking into consideration
any mitigating factors such as the value of any non-competition restrictions or similar factors), the Company shall reduce (but not below
zero) the aggregate present value of the Payments under the Agreement to the Reduced Amount (as defined below), if reducing the Payments
under this Agreement will provide the Executive with a greater net after-tax amount than would be the case if no such reduction was made
(for clarity, if not reducing the Payments will provide the Executive with a greater net after-tax amount, then no reduction shall occur).
The Payments shall be reduced as described in the preceding sentence only if (A) the net amount of the Payments, as so reduced (and
after subtracting the net amount of federal, state and local income and payroll taxes on the reduced Payments), is greater than or equal
to (B) the net amount of the Payments without such reduction (but after subtracting the net amount of federal, state and local income
and payroll taxes on the Payments and the amount of Excise Tax (as defined below) to which the Executive would be subject with respect
to the unreduced Payments). Only amounts payable under this Agreement shall be reduced pursuant to this Section 5(l), and any reduction
shall be made in accordance with Section 409A of the Code.
12
(ii) The
“Reduced Amount” shall be an amount expressed in present value that maximizes the aggregate present value of Payments
under this Agreement without causing any Payment under this Agreement to be subject to the Excise Tax, determined in accordance with
Section 280G(d)(4) of the Code. The term “Excise Tax” means the excise tax imposed under Section 4999
of the Code, together with any interest or penalties imposed with respect to such excise tax.
(iii) All
determinations to be made under this Section 5(l) shall be made by an independent registered public accounting firm or consulting
firm selected by the Company immediately prior to a change of control, which shall provide its determinations and any supporting calculations
both to the Company and the Executive within ten days of the change of control. Any such determination by such firm shall be binding
upon the Company and the Executive. All fees and expenses of the accounting or consulting firm in performing the determinations referred
to in this Section 5(l) shall be borne solely by the Company.
(m) Resignation
from Positions. Upon termination of the Executive’s employment with the Company for any reason, the Executive shall,
as may be requested by the Company, resign from any position he then holds as an officer, director or fiduciary of the Company or any
Company-related entity. In furtherance of the foregoing, the Executive shall execute and deliver to the Company any letters, documents
and other instruments necessary or appropriate to effect such resignation.
6. Definitions.
For purposes of this Agreement, the following terms shall be defined as set forth below:
(a) Business.
“Business” shall mean any business that is conducted by the Company during the Executive’s employment, or that
is under consideration by the Board of Directors with respect to which the Executive was materially involved or otherwise received Confidential
Information during the 12 months prior to the Executive’s termination of employment.
13
(b) Cause.
“Cause” shall mean the Executive’s (i) commission of a felony, a crime of moral turpitude or any crime
committed against MFA, other than traffic violations; (ii) engagement in willful misconduct, willful or gross negligence, or fraud,
embezzlement or misappropriation relating to significant amounts, in each case in connection with the performance of his duties under
this Agreement; (iii) failure to adhere to the lawful directions of the Board of Directors or the Current CEO (as applicable) that
are reasonably consistent with the Executive’s duties and position provided for herein; (iv) breach in any material respect
of any of the provisions of Section 7 of this Agreement; (v) material violation of the Company’s Code of Conduct or any
other material written policy of the Company, including without limitation, the Company’s nondiscrimination and harassment policy;
or (vi) breach in any material respect of the terms and provisions of this Agreement resulting in material and demonstrable economic
injury to MFA. Notwithstanding the foregoing, (i) the Executive shall be given written notice of any action or failure to act that
is alleged to constitute Cause (a “Default”), and if curable, an opportunity for 20 business days from the date of
such notice in which to cure such Default, such period to be subject to extension in the discretion of the Board of Directors and (ii) regardless
of whether the Executive is able to cure any Default, the Executive shall not be deemed to have been terminated for Cause without (A) reasonable
prior written notice to the Executive setting forth the reasons for the decision to terminate the Executive for Cause, (B) an opportunity
for the Executive, together with his counsel, to be heard by the Board of Directors, and (C) delivery to the Executive of a Notice
of Termination approved by the Board of Directors, stating its good faith opinion that the Executive has engaged in actions or conduct
described in the preceding sentence, which notice specifies the particulars of such action or conduct in reasonable detail; provided,
however, MFA may suspend the Executive with pay until such time as his right to appear before the Board of Directors has been exercised,
so long as such appearance is within two weeks of the date of suspension. For avoidance of doubt and notwithstanding the Executive’s
cure rights, if any, if MFA reasonably determines that it is necessary to place the Executive on administrative leave, or to relieve
the Executive of some or all of the Executive’s duties so that MFA may investigate any potential wrongdoing or misconduct, or pending
resolution of any act, event or omission giving rise to Cause during any applicable cure period, MFA’s doing so shall not be deemed
to be either a breach by MFA of any provision of this Agreement or a termination by MFA of the Executive’s employment without Cause
nor shall such action constitute a basis for the Executive to terminate the Executive’s employment for Good Reason.
(c) Change
of Control. A “Change of Control” shall mean the occurrence of any one of the following events:
(i) any
“person,” as such term is used in Sections 13(d) and 14(d) of the Act (other than MFA, any of its affiliates or
any trustee, fiduciary or other person or entity holding securities under any employee benefit plan or trust of MFA or any of its affiliates,
and other than the Executive) together with all “affiliates” and “associates” (as such terms are defined in Rule 12b-2
under the Act) of such person, shall become the “beneficial owner” (as such term is defined in Rule 13d-3 under the
Act), directly or indirectly, of securities of MFA representing 30% or more of either (A) the combined voting power of MFA’s
then outstanding securities having the right to vote in an election of the Board of Directors (“voting securities”),
or (B) the then outstanding shares of common stock of MFA (“Shares”) (in either such case other than as a result
of an acquisition of securities directly from MFA); or
14
(ii) persons
who, as of the Effective Date of this Agreement, constitute MFA’s Board of Directors (the “Incumbent Directors”)
cease for any reason, including, without limitation, as a result of a tender offer, proxy contest, merger or similar transaction, to
constitute at least a majority of the Board of Directors, provided that any person becoming a Director of MFA subsequent to the Effective
Date whose election or nomination for election was approved and/or ratified by a vote of at least a majority of the Incumbent Directors
shall, for purposes of this Agreement, be considered an Incumbent Director; or
(iii) consummation
of (A) any consolidation or merger of MFA or any subsidiary where the stockholders of MFA, immediately prior to the consolidation
or merger, would not, immediately after the consolidation or merger, beneficially own (as such term is defined in Rule 13d-3 under
the Act), directly or indirectly, shares representing in the aggregate 50% or more of the voting securities of the corporation issuing
cash or securities in the consolidation or merger (or of its ultimate parent corporation, if any), (B) any sale, lease, exchange
or other transfer (in one transaction or a series of transactions contemplated or arranged by any party as a single plan) of all or substantially
all of the assets of MFA or (C) any plan for the liquidation or dissolution of MFA.
Notwithstanding the foregoing, a “Change
of Control” shall not be deemed to have occurred for purposes of the foregoing clause (i) solely as the result of an acquisition
of securities by MFA which, by reducing the number of Shares or other voting securities outstanding, increases (x) the proportionate
number of Shares beneficially owned by any person to 30% or more of the Shares then outstanding or (y) the proportionate voting
power represented by the voting securities beneficially owned by any person to 30% or more of the combined voting power of all then outstanding
voting securities; provided, however, that, if any person referred to in clause (x) or (y) of this sentence shall thereafter
become the beneficial owner of any additional Shares or other voting securities (other than pursuant to a stock split, stock dividend,
or similar transaction), then a “Change of Control” shall be deemed to have occurred for purposes of this Section 6(c).
(d) Code.
“Code” shall mean the Internal Revenue Code of 1986, as amended.
(e) Competitor.
“Competitor” shall mean any entity or person that is engaged in the Business, including, without limitation, (i) any
mortgage REIT, (ii) any entity or person engaged in any element of acquiring mortgage backed securities (“MBS”),
single family residential mortgage loans (“Whole Loans”), credit risk transfer securities (“CRTs”)
or other products or instruments in which the Company invests, including any private or public investment firm or broker dealer whose
business strategy is based on or who engages in the trading, sales, investment or management of such securities, products or instruments,
(iii) any entity that manages or advises (including any external advisor) either (A) a mortgage REIT or (B) an entity
or person engaged in any element of acquiring MBS, Whole Loans, CRTs or other products or instruments in which the Company invests, including
any private or public investment firm or broker dealer whose business strategy is based on or who engages in the trading, sales, investment
or management of such securities, products or instruments, and (iv) any entity or person engaged in the management or sale of single
family residential real estate that is acquired as a result of foreclosure, short sale, deed-in-lieu or other actions undertaken by such
entity or person in respect of investments made by such entity or person in Whole Loans.
15
(f) Disability.
“Disability” shall mean the Executive’s inability for a period of six consecutive months, to render substantially
the services provided for in this Agreement with or without a reasonable accommodation by reason of mental or physical disability, whether
resulting from illness, accident or otherwise, other than by reason of chronic or persistent abuse of any substance (such as narcotics
or alcohol), provided that a Disability for purposes of Section 5(a) shall qualify as a Disability under Section 409A
of the Code to the extent required by Section 409A of the Code. Notwithstanding the foregoing, no circumstances or condition shall
constitute a Disability to the extent that, if it were, a 20% tax would be imposed under Section 409A of the Code; provided that,
in such a case, the event or condition shall continue to constitute a Disability to the maximum extent possible (e.g., if applicable,
in respect of vesting without an acceleration of distribution) without causing the imposition of such 20% tax. In addition, nothing herein
shall limit or restrict the payment of any amount subject to Section 409A of the Code upon an otherwise permitted payment event
under Section 409A of the Code, including upon a separation from service.
(g) Good
Reason. “Good Reason” shall mean:
(i) a
material diminution in the Executive’s title, duties or responsibilities (other than in connection with the Executive’s disability);
(ii) relocation
of the Executive’s place of employment without his consent outside the New York City metropolitan area;
(iii) the
failure of MFA to pay within 60 business days any material payment or benefits due from MFA;
(iv) the
material failure by MFA to honor any of its material obligations to the Executive; or
(v) solely
for purposes of Section 5(f), a reduction in any of: Base Salary, Target Bonus, TRSU Grant Date Value (as defined in Exhibit B
hereto) or PRSU Grant Date Value (as defined in Exhibit B hereto) from the level in effect immediately prior to such reduction or,
in the case of the RSUs, from the most recent annual grant received by the Executive prior to such reduction.
For Good Reason to exist, the Executive must
provide written notice of an event purportedly constituting Good Reason within 90 days of its occurrence, MFA must have failed to cure
such event within 15 days of such notice and the Executive must provide written notice of his decision to terminate employment, such
notice to be provided within 15 days of the expiration of such cure period. The effective date of such termination shall be
the end of the period of Garden Leave.
16
(h) Notice
of Termination. “Notice of Termination” means the written notice of termination of the Executive’s employment
delivered by, as applicable, the Executive or MFA.
(i) Restricted
Period. “Restricted Period” shall mean the period commencing on the Effective Date and ending on the date that
is 15 months following the Executive’s termination of employment for any reason; provided that, if the Executive’s employment
is terminated (A) prior to the CEO Retirement Date or (B) following the CEO Retirement Date and the Executive is not the Chief
Executive Officer of MFA at the time of such termination, then, the Restricted Period shall end on the date that is 12 months following
the Executive’s termination of employment for any reason; provided further that, the Restricted Period shall be reduced by any
applicable Garden Leave Period that arises in connection with the Executive’s termination of employment or, if applicable, any
period of notice provided pursuant to Section 1(b).
7. Covenants.
(a) Confidentiality.
During the Term of Employment, and at all times thereafter, the Executive shall maintain the confidentiality of all confidential or proprietary
information of the Company, or of any other person or entity with which the Executive has been involved as a direct or indirect result
of his employment by, or performance of consulting or other services (including, without limitation, as a director, officer, advisor,
agent, consultant or other independent contractor) for, the Company (“Confidential Information”), and, except in furtherance
of his employment by the Company or as specifically required by law or by court order or as permitted by Section 7(g) or in
the course of carrying out his duties for the Company, he shall not directly or indirectly disclose any such information to any person
or entity; nor shall he use Confidential Information for any purpose except for the benefit of the Company. For purposes of this Agreement,
“Confidential Information” includes, without limitation: client or customer lists, identities, contacts, business
and financial information; investment strategies; pricing information or policies, fees or commission arrangements of the Company; marketing
plans, projections, presentations or strategies of the Company; financial and budget information of the Company; personnel information,
personnel lists, resumes, personnel data, organizational structure, compensation and performance evaluations; information regarding the
existence or terms of any agreement or relationship between the Company and any other party; and any other information of whatever nature,
which gives to the Company an opportunity to obtain an advantage over its competitors who or which do not have access to such information.
This restriction shall apply regardless of whether such Confidential Information is in written, graphic, recorded, photographic, data
or any machine readable form or is orally conveyed to, or memorized by, the Executive; provided, however, that this Section 7(a) shall
not apply to Confidential Information that is or becomes publicly known through no act or omission on the Executive’s part. Anything
to the contrary notwithstanding, nothing in this Agreement shall prevent the Executive from retaining papers and other materials of a
personal nature, including personal diaries, calendars and Rolodexes, information relating to his compensation or relating to reimbursement
of expenses, and copies of plans, programs and agreements relating to his employment.
17
(b) Non-Competition
and Non-Solicitation. The Executive acknowledges that during the Executive’s employment with the Company prior to and after
the Effective Date, (I) the Executive has had and will continue to have access to trade secrets and other Confidential Information
of the Company, which, if disclosed, would unfairly and inappropriately assist in competition against the Company; (II) in the course
of the Executive’s employment by a Competitor during the Restricted Period, there is significant risk that the Executive would
disclose or improperly use such trade secrets and Confidential Information; (III) the Company has substantial relationships with
its customers and the Executive has had and will continue to have access to these customers; (IV) the Executive has generated and
will continue to generate goodwill for the Company in the course of the Executive’s employment; and (V) the Executive’s
services are unique and irreplaceable. Therefore, in consideration of the Executive’s continued employment with the
Company, of the compensation and benefits provided to the Executive under this Agreement, of MFA’s agreement to make severance
benefits available pursuant to Section 5, and of the Executive’s being granted access to the customers, trade secrets and
other Confidential Information of the Company, the Executive agrees that the following restrictions on the Executive’s activities
during and after the Executive’s employment are necessary, appropriate and reasonable to protect the goodwill, Confidential Information
and other legitimate interests of the Company from unfair and inappropriate competition:
(i) During
the Restricted Period, the Executive will not, without the prior written consent of MFA, within the United States, manage, operate, control
or be connected as a stockholder (other than as a holder of shares publicly traded on a stock exchange or the NASDAQ National Market
System, provided that the Executive shall not own more than five percent of the outstanding shares of any publicly traded company) or
partner with, or serve as an officer, director, employee or consultant of, any Competitor. Notwithstanding the foregoing, nothing herein
shall prevent the Executive during the Restricted Period from providing services to or otherwise being associated with an entity that
is engaged in the Business so long as (A) the Executive’s services are not provided, directly or indirectly, within the division,
subsidiary, affiliate or business unit of the entity that engages in the Business and (B) the Executive has no responsibilities
regarding such Business.
(ii) During
the Restricted Period, the Executive will not, without the prior written consent of MFA, directly or indirectly (individually,
or through or on behalf of another entity as owner, partner, agent, employee, consultant, or in any other capacity), engage in any activity
intentionally to interfere with, disrupt, diminish or damage the business of the Company, or its relationship with any client, supplier
or other business relationship of the Company.
(iii) During
the Executive’s employment with the Company and during the period commencing on the Executive’s date of termination of employment
for any reason and ending on the second anniversary of the Executive’s termination of employment, the Executive will not, without
the prior written consent of MFA, directly or indirectly (individually, or through or on behalf of another entity as owner,
partner, agent, employee, consultant, or in any other capacity), (A) solicit, encourage, or engage in any activity to induce any
employee of MFA or its affiliates to terminate employment with MFA or its affiliates, or to become employed by, or to enter into a business
relationship with, any other person or entity; or (B) hire or retain any person who was an employee of MFA or its affiliates within
the six month period preceding such action; provided that, (x) this Section 7(b)(iii) shall not apply to any administrative
employee of MFA or its affiliates or any person who was an administrative employee of MFA or its affiliates and (y) any hiring or
solicitation pursuant to a general solicitation conducted by an entity that has hired or agreed to hire the Executive and that does not
directly or indirectly target current or former employees of MFA or its affiliates, or by a headhunter employed by such entity, which
in either case does not involve the Executive, shall not be a violation of this Section 7(b)(iii).
18
(c) MFA
Materials. The Executive acknowledges that all originals and copies of materials, records and documents generated by him or coming
into his possession during his employment by MFA are the sole property of MFA (“MFA Materials”). During his employment,
and at all times thereafter, the Executive shall not remove, or cause to be removed, from the premises of MFA, copies of any record,
file, memorandum, document, computer related information or equipment, or any other item relating to the business of MFA, except in furtherance
of his duties under this Agreement. When the Executive terminates his employment with MFA, or upon request of MFA at any time, the Executive
shall promptly deliver to MFA all originals and copies of MFA Materials in his possession or control and shall not retain any originals
or copies in any form. The Executive further agrees to delete or destroy any and all documents, files and/or backup files containing
MFA Materials on any computer or storage device owned by and/or within the care, custody or control of the Executive.
(d) No
Disparagement. Each of the Executive and MFA agrees that, except as required by applicable law or compelled by process of law or
as otherwise permitted pursuant to Section 7(g), during and after the Term of Employment they shall not make any derogatory, disparaging
or critical statement about the other party hereto or, further in the case of statements by the Executive about (i) MFA, its parent,
affiliates, or subsidiaries, if any; (ii) any product or service provided by MFA and its parent, affiliates or subsidiaries, if
any; or (iii) MFA’s and its parent’s, affiliates’ or subsidiaries’, if any, prospects for the future. Nothing
in this Section 7(d) shall (A) prohibit either MFA or the Executive from testifying truthfully in any legal or administrative
proceeding or from truthfully responding to any untrue statement by the other party or (B) prohibit the Executive from making truthful
statements in the course of carrying out his duties for MFA.
(e) Cooperation
with Respect to Litigation. During the Term of Employment and at all times thereafter, the Executive agrees to give prompt written
notice to MFA of any claim against the Company after becoming aware of such claim and (to the extent reasonably requested by MFA) to
reasonably cooperate, in good faith and to the best of his ability, with MFA in connection with any and all pending, potential or future
claims, investigations or actions which directly or indirectly relate to any action, event or activity about which the Executive may
have knowledge in connection with or as a result of his employment by the Company. Such cooperation will include all assistance that
MFA, its counsel or representatives may reasonably request, including reviewing documents, meeting with counsel, providing factual information
and material, and appearing or testifying as a witness; provided, however, that MFA will promptly reimburse the Executive for all reasonable
expenses, including travel, lodging and meals, incurred by him in fulfilling his obligations under this Section 7(e) and, except
as may be required by law or by court order, should the Executive then be employed by an entity other than MFA, such cooperation will
not materially interfere with the Executive’s then current employment.
19
(f) Remedies.
(i) The
Executive agrees that these restraints are necessary for the reasonable and proper protection of the Company and its trade secrets and
Confidential Information and that each and every one of the restraints is reasonable in respect to subject matter, length of time and
geographic area, and that these restraints, individually or in the aggregate, will not prevent the Executive from obtaining other suitable
employment during the period in which the Executive is bound by the restraints. The Executive agrees that, before providing
services, whether as an employee or consultant, to any entity during the Restricted Period, the Executive will provide a copy of this
Agreement to such entity and will certify in writing to MFA that the Executive has done so. Notwithstanding the foregoing terms, nothing
in this Section 7 shall otherwise restrict or limit the Executive from providing services following the termination of the Executive’s
employment that are not expressly prohibited by the restrictions herein.
(ii) The
Executive acknowledges that each of these covenants has a unique, very substantial and immeasurable value to the Company, that the Executive
has sufficient assets and skills to provide a livelihood while such covenants remain in force and that, as a result of the foregoing,
in the event that the Executive breaches such covenants, monetary damages would be an insufficient remedy for the Company and equitable
enforcement of the covenant would be proper. The Executive therefore agrees that the Company, in addition to any other remedies
available to it, will be entitled to preliminary and permanent injunctive relief against any breach by the Executive of any of those
covenants, without the necessity of showing actual monetary damages or the posting of a bond or other security. The Executive
also agrees that, in addition to any other remedies available to the Company and notwithstanding any provision of this Agreement to the
contrary, in the event Executive breaches in any material respect any of his obligations under this Section 7, the Company may immediately
cease all payments under Sections 5(a), 5(b), 5(c) or 5(f) as applicable, all equity-based awards granted under this Agreement
may be immediately forfeited, and the Company may require that the Executive repay any after-tax amounts previously paid to the Executive
under Sections 5(a), 5(b) or 5(c), as applicable, and any stock delivered or other amounts paid (each on an after-tax basis) with
respect to any equity-based awards granted under this Agreement or the Former Employment Agreement.
20
(iii) The
Executive and MFA further agree that each restriction set forth in this Section 7 and each distinct portion and application of each
such restriction is intended to be separate and independent. If any such restriction, or any distinct and grammatically severable portion
thereof, is determined to be invalid or unenforceable, such restriction or portion may be severed only to the extent permitted by applicable
law, and the remaining restrictions and portions shall remain in full force and effect. Nothing in this Agreement shall be construed
to authorize a court to add to, rearrange, revise or otherwise rewrite any restriction, except to the extent permitted by applicable
law. The Executive further covenants that the Executive will not challenge the reasonableness or enforceability of any of the covenants
set forth in this Section 7, it being understood that the Executive shall not be considered to have challenged the enforceability
of this Section 7 by arguing that his conduct did not, in fact, violate the terms of this Section 7. The Executive further
covenants that he will reimburse MFA and its affiliates for all costs (including reasonable attorneys’ fees) incurred in connection
with any action to enforce any of the provisions of this Section 7 if either MFA and/or its affiliates prevails on any material
issue involved in such dispute or if the Executive challenges the reasonability or enforceability of any of the provisions of this Section 7.
It is also agreed that each of MFA’s affiliates will have the right to enforce all of the Executive’s obligations to that
affiliate under this Agreement, including without limitation pursuant to this Section 7.
(g) Permitted
Conduct.
(i) Nothing
in this Agreement, including the obligations set forth in this Section 7, restricts or prohibits the Executive from initiating communications
directly with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible
violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority
or a government agency or entity, including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor
Relations Board, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General (collectively,
the “Regulators”), or from making other disclosures that are protected under the whistleblower provisions of state
or federal law or regulation. The Executive does not need the prior authorization of the Company to engage in such communications with
the Regulators, respond to such inquiries from the Regulators, provide confidential information or documents to the Regulators, or make
any such reports or disclosures to the Regulators. The Executive is not required to notify the Company that he has engaged in such communications
with the Regulators.
21
(ii) The
Company hereby notifies the Executive that federal law provides criminal and civil immunity to federal and state claims for trade secret
misappropriation to individuals who disclose a trade secret to their attorney, a court, or a government official in certain, confidential
circumstances that are set forth at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related to the reporting or investigation
of a suspected violation of the law, or in connection with a lawsuit for retaliation for reporting a suspected violation of the law.
Nothing in this Agreement is intended to limit any rights under such federal law.
8. Indemnification.
MFA shall indemnify the Executive to the fullest extent permitted by Maryland law as amended from time to time in connection with the
Executive’s duties with MFA, against all costs, expenses, liabilities and losses (including, without limitation, attorneys’
fees, judgments, fines, penalties, ERISA excise taxes and amounts paid in settlement) actually and reasonably incurred by the Executive
in connection with an action, suit or proceeding. While the Executive is an officer of MFA, and for six years thereafter, MFA (or any
successor thereto) shall provide comprehensive coverage under its officers and directors insurance policy (or policies) on substantially
the same terms and levels that it provides to its senior executive officers, at MFA’s sole cost.
9. Clawback
Policy. The Executive agrees that all bonuses, equity compensation and other incentive compensation provided by the Company shall
be subject to any applicable clawback policy implemented by the Board of Directors from time to time.
10. Assignability;
Binding Nature. This Agreement shall inure to the benefit of MFA and the Executive and their respective successors, heirs (in the
case of the Executive) and assigns. No rights or obligations of MFA under this Agreement may be assigned or transferred by MFA except
that any such rights or obligations may be assigned or transferred pursuant to a merger or consolidation in which MFA is not the continuing
entity, or the sale or liquidation of all or substantially all of the assets of MFA, provided that the assignee or transferee is the
successor to all or substantially all of the assets of MFA and such assignee or transferee assumes the liabilities, obligations and duties
of MFA, as contained in this Agreement, either contractually or as a matter of law. This Agreement shall not be assignable by the Executive;
provided however that, in the event of the Executive’s death or a judicial determination of his incapacity, references to the Executive
in this Agreement shall be deemed, as appropriate, to be references to his heirs, executor(s) or other legal representative(s).
11. Representation.
MFA and the Executive each represent and warrant that it or he is fully authorized and empowered to enter into this Agreement and that
its or his entering into this Agreement and the performance of its or his obligations under this Agreement will not violate any agreement
to which it or he is a party.
12. Entire
Agreement. This Agreement contains the entire agreement between MFA and the Executive concerning the subject matter hereof and upon
the Effective Date supersedes all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral,
between them with respect thereto, including without limitation, the Former Employment Agreement, except as otherwise provided in Section 3(b)(ii).
13. Amendment
or Waiver. This Agreement can only be changed, modified or amended in a writing that is signed by both the Executive and MFA and
that specifically identifies the provision(s) of this Agreement that are being changed, modified or amended. No waiver by either
MFA or the Executive at any time of any breach by the other party of any condition or provision of this Agreement shall be deemed a waiver
of a similar or dissimilar condition or provision at the same or at any prior or subsequent time. Any waiver must be in writing and signed
by the Executive or the Board of Directors, as the case may be.
22
14. Severability.
In the event that any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, in whole
or in part, the remaining provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect to the fullest
extent permitted by law.
15. Reasonableness.
Except as otherwise provided in Section 7, to the extent that any provision or portion of this Agreement is determined to be unenforceable
by a court of law or equity, that provision or portion of this Agreement shall nevertheless be enforceable to the extent that such court
determines is reasonable.
16. Survivorship.
The respective rights and obligations of the parties hereunder shall survive any termination of this Agreement to the extent necessary
to the intended preservation of such rights and obligations. For the avoidance of doubt, the covenants in Section 7 of this Agreement
shall survive any termination or expiration of this Agreement and termination of the Executive’s employment for any reason.
17. Governing
Law. This Agreement, the rights and obligations of the parties hereto, and any claims or disputes relating thereto, shall be governed
by and construed in accordance with the laws of the State of Maryland (without regard to its choice of law provisions). Each
of the parties agrees that any dispute between the parties shall be resolved only in the courts of the State of Maryland or the United
States District Court for the District of Maryland and the appellate courts having jurisdiction of appeals in such courts. In
that context, and without limiting the generality of the foregoing, each of the parties hereto irrevocably and unconditionally (a) submits
for himself or itself in any proceeding relating to this Agreement or the Executive’s employment by MFA or any affiliate, or for
the recognition and enforcement of any judgment in respect thereof (a “Proceeding”), to the exclusive jurisdiction
of the courts of the State of Maryland, the court of the United States of America for the District of Maryland, and appellate courts
having jurisdiction of appeals from any of the foregoing, and agrees that all claims in respect of any such Proceeding shall be heard
and determined in such Maryland State court or, to the extent permitted by law, in such federal court; (b) consents that any such
Proceeding may and shall be brought in such courts and waives any objection that he or it may now or thereafter have to the venue or
jurisdiction of any such Proceeding in any such court or that such Proceeding was brought in an inconvenient court and agrees not to
plead or claim the same; (c) waives all right to trial by jury in any Proceeding (whether based on contract, tort or otherwise)
arising out of or relating to this Agreement or the Executive’s employment by MFA or any affiliate, or his or its performance under
or the enforcement of this Agreement; (d) agrees that service of process in any such Proceeding may be effected by mailing a copy
of such process by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such party at his or
its address as provided in Section 19; and (e) agrees that nothing in this Agreement shall affect the right to effect service
of process in any other manner permitted by the laws of the State of Maryland.
18. Legal
Fees.
23
(a) MFA
shall pay directly all reasonable legal fees incurred by the Executive in connection with the negotiation, preparation and execution
of this Agreement up to $10,000.
(b) Subject
to Section 7(f), MFA shall reimburse the Executive (and his beneficiaries) any reasonable costs and expenses (including, without
limitation, reasonable attorneys’ fees and other reasonable costs of counsel) incurred by the Executive (or any of his beneficiaries)
in resolving any controversy, dispute or claim arising out of or relating to this Agreement (including, for the avoidance of doubt, with
respect to any equity grant described in this Agreement), if the Executive (or his beneficiaries) is the prevailing party with respect
to at least one material issue asserting a material breach of such Agreement by the Company.
19. Notices.
Any notice given to either party shall be in writing and shall be deemed to have been given when delivered (a) personally, (b) via
electronic mail with proof of delivery, (c) by an overnight courier with proof of delivery, or (d) via certified or registered
mail, postage prepaid, return receipt requested, in each case, duly addressed to the party concerned, if to MFA, at its principal executive
office (or, in the case of electronic mail, addressed to the General Counsel), and if to the Executive, at the address of the Executive
shown on MFA’s records (or, in the case of electronic mail, addressed to the Executive’s employment email address or personal
email address on file with MFA) or at such other address as such party may give notice of.
20. Headings.
The headings of the Sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning
or construction of any provision of this Agreement.
21. Counterparts.
This Agreement may be executed in two or more counterparts. Signatures delivered by facsimile (including by “pdf”)
shall be deemed effective for all purposes.
[remainder of the page left intentionally
blank]
24
IN WITNESS WHEREOF, the undersigned have executed
this Agreement as of the date first written above.
MFA FINANCIAL, INC.
By:
/s/ Craig L. Knutson
Name: Craig L. Knutson
Title: Chief Executive Officer
EXECUTIVE:
By:
/s/ Bryan Wulfsohn
Name:
Bryan Wulfsohn
25
Exhibit A
Annual Performance Bonus
The following summarizes the material terms of
the Annual Bonus for the Performance Period beginning December 1, 2026 and each subsequent Performance Period in accordance with
Section 3(b) of the Agreement to which this Exhibit A is attached. Unless otherwise specified in this Exhibit A,
all defined terms have the meanings set forth in the Agreement.
1. Performance
Period. The Annual Bonus shall be payable for the Performance Period beginning December 1, 2026 and each subsequent Performance
Period, it being understood that the Executive’s annual bonus for the 12-month period beginning on December 1, 2025 shall
be determined and paid in accordance with the terms of the Former Employment Agreement, as further described in Section 3(b)(ii) of
the Agreement. The Executive shall be eligible to receive the Annual Bonus only if the Executive remains employed by the Company through
the date on which the Annual Bonus is paid; provided that, the Executive shall receive any unpaid Annual Bonus for the Performance Period
immediately preceding the Executive’s date of termination of employment (which, for the avoidance of doubt and consistent with
Section 5(e) of the Agreement shall not include any Performance Period which ends during the Garden Leave Period), if the Executive’s
employment is terminated by the Company without Cause or by the Executive for Good Reason, or if the Executive’s employment is
terminated by death or Disability, subject to compliance with Section 5(j) of the Agreement (except in the event of death).
Any Annual Bonus shall be subject to achievement of the performance goals described herein. The Executive shall not receive any unpaid
Annual Bonus if the Executive’s employment is terminated by the Company for Cause or by the Executive (other than for Good Reason
as described above).
2. Target
Bonus. For each Performance Period, the Executive’s target annual bonus (the “Target Bonus”) shall be $1,700,000.
The Compensation Committee may increase or decrease the Executive’s Target Bonus for a Performance Period; provided that, the Executive’s
Target Bonus may only be decreased if such decrease is part of an overall Company reduction of executive target bonuses and the applicable
decrease (on a percentage basis) is substantially equivalent to that applicable to other senior executives of MFA. For the avoidance
of doubt, if the Executive’s Target Bonus is increased for any Performance Period, such increased amount shall constitute the “Target
Bonus” for all purposes of this Agreement and any decrease of such Target Bonus shall be subject to the proviso in the preceding
sentence.
3. Calculation
of Annual Bonus. The Executive is eligible to receive an Annual Bonus from zero to two times the Target Bonus for each Performance
Period, and the actual amount of the Annual Bonus payable to the Executive, if any, for each Performance Period, shall be determined
by the Compensation Committee in accordance with the following: (a) 75% of the Target Bonus shall be based on achievement of objective
performance goals established by the Compensation Committee, and (b) 25% of the Target Bonus shall be based on such factors as determined
by the Compensation Committee, including individual performance.
4. Payment
of Annual Bonus. The Annual Bonus shall be paid in cash between January 1 and March 15 following the end of the Performance
Period. All determinations with respect to the Annual Bonus, including the amount, if any, which is payable to the Executive for each
Performance Period, shall be made by the Compensation Committee, in good faith. Any such determinations shall be final and binding on
the Executive and MFA.
26
Exhibit B
Summary of the Company’s Long Term Incentive
Program
The following summarizes certain material components
of the Company’s Long Term Incentive Program as applicable to grants under Section 3(c) of the Agreement to which this
Exhibit B is attached. Notwithstanding any provision of the Agreement or this Exhibit B, all grants under Section 3(c) of
the Agreement shall be subject to, and consistent with, the terms and conditions of the Equity Compensation Plan and the Award Agreements.
Unless otherwise specified in this Exhibit B, all defined terms have the meanings set forth in the Agreement.
1. Annual
Grants.
To the extent that the Executive is still employed
by MFA on each applicable grant date and has not delivered or received a Notice of Termination, within the first five trading days of
each calendar year during the Term of Employment, the Executive shall receive grants of RSUs subject to time vesting (“TRSUs”)
and RSUs which vest based on the achievement of performance goals (“PRSUs”). The TRSU and PRSU grants shall be subject
to the terms of the applicable Award Agreements and the Equity Compensation Plan.
2. TRSUs
The annual grant of TRSUs will provide for a
grant of TRSUs with respect to a number shares of MFA common stock equal to a specified dollar value (the “TRSU Grant Date Value”)
divided by the closing price of MFA common stock on the date of grant, rounded to the nearest whole share. The TRSU Grant Date Value
shall be equal to $1,160,000; provided that, the Committee may increase or decrease such amount upon reasonable notice and consultation
with the Executive.
The TRSUs will become fully vested on the third
December 31 following the date of grant, provided that the Executive remains employed for the entire vesting period and subject
to vesting as set forth in the applicable Award Agreement, and as described in Sections 5(a), 5(b), 5(c) and 5(f) of the Agreement.
Any unvested TRSUs shall be forfeited as of the date of Executive’s termination of employment, except as provided in the applicable
Award Agreement, as described in Sections 5(a), 5(b), 5(c) and 5(f) of the Agreement.
Upon the settlement date set forth in the applicable
Award Agreement, the Executive will receive one share of common stock of MFA for each vested TRSU.
In the event that dividends are declared with
respect to the common stock of MFA during the period in which the TRSUs are outstanding, the Executive shall be credited with an amount,
per TRSU, equal to the amount of dividends declared and paid in respect of one share of common stock of MFA. Such credited amount
will be credited and paid in accordance with, and subject to the terms of, Exhibit C.
3. PRSUs
As further described below, 50% of each annual
grant of PRSUs (the “Absolute TSR PRSUs”) will vest based on MFA’s average total shareholder return (“Average
TSR”) for the three year performance period beginning on January 1 of the year of grant (the “TSR Performance
Period”), and 50% of each annual grant of PRSUs (the “Relative TSR PRSUs”) will vest based on MFA’s
TSR compared to the TSR of designated peer group companies, as set forth in the applicable Award Agreement, during the TSR Performance
Period.
27
Each annual grant of PRSUs will provide for a
target grant of Absolute TSR PRSUs (the “Absolute TSR Target Award”) and a target grant of Relative TSR PRSUs (the
“Relative TSR Target Award”).
The Absolute TSR Target Award shall be a number
of PRSUs equal to (a) divided by (b), where (a) is equal to 50% of the PRSU Grant Date Value (as defined below) and (b) is
equal to the grant date fair value per unit of one Absolute TSR PRSU. The Relative TSR Target Award shall be a number of PRSUs equal
to (a) divided by (b), where (a) is equal to 50% of the PRSU Grant Date Value and (b) is equal to the grant date fair
value per unit of one Relative TSR PRSU. The “PRSU Grant Date Value” shall be equal to $1,740,000, provided that, the Committee
may increase or decrease such amount, upon reasonable notice and consultation with the Executive.
Each TSR Performance Period shall be the three-year
period beginning on January 1st of the calendar year in which the applicable grant of PRSUs is made.
The PRSUs will vest on the last day of the applicable
TSR Performance Period, to the extent that the total shareholder return performance goals described below are achieved, provided that
the Executive remains employed for the entire vesting period and subject to vesting as set forth in the applicable Award Agreement, as
described in Sections 5(a), 5(b), 5(c) and 5(f) of the Agreement. Any unvested PRSUs shall be forfeited as of the date of Executive’s
termination of employment, except as provided in the applicable Award Agreement, as described in Sections 5(a), 5(b), 5(c) and 5(f) of
the Agreement.
Upon the settlement date set forth in the applicable
Award Agreement, the Executive will receive one share of common stock of MFA for each vested PRSU. Notwithstanding anything to the contrary
in this Exhibit B, the fair market value of the shares of MFA common stock delivered, measured as of the last day of the TSR Performance
Period (or, if earlier, the date on which the PRSUs are settled pursuant to terms of the applicable Award Agreement), shall not exceed
400% of the fair market value of the target amount of PRSUs measured on the grant date (the “Maximum Cap”), and any
and all amounts otherwise payable pursuant to the applicable Award Agreement in excess of the Maximum Cap shall be forfeited, provided
that, payment with respect to the dividend equivalent rights described below for dividends declared and paid following the end of the
Performance Period shall not count against the Maximum Cap.
For purposes of the PRSUs, TSR of MFA and each
applicable peer group company for the vesting period shall be calculated as follows:
· “TSR”
is equal to (x) the Average Final Price minus the Average Initial Price, plus Dividends
Paid on common stock in respect of the TSR Performance Period, divided by (y) the Average
Initial Price.
28
· The
“Average Initial Price” is equal to the average of the daily closing price
of common stock during the last 20 trading days immediately prior to the first day of the
TSR Performance Period.
· The
“Average Final Price” is equal to the average of the daily closing price
of common stock during the last 20 trading days in the TSR Performance Period.
· The
“Dividends Paid” shall equal the cumulative dividends (including any stock
dividends) paid per share of common stock in respect of the TSR Performance Period. For this
purpose, dividends declared, but not yet paid, on a share within the 45 day period preceding
the applicable vesting date will be counted as Dividends Paid. Notwithstanding the foregoing,
if any dividends were included in Dividends Paid for purposes of calculating TSR for the
year prior to the year in which the TSR Performance Period commences, then such dividends
will not be included in Dividends Paid for purposes of calculating TSR for any subsequent
performance period.
Absolute TSR PRSUs
For purposes of the TSR PRSUs, the “Average
TSR” for the Performance Period is the TSR, divided by 3, and the “Target TSR” is an 8% per annum simple
cumulative return over the TSR Performance Period. MFA’s Average TSR will be compared to the Target TSR to determine whether and
to what extent the Absolute TSR PRSUs will vest.
The number of Absolute TSR PRSUs that will vest
at the end of the Performance Period shall be determined by comparing the MFA’s Average TSR to the Target TSR (8% per year), up
to a maximum vesting of 200% of the Absolute TSR Target Award (subject to the Maximum Cap described above). Any Absolute TSR PRSUs that
do not vest at the end of the TSR Performance Period shall be forfeited.
Example Calculations
Set forth below are examples addressing
vesting of Absolute TSR PRSUs. The examples below are intended to be used purely for illustrative purposes and assume that the Absolute
TSR Target Award for the applicable grant of Absolute TSR PRSUs is equal to 50,000, and assume that the Maximum Cap does not apply.
Example 1:
If MFA’s Average TSR over the
TSR Performance Period was 2%, then the portion of the Absolute TSR PRSUs that would be eligible to vest would be equal to: (2/8) of
the Absolute TSR Target Award, or 12,500 PRSUs.
Example 2:
If MFA’s Average TSR over the
TSR Performance Period was 12%, then the portion of the Absolute TSR PRSUs that would be eligible to vest would be equal to: (12/8) of
the Absolute TSR Target Award, or 75,000 PRSUs.
29
Example 3:
If MFA’s Average TSR over the
TSR Performance Period was 16%, then the portion of the Absolute TSR PRSUs that would be eligible to vest would be equal to (16/8) of
the Absolute TSR Target Award, or 100,000 PRSUs (maximum vesting).
Relative TSR PRSUs
At the end of each TSR Performance Period, MFA’s
TSR and the TSR of each of the designated peer group companies will be ranked from highest to lowest, and the “Relative TSR
Vesting Percentage” shall be determined based on MFA’s TSR as compared to the TSR of the designated peer group companies
for the TSR Performance Period as follows:
MFA’s
TSR Rank
Relative
TSR Vesting Percentage
80th
percentile or above
200%
50th
percentile
100%
25th
percentile or below
0%
If MFA’s TSR Rank is between the 25th percentile
and the 50th percentile, or between the 50th percentile and the 80th percentile, the Relative TSR Vesting Percentage will be interpolated.
Notwithstanding the provisions set forth above,
in the event that the MFA’s TSR is a negative number, the Relative TSR Vesting Percentage shall not exceed 100%.
The number of Relative TSR PRSUs that will vest
for the TSR Performance Period shall be determined by multiplying the Relative TSR Target Award by the Relative TSR Vesting Percentage.
For the avoidance of doubt, in no event shall
any Relative TSR PRSUs vest if MFA’s TSR Rank is at or below the 25th percentile.
The Executive shall not be eligible to receive
more than 200% of the Relative TSR Target Award based on MFA’s TSR Rank.
Example Calculations
Set forth below are examples addressing
vesting of Relative TSR PRSUs. The examples below are intended to be used purely for illustrative purposes and assume that the Relative
TSR Target Award for the applicable grant of Relative TSR PRSUs is equal to 50,000, MFA’s TSR is a positive number, and the Maximum
Cap does not apply.
30
Example 1:
If MFA’s TSR Rank at the end
of the TSR Performance Period was 15 out of 18, MFA would be in the 17th percentile. Because MFA’s TSR Rank would be below the
25th percentile, the Relative TSR Vesting Percentage would be equal to 0, so that none of the Relative TSR Target Award would become
vested. 100% of the Relative TSR Target Award for that TSR Performance Period would be forfeited.
Example 2:
If MFA’s TSR Rank at the end
of the TSR Performance Period was nine out of 18, MFA would be in the 50th percentile. The Relative TSR Vesting Percentage would be equal
to 100, so that 100% of the Relative TSR Target Award (50,000 PRSUs) would become vested.
Example 3:
If MFA’s TSR Rank at the end
of the TSR Performance Period was two out of 18, MFA would be in the 89th percentile. The Relative TSR Vesting Percentage would be equal
to 200, so that 200% of the Relative TSR Target Award (100,000 PRSUs) would become vested.
Dividend Equivalent Rights on PRSUs
In the event that dividends are declared with
respect to the common stock of MFA during the period beginning on the grant date of the PRSUs and ending on the date on which the PRSUs
are settled, then an amount equal to the dividends that the Executive would have received if the Executive had owned a number of shares
of MFA common stock equal to the number of outstanding PRSUs as of the date the dividend is declared shall be accrued in a bookkeeping
account. Accrued dividend amounts shall be credited and paid in accordance with, and subject to the terms of, Exhibit D. For the
avoidance of doubt, accrued dividend amounts shall only be payable to the extent that the underlying PRSUs vest and are distributed.
4. Withholding
Obligations
The parties hereto acknowledge and understand
that MFA or the Executive may require or elect (as the case may be) that the Executive satisfy any federal, state or local tax withholding
obligation with respect to TRSUs and PRSUs by withholding shares from the shares otherwise issuable to the Executive, provided that such
shares shall not exceed the minimum applicable tax withholding required by law, or such higher amount that does not result in adverse
accounting treatment for the Company, as approved in advance by the Compensation Committee.
5. Committee
Determinations
All determinations with respect to the TRSUs
and PRSUs shall be made by the Compensation Committee, in good faith and in compliance with this Exhibit B. Any such determinations
shall be final and binding on the Executive and MFA.
31
Exhibit C
Form TRSU Award
32
MFA FINANCIAL, INC.
EQUITY
COMPENSATION PLAN
PHANTOM SHARE AWARD AGREEMENT
(TIME
BASED VESTING)
AGREEMENT, dated
as of the ____ of January, 20__ (the “Grant Date”), by and between MFA Financial, Inc., a Maryland corporation (the “Company”),
and Bryan Wulfsohn (the “Grantee”).
WHEREAS, the Company maintains the MFA Financial, Inc.
Equity Compensation Plan, as it may be amended from time to time (the “Plan”) (capitalized terms used but not defined herein
shall have the respective meanings ascribed thereto by the Plan);
WHEREAS, the Grantee, as an employee of the Company
or a subsidiary of the Company, is an Eligible Person;
WHEREAS, the Company and the Grantee entered into
that certain Amended and Restated Employment Agreement, entered into as of October 2, 2026 (as may be amended and/or restated from
time to time, the “Employment Agreement”); and
WHEREAS, the Committee has determined that it is
in the best interests of the Company and its stockholders to grant Phantom Shares to the Grantee subject to the terms and conditions set
forth below.
NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:
1. Grant
of Phantom Shares.
The Company hereby grants the Grantee [NUMBER] Phantom Shares. The
Phantom Shares are subject to the terms and conditions of this Agreement and are also subject to the provisions of the Plan. The Plan
is hereby incorporated by reference as though set forth herein in its entirety.
2. Vesting.
The Phantom Shares shall be subject to the terms and conditions set
forth in this Section 2.
(a) Except
as otherwise provided herein, 100% of the Phantom Shares shall vest on December 31, 20__, (the “Vesting Date”) provided
that the Grantee has not had a Termination of Service prior to such date.
(b) The
following terms shall apply in the event of Termination of Service:
(i) In
the event that, prior to the Vesting Date, the Grantee experiences a Termination of Service by the Company without Cause (as defined in
the Employment Agreement) or a Termination of Service by the Grantee for Good Reason (as defined in the Employment Agreement), then, subject
to Section 5(j) of the Employment Agreement relating to execution of a release, the Phantom Shares shall become fully vested
as of the date of the Grantee’s Termination of Service. For the avoidance of doubt, the vesting described in this Section 2(b)(i) shall
apply regardless of whether the Grantee’s Termination of Service occurs at any time prior to or following a Change of Control.
33
(ii) In
the event the Grantee experiences a Termination of Service on account of death or Disability (as defined in the Employment Agreement)
prior to the Vesting Date, then the Phantom Shares shall become fully vested as of the date of the Grantee’s Termination of Service;
provided that in the event of the Grantee’s Disability, such vesting shall be subject to Section 5(j) of the Employment
Agreement relating to execution of a release.
(iii) Notwithstanding
the foregoing provisions of this Section 2(b), if the circumstances described in clauses (A) or (B) below occur, then for
purposes of this Agreement, the Executive’s termination of employment shall not constitute a termination by the Company without
Cause or a termination by the Executive for Good Reason, and the Executive shall not be entitled to any vesting pursuant to this Section 2(b):
(A) In
connection with the Grantee’s Termination of Service with the Company, the Company is managed by an external manager pursuant to
a management and advisory contract and such external manager has provided the Grantee with an offer of employment (I) on economic
terms that are at least substantially equivalent in form and economic substance (and not in the aggregate) to those provided to the Grantee
immediately prior to such Termination of Service and (II) on terms that would not be deemed to trigger Good Reason (an offer of employment
that meets the requirements of (I) and (II), a “Qualifying Offer”).
(B) A
Change of Control occurs and immediately following such Change of Control, the Company is managed by an external manager pursuant to a
management and advisory contract and such external manager has provided the Grantee with a Qualifying Offer.
If the circumstances described in the preceding clauses (A) or
(B) occur and the Grantee accepts the external manager’s Qualifying Offer, then the Phantom Shares granted pursuant to this
Agreement shall not be forfeited upon the Grantee’s Termination of Service with the Company and shall remain outstanding and continue
to vest as long as the Grantee remains employed by the external manager. For the avoidance of doubt, upon the Grantee’s termination
of employment with the external manager, the Phantom Shares granted pursuant to this Agreement shall be treated in accordance with the
terms of this Agreement, applied as though the Grantee’s employment with the Company had terminated.
(c) Except
as otherwise provided in this Section 2 or as otherwise may be agreed to in writing between the Grantee and the Company, if the Grantee
experiences a Termination of Service for any reason, any unvested Phantom Shares shall, with no further action, be forfeited and cease
to be outstanding as of the Grantee’s Termination of Service.
34
3. Settlement.
Each vested and outstanding Phantom Share shall be settled in one share
of Common Stock of the Company (a “Share”) within 60 days following the date on which such Phantom Share vests as set forth
in Section 2 above (the “Settlement Date”). To the extent payment described in this Section 3 is required to be
delayed six months pursuant to the rules of Section 409A of the Code related to “specified employees,” such payment
shall not be made before the date which is six months after the date of Grantee’s Termination of Service. Any delayed payment shall
be made to the Grantee on the first day of the seventh month following the Grantee’s Termination of Service (or within 30 days following
the Grantee’s death, if earlier).
4. Dividend Equivalents.
In connection with the grant of the Phantom Shares made hereby, the
Grantee has the right to receive, with respect to each outstanding Phantom Share (whether or not vested) that has not been forfeited in
accordance with Section 2, cash in an amount equal to the cash dividend distributions declared on a Share to the Company’s
stockholders (each, a “Dividend Payment”) during the period from the Grant Date through the Settlement Date. The Company shall
make such cash payment to the Grantee within 15 days of the date on which the Dividend Payment is paid to the Company’s stockholders,
and in any event no later than December 31 of the year in which the Dividend Payment is paid.
5. Miscellaneous.
(a) The value of a Phantom Share may decrease depending upon
the Fair Market Value of a Share from time to time. Neither the Company nor the Committee, nor any other party associated with the Plan,
shall be held liable for any decrease in the value of the Phantom Shares. If the value of such Phantom Shares decrease, there will be
a decrease in the underlying value of what is distributed to the Grantee under the Plan and this Agreement.
(b) With respect to this Agreement, (i) the Phantom Shares
are bookkeeping entries and the Grantee shall not have any rights of a shareholder with respect to Common Stock unless and until the Phantom
Shares vest and are settled by the issuance of such Shares of Common Stock, (ii) the obligations of the Company under the Plan are
unsecured and constitute a commitment by the Company to make benefit payments in the future, (iii) to the extent that any person
acquires a right to receive payments from the Company under the Plan, such right shall be no greater than the right of any general unsecured
creditor of the Company, (iv) all payments under the Plan (including distributions of Shares) shall be paid from the general funds
of the Company and (v) no special or separate fund shall be established or other segregation of assets made to assure such payments
(except that the Company may in its discretion establish a bookkeeping reserve to meet its obligations under the Plan). The award of Phantom
Shares is intended to be an arrangement that is unfunded for tax purposes and for purposes of Title I of the Employee Retirement Income
Security Act of 1974, as amended.
(c) THIS
AGREEMENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF MARYLAND, WITHOUT REFERENCE TO PRINCIPLES OF CONFLICT OF LAWS. The captions of
this Agreement are not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified
except by a written agreement executed by the parties hereto or their respective successors and legal representatives. The invalidity
or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this
Agreement.
35
(d) The Committee may construe and interpret this Agreement and
establish, amend and revoke such rules, regulations and procedures for the administration of this Agreement as it deems appropriate. In
this connection, the Committee may correct any defect or supply any omission, or reconcile any inconsistency in this Agreement or in any
related agreements, in the manner and to the extent it shall deem necessary or expedient to make the Plan fully effective. All decisions
and determinations by the Committee in the exercise of this power shall be final and binding upon the Company and the Grantee.
(e) All notices hereunder shall be in writing and, if to the
Company, shall be delivered to the Board or mailed to its principal office, addressed to the attention of the Committee and, if to the
Grantee, shall be delivered personally or mailed to the Grantee at the address appearing in the records of the Company. Such addresses
may be changed at any time by written notice to the other party given in accordance with this Section 5(e).
(f) The failure of the Grantee or the Company to insist upon
strict compliance with any provision of this Agreement or the Plan, or to assert any right the Grantee or the Company, respectively, may
have under this Agreement or the Plan, shall not be deemed to be a waiver of such provision or right or any other provision or right of
this Agreement or the Plan.
(g) Nothing
in this Agreement shall (i) confer on the Grantee any right to continue in the service of the Company or its Subsidiaries or otherwise
confer any additional rights or benefits upon the Grantee with respect to the Grantee’s employment with the Company or (ii) interfere
in any way with the right of the Company or its Subsidiaries and its stockholders to terminate the Grantee’s service at any time.
(h) If
any change is made to the outstanding Common Stock or the capital structure of the Company, the Phantom Shares shall be adjusted in accordance
with the Plan.
(i) The
Phantom Shares and the rights relating thereto shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment,
pledge, encumbrance, attachment, garnishment, levy, execution, or other legal or equitable process, either voluntary or involuntary; and
any attempt to anticipate, alienate, sell, transfer, assign, pledge, encumber, attach or garnish, or levy or execute on the Phantom Shares
and the rights relating thereto shall be void.
(j) The
Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors
and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Grantee
and the Grantee’s beneficiaries, executors, administrators and the person(s) to whom the Phantom Shares may be transferred
by will or the laws of descent or distribution.
(k) The
Plan is discretionary and may be amended, suspended or discontinued by the Company at any time, in its discretion. The grant of the Phantom
Shares in this Agreement does not create any contractual right or other right to receive any Phantom Shares or other Grants in the future.
Future Grants, if any, will be at the sole discretion of the Company. Any amendment, suspension or discontinuation of the Plan shall
not constitute a change or impairment of the terms and conditions of the Grantee’s employment with the Company.
36
(l) The
issuance and transfer of Shares shall be subject to compliance by the Company and the Grantee with all applicable requirements of federal
and state securities laws and with all applicable requirements of any stock exchange on which the Shares may be listed. No shares of Common
Stock shall be issued or transferred unless and until any then applicable requirements of state and federal laws and regulatory agencies
have been fully complied with to the satisfaction of the Company and its counsel.
(m) The
Grantee shall be required to pay to the Company or make arrangements satisfactory to the Company regarding payment of any federal, state
or local taxes of any kind that are required by law to be withheld with respect to the Phantom Shares. Except as may be otherwise permitted
by the Committee, to satisfy such obligation, the Company shall withhold a number of Shares to be issued pursuant to this Agreement with
an aggregate Fair Market Value as of the date withholding is effected that would satisfy the withholding amount due; provided,
however, that no Shares shall be withheld with an aggregate value exceeding the minimum amount of tax required to be withheld
by law or such higher amount that does not result in adverse accounting treatment for the Company, as approved in advance by the Committee.
Notwithstanding anything contained in the Plan or this Agreement to the contrary, the Grantee’s satisfaction of any tax withholding
requirements imposed by the Committee shall be a condition precedent to the Company’s obligation as may otherwise be provided hereunder
to provide Shares to the Grantee, and the failure of the Grantee to satisfy such requirements with respect to this Grant shall cause
this Grant to be forfeited.
(n) The
Phantom Shares shall be subject to any applicable clawback policy implemented by the Board from time to time.
(o) The
Phantom Shares are intended to comply with Section 409A of the Code or an exemption thereunder and shall be construed and interpreted
in a manner that is consistent with the requirements for avoiding additional taxes or penalties under Section 409A of the Code and
administered in accordance with Section 27 of the Plan. Notwithstanding the foregoing, the Company makes no representations that
the payments and benefits provided under this Agreement comply with Section 409A of the Code and in no event shall the Company be
liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Grantee on account of non-compliance
with Section 409A of the Code. Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of the
Grantee’s execution of a release, directly or indirectly, result in the Grantee designating the calendar year of payment of any
amounts of deferred compensation subject to section 409A of the Code, and if a payment that is subject to execution of a release could
be made in more than one taxable year, payment shall be made in the later taxable year, to the extent required by Section 409A of
the Code.
37
(p) This
Agreement contains the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements,
written or oral, with respect thereto; provided that, for the avoidance of doubt, Section 7(f) of the Employment Agreement,
which provides for forfeiture of equity awards and repayment of any shares or other amounts received pursuant to equity awards in the
event that the Grantee breaches his obligations under Section 7 of the Employment Agreement, shall apply to the Phantom Shares and
any amounts paid to the Grantee pursuant to this Agreement, and is hereby incorporated by reference. In the event of any inconsistency
between the terms of this Agreement and the Employment Agreement, the terms of this Agreement shall govern.
[remainder of the page left intentionally
blank]
38
IN WITNESS WHEREOF, the Company and the Grantee
have executed this Agreement as of the day and year first above written.
MFA FINANCIAL, INC.
By:
Name:
Title:
The Grantee hereby agrees and acknowledges that
(a) the Grantee will be bound by the terms and conditions of this Agreement and the Plan and (b) all determinations by the Committee
will be final and binding on all persons.
Name: Bryan Wulfsohn
39
Exhibit D
Form PRSU Award
40
MFA FINANCIAL, INC.
EQUITY
COMPENSATION PLAN
PHANTOM SHARE AWARD AGREEMENT
(PERFORMANCE
BASED VESTING)
AGREEMENT, dated
as of the ____ day of January, 20__ (the “Grant Date”), by and between MFA Financial, Inc., a Maryland corporation (the
“Company”), and Bryan Wulfsohn (the “Grantee”).
WHEREAS, the Company maintains the MFA Financial, Inc.
Equity Compensation Plan, as it may be amended from time to time (the “Plan”) (capitalized terms used but not defined herein
shall have the respective meanings ascribed thereto by the Plan);
WHEREAS, the Grantee, as an employee of the Company
or a subsidiary of the Company, is an Eligible Person;
WHEREAS, the Company and the Grantee entered into
that certain Amended and Restated Employment Agreement, entered into as of October 2, 2026 (as may be amended and restated from time
to time, the “Employment Agreement”); and
WHEREAS, the Committee has determined that it is
in the best interests of the Company and its stockholders to grant Phantom Shares to the Grantee subject to the terms and conditions set
forth below.
NOW, THEREFORE, IT IS HEREBY AGREED AS FOLLOWS:
1. Grant
of Phantom Shares.
(a) The
Phantom Shares are subject to the terms and conditions of this Agreement and are also subject to the provisions of the Plan. The Plan
is hereby incorporated by reference as though set forth herein in its entirety.
(b) The
target amount of Phantom Shares granted pursuant to this Agreement is [TARGET] Phantom Shares (the “Target Amount”); provided
that the Grantee has the opportunity to earn up to [200% OF TARGET] Phantom Shares (the “Maximum Amount”), subject to the
Maximum Cap described in Section 4(e), based upon achievement of performance goals and the terms and conditions described herein.
(i) With
respect to the Target Amount, [NUMBER] Phantom Shares (the “Absolute TSR Target Shares”), and with respect to the Maximum
Amount, [200% OF ABSOLUTE TSR TARGET SHARES] Phantom Shares will vest based on the Company’s total shareholder return for the TSR
Performance Period (as defined below) subject to the Grantee’s continued service with the Company through December 31, 20__
(the “Vesting Date”), except as provided in Section 2 below.
(ii) With
respect to the Target Amount, [NUMBER] Phantom Shares (the “Relative TSR Target Shares”), and with respect to the Maximum
Amount, [200% OF RELATIVE TSR TARGET SHARES] Phantom Shares will vest based on the Company’s total shareholder return compared
to the total shareholder return of the peer group companies listed on Appendix 1 to Exhibit A attached hereto (the
“Peer Group Companies”) for the TSR Performance Period subject to the Grantee’s continued service with the Company
through the Vesting Date except as provided in Section 2 below.
41
2. Vesting.
(a) Subject
to Section 2(b) and Section 2(c) and the Maximum Cap (as defined in Section 4(e)), the number of Phantom Shares
granted hereunder that shall vest on the Vesting Date, if any, shall be calculated in accordance with Exhibit A attached hereto
based upon the achievement of the performance goals set forth on Exhibit A (the “Performance Goals”) during the
period beginning on January 1, 20[ ] and ending on the Vesting Date (December 31, 20[ ]), or if earlier, a Change of Control
(such period, the “TSR Performance Period”); provided that, to the extent that any fractional Shares result, the number
of Phantom Shares eligible for settlement (as set forth in Section 4) shall be rounded up to the nearest whole share. Any Phantom
Shares granted hereunder that do not vest on the Vesting Date shall be forfeited.
(b) Except
as otherwise set forth in Section 2(c), the following terms shall apply in the event of a Termination of Service:
(i) If,
prior to the Vesting Date, the Grantee experiences a Termination of Service by the Company without Cause (as defined in the Employment
Agreement) or a Termination of Service by the Grantee for Good Reason (as defined in the Employment Agreement), then, subject to Section 5(j) of
the Employment Agreement relating to execution of a release, as of the Vesting Date, the Grantee shall vest in the number of Phantom Shares
that would have vested on the Vesting Date based upon achievement of the Performance Goals if the Grantee remained employed through the
Vesting Date.
(ii) If,
prior to the Vesting Date, the Grantee experiences a Termination of Service on account of the Grantee’s death or Disability (as
defined in the Employment Agreement), then the number of Phantom Shares that shall vest, if any, on the Vesting Date shall be the number
of Phantom Shares that would have vested on the Vesting Date based upon achievement of the Performance Goals if the Grantee remained employed
through the Vesting Date; provided that, such vesting shall be subject to Section 5(j) of the Employment Agreement relating
to execution of a release, if the Grantee experiences a Termination of Service on account of the Grantee’s Disability.
(iii) If
the Grantee experiences a Termination of Service by the Company for Cause, then all Phantom Shares granted pursuant to this Agreement,
whether or not vested, shall immediately be cancelled for no consideration, and the Grantee shall cease to have any rights under this
Agreement.
(c) If
a Change of Control occurs during the Performance Period, the number of Phantom Shares that vest pursuant to this Agreement shall be calculated
as described in this Section 2(c), subject to the Maximum Cap. Notwithstanding anything to the contrary, the Committee may take such
additional actions with respect to the Phantom Shares as it deems appropriate pursuant to the Plan.
42
(i) In
lieu of measuring performance as of the end of the Performance Period, the Committee shall calculate a “Change of Control Amount”
as of the closing date of the Change of Control (the “Change of Control Date”), determined in accordance with Exhibit A.
(ii) If
the Grantee continues in service through the Vesting Date, the Change of Control Amount shall vest on the Vesting Date.
(iii) If
the Grantee experiences a Termination of Service due to death or Disability upon or following the Change of Control and prior to the Vesting
Date, then upon such Termination of Service, the Grantee shall vest in the Change of Control Amount, subject in the case of the Grantee’s
Disability, to Section 5(j) of the Employment Agreement relating to execution of a release.
(iv) If
the Grantee experiences a Termination of Service by the Company without Cause or for Good Reason upon or following the Change of Control
and prior to the Vesting Date, then upon such Termination of Service, the Grantee shall vest in the Change of Control Amount, subject
to Section 5(j) of the Employment Agreement relating to execution of a release.
(v) If
the Grantee experiences a Termination of Service on account of the Grantee’s death or Disability, termination by the Company without
Cause or termination by the Grantee for Good Reason prior to the Change of Control Date, and a Change of Control occurs following the
such Termination of Service and prior to the Vesting Date, then as of the date of the Change of Control, the Grantee shall vest in the
Change of Control Amount, subject to Section 5(j) of the Employment Agreement relating to execution of a release.
(vi) For
the avoidance of doubt, if the Change of Control Date occurs after the Vesting Date but prior to settlement of the vested Phantom Shares,
the number of Phantom Shares that vest pursuant to this Agreement shall be determined in accordance with Exhibit A without regard
to the occurrence of the Change of Control.
(d) Notwithstanding
the foregoing provisions of this Section 2, if the circumstances described in clauses (i) or (ii) below occur, then for
purposes of this Agreement, the Grantee’s termination of employment shall not constitute a termination by the Company without Cause
or a termination by the Grantee for Good Reason, and the Grantee shall not be entitled to any vesting pursuant to this Section 2:
(i) In
connection with the Grantee’s Termination of Service with the Company, the Company is managed by an external manager pursuant to
a management and advisory contract and such external manager has provided the Grantee with an offer of employment (A) on economic
terms that are at least substantially equivalent in form and economic substance (and not in the aggregate) to those provided to the Grantee
immediately prior to such Termination of Service and (B) on terms that would not be deemed to trigger Good Reason (an offer of employment
that meets the requirements of (A) and (B), a “Qualifying Offer”).
(ii) A
Change of Control occurs and immediately following such Change of Control, the Company is managed by an external manager pursuant to a
management and advisory contract and such external manager has provided the Grantee with a Qualifying Offer.
43
If the circumstances described in the preceding clauses (i) or
(ii) occur and the Grantee accepts the external manager’s Qualifying Offer, then the Phantom Shares granted pursuant to this
Agreement shall not be forfeited upon the Grantee’s Termination of Service with the Company and shall remain outstanding and continue
to vest as long as the Grantee remains employed by the external manager. For the avoidance of doubt, upon the Grantee’s termination
of employment with the external manager, the Phantom Shares granted pursuant to this Agreement shall be treated in accordance with the
terms of this Agreement, applied as though the Grantee’s employment with the Company had terminated.
(e) Except
as otherwise provided in this Section 2, if the Grantee experiences a Termination of Service for any reason prior to the Vesting
Date, the Phantom Shares granted hereunder shall, with no further action, be forfeited and cease to be outstanding as of the Grantee’s
Termination of Service.
(f) Any
Phantom Shares granted hereunder that do not vest as of the Vesting Date shall, with no further action, be forfeited and cease to be outstanding
as of the Vesting Date.
3. Dividend Equivalents.
(a) With
respect to each outstanding Phantom Share granted hereunder that vests in accordance with Section 2 and Exhibit A (such shares
being the “Vested Phantom Shares”), the Grantee shall receive additional Phantom Shares (such additional Phantom Shares being
the “Dividend Phantom Shares”), which Dividend Phantom Shares will reflect the cash dividend distributions declared in the
ordinary course on a share (“Share”) of Common Stock of the Company (each, a “Dividend Payment”) during the period
beginning on the Grant Date and ending on the Vesting Date (or if earlier, the date on which the Phantom Shares are settled pursuant
to Section 4) (such period, the “Dividend Period”).
(b) Dividend
Payments shall be deemed to have been payable only with respect to Vested Phantom Shares and shall be made in the form of Dividend Phantom
Shares. The Dividend Phantom Shares shall settle in the form of additional Shares at the time the Phantom Shares granted hereunder are
settled pursuant to Section 4.
(c) The
number of Dividend Phantom Shares to be distributed as contemplated by subsections 3(a) and 3(b) shall be calculated as follows:
with respect to each Vested Phantom Share, the Company will, as of the date of any Dividend Payment during the Dividend Period, credit
to the Grantee an amount (per each Vested Phantom Share) equal to the amount of the cash dividend declared and paid in respect of one
Share. Such credited amount will be credited in the form of hypothetical additional Phantom Shares (such hypothetical Phantom Shares,
“DER Phantom Shares”), the number of which will be calculated (rounded up to the nearest whole share) based on the Fair Market
Value (i.e., closing market price) of a Share as of the payment date of the applicable cash dividend. Any and all DER Phantom Shares
credited to the Grantee in respect of the Dividend Period will be subject to compounding through the end of the Dividend Period (i.e.,
deemed reinvestment in Shares), such that they will be credited with additional hypothetical DER Phantom Shares to the extent of any
additional dividends declared during the Dividend Period and the number of which additional hypothetical DER Phantom Shares will also
be calculated (rounded up to the nearest whole share) based on the Fair Market Value of a Share as of the payment date of the applicable
cash dividend. The number of Dividend Phantom Shares to be received by the Grantee in respect of Vested Phantom Shares shall be the sum
of all DER Phantom Shares credited to the Grantee (inclusive of all additional DER Phantom Shares credited to the Grantee resulting from
compounding as contemplated in the preceding sentence).
44
(d) In
the event that dividends are declared with respect to the Common Stock of the Company during the period beginning on the Vesting Date
and ending on the date on which the Vested Phantom Shares are settled pursuant to Section 4, then an amount equal to the dividends
that the Grantee would have received if the Grantee had owned a number of Shares equal to the sum of the Vested Phantom Shares and any
Dividend Phantom Shares credited to the Grantee (as contemplated in Section 3(c) above) as of the date the dividend is declared
shall be paid to the Grantee in cash on the date such dividends are paid to holders of the Common Stock of the Company.
4. Settlement.
(a) Subject
to subsections (b), (c), (d) and (e) below, each vested and outstanding Phantom Share that vests pursuant to this Agreement
(which, for the avoidance of doubt, shall equal the sum of Vested Phantom Shares and Dividend Phantom Shares) shall be settled in one
Share on or about January 2, 20__1 (the “Settlement Date”).
(b) The
following terms shall apply in the event of a Termination of Service prior to the Settlement Date:
(i) In
the event that the Grantee’s Termination of Service occurs on or prior to the Vesting Date, each Phantom Share that vests pursuant
to this Agreement shall be settled in one Share in January 20__.2
(ii) In
the event that the Grantee’s Termination of Service occurs following the Vesting Date, then to the extent not previously settled
pursuant to Section 4(c) below, each Phantom Share that vested pursuant to this Agreement shall be settled in one Share within
30 days following such Termination of Service.
(iii) Notwithstanding
the preceding clauses (i) and (ii), in the event that the Grantee’s Termination of Service occurs on or prior to the Vesting
Date and within 24 months following a Change of Control that constitutes a “change in control event” for purposes of Section 409A
of the Code, each Phantom Share that becomes vested pursuant to this Agreement shall be settled in one Share within 60 days following
such Termination of Service.
(c) The
following terms shall apply in the event a Change of Control that constitutes a “change in control event” for purposes of
Section 409A of the Code occurs prior to the Settlement Date:
(i) Except
as otherwise provided in Section 4(b)(iii), in the event a Change of Control that constitutes a “change in control event”
for purposes of Section 409A of the Code occurs on or prior to the Vesting Date, each Phantom Share that becomes vested pursuant
to this Agreement shall be settled in one Share in January 20__3; and
1 Note to draft: To be January 2
immediately following the first anniversary of the Vesting Date.
2 Note to draft: To be January
immediately following the Vesting Date.
3 Note to draft: To be January
immediately following the Vesting Date.
45
(ii) In
the event a Change of Control that constitutes a “change in control event” for purposes of Section 409A of the Code occurs
following the Vesting Date, each Phantom Share that became vested pursuant to this Agreement shall be settled in one Share within 30 days
following the date of the Change of Control.
(d) To
the extent any payment described in this Section 4 is required to be delayed six months pursuant to the rules of Section 409A
of the Code related to “specified employees,” such payment shall not be made before the date which is six months after the
date of Termination of Service. Any delayed payment shall be made to the Grantee on the first day of the seventh month following the
Grantee’s Termination of Service (or within 30 days following the Grantee’s death, if earlier).
(e) Notwithstanding
anything in this Agreement to the contrary, the Fair Market Value of the Shares delivered pursuant to this Agreement, measured as of the
last day of the Performance Period (or, if earlier, the date on which the Phantom Shares are settled pursuant to this Section 4)
shall not exceed 400% of the Fair Market Value of the Target Amount of Phantom Shares measured on the Grant Date (the “Maximum Cap”),
and any and all amounts otherwise payable pursuant to this Agreement in excess of the Maximum Cap shall be forfeited, provided
that, for the avoidance of doubt, payment with respect to the dividend equivalent rights described above for dividends declared and paid
following the Vesting Date shall not count against the Maximum Cap.
5. Miscellaneous.
(a) The value of a Phantom Share may decrease depending upon
the Fair Market Value of a Share from time to time. Neither the Company nor the Committee, nor any other party associated with the Plan,
shall be held liable for any decrease in the value of the Phantom Shares. If the value of such Phantom Shares decrease, there will be
a decrease in the underlying value of what is distributed to the Grantee under the Plan and this Agreement.
(b) With respect to this Agreement, (i) the Phantom Shares
are bookkeeping entries and the Grantee shall not have any rights of a shareholder with respect to Common Stock unless and until the Phantom
Shares vest and are settled by the issuance of such Shares of Common Stock, (ii) the obligations of the Company under the Plan are
unsecured and constitute a commitment by the Company to make benefit payments in the future, (iii) to the extent that any person
acquires a right to receive payments from the Company under the Plan, such right shall be no greater than the right of any general unsecured
creditor of the Company, (iv) all payments under the Plan (including distributions of Shares) shall be paid from the general funds
of the Company and (v) no special or separate fund shall be established or other segregation of assets made to assure such payments
(except that the Company may in its discretion establish a bookkeeping reserve to meet its obligations under the Plan). The award of Phantom
Shares is intended to be an arrangement that is unfunded for tax purposes and for purposes of Title I of the Employee Retirement Income
Security Act of 1974, as amended.
(c) THIS
AGREEMENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF MARYLAND, WITHOUT REFERENCE TO PRINCIPLES OF CONFLICT OF LAWS. The captions of
this Agreement are not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified
except by a written agreement executed by the parties hereto or their respective successors and legal representatives. The invalidity
or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this
Agreement.
46
(d) The Committee may construe and interpret this Agreement and
establish, amend and revoke such rules, regulations and procedures for the administration of this Agreement as it deems appropriate. In
this connection, the Committee may correct any defect or supply any omission, or reconcile any inconsistency in this Agreement or in any
related agreements, in the manner and to the extent it shall deem necessary or expedient to make the Plan fully effective. All decisions
and determinations by the Committee in the exercise of this power shall be final and binding upon the Company and the Grantee.
(e) All notices hereunder shall be in writing and, if to the
Company, shall be delivered to the Board or mailed to its principal office, addressed to the attention of the Committee and, if to the
Grantee, shall be delivered personally or mailed to the Grantee at the address appearing in the records of the Company. Such addresses
may be changed at any time by written notice to the other party given in accordance with this Section 5(e).
(f) The failure of the Grantee or the Company to insist upon
strict compliance with any provision of this Agreement or the Plan, or to assert any right the Grantee or the Company, respectively, may
have under this Agreement or the Plan, shall not be deemed to be a waiver of such provision or right or any other provision or right of
this Agreement or the Plan.
(g) Nothing
in this Agreement shall (i) confer on the Grantee any right to continue in the service of the Company or its Subsidiaries or otherwise
confer any additional rights or benefits upon the Grantee with respect to the Grantee’s employment with the Company or (ii) interfere
in any way with the right of the Company or its Subsidiaries and its stockholders to terminate the Grantee’s service at any time.
(h) If
any change is made to the outstanding Common Stock or the capital structure of the Company, the Phantom Shares shall be adjusted in accordance
with the Plan.
(i) The
Phantom Shares and the rights relating thereto shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment,
pledge, encumbrance, attachment, garnishment, levy, execution, or other legal or equitable process, either voluntary or involuntary; and
any attempt to anticipate, alienate, sell, transfer, assign, pledge, encumber, attach or garnish, or levy or execute on the Phantom Shares
and the rights relating thereto shall be void.
(j) The
Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors
and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Grantee
and the Grantee’s beneficiaries, executors, administrators and the person(s) to whom the Phantom Shares may be transferred
by will or the laws of descent or distribution.
(k) The
Plan is discretionary and may be amended, suspended or discontinued by the Company at any time, in its discretion. The grant of the Phantom
Shares in this Agreement does not create any contractual right or other right to receive any Phantom Shares or other Grants in the future.
Future Grants, if any, will be at the sole discretion of the Company. Any amendment, suspension or discontinuation of the Plan shall not
constitute a change or impairment of the terms and conditions of the Grantee’s employment with the Company.
47
(l) The
issuance and transfer of Shares shall be subject to compliance by the Company and the Grantee with all applicable requirements of federal
and state securities laws and with all applicable requirements of any stock exchange on which the Shares may be listed. No shares of Common
Stock shall be issued or transferred unless and until any then applicable requirements of state and federal laws and regulatory agencies
have been fully complied with to the satisfaction of the Company and its counsel.
(m) The
Grantee shall be required to pay to the Company or make arrangements satisfactory to the Company regarding payment of any federal, state
or local taxes of any kind that are required by law to be withheld with respect to the Phantom Shares. Except as may be otherwise permitted
by the Committee, to satisfy such obligation, the Company shall withhold a number of Shares to be issued pursuant to this Agreement with
an aggregate Fair Market Value as of the date withholding is effected that would satisfy the withholding amount due; provided,
however, that no Shares shall be withheld with an aggregate value exceeding the minimum amount of tax required to be withheld
by law or such higher amount that does not result in adverse accounting treatment for the Company, as approved in advance by the Committee.
Notwithstanding anything contained in the Plan or this Agreement to the contrary, the Grantee’s satisfaction of any tax withholding
requirements imposed by the Committee shall be a condition precedent to the Company’s obligation as may otherwise be provided hereunder
to provide Shares to the Grantee, and the failure of the Grantee to satisfy such requirements with respect to this Grant shall cause
this Grant to be forfeited.
(n) The
Phantom Shares shall be subject to any applicable clawback policy implemented by the Board from time to time.
(o) The
Phantom Shares are intended to comply with Section 409A of the Code or an exemption thereunder and shall be construed and interpreted
in a manner that is consistent with the requirements for avoiding additional taxes or penalties under Section 409A of the Code and
administered in accordance with Section 27 of the Plan. Notwithstanding the foregoing, the Company makes no representations that
the payments and benefits provided under this Agreement comply with Section 409A of the Code and in no event shall the Company be
liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Grantee on account of non-compliance
with Section 409A of the Code. Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of
the Grantee’s execution of a release, directly or indirectly, result in the Grantee designating the calendar year of payment of
any amounts of deferred compensation subject to section 409A of the Code, and if a payment that is subject to execution of a release
could be made in more than one taxable year, payment shall be made in the later taxable year, to the extent required by Section 409A
of the Code.
(p) This
Agreement, including Exhibit A and Appendix 1 to Exhibit A, contains the entire agreement between the parties with respect to
the subject matter hereof and supersedes all prior agreements, written or oral, with respect thereto; provided that, for the avoidance
of doubt, Section 7(f) of the Employment Agreement, which provides for forfeiture of equity awards and repayment of any shares
or other amounts received pursuant to equity awards in the event that the Grantee breaches his obligations under Section 7 of the
Employment Agreement, shall apply to the Phantom Shares and any amounts paid to the Grantee pursuant to this Agreement, and is hereby
incorporated by reference. In the event of any inconsistency between the terms of this Agreement and the Employment Agreement, the terms
of this Agreement shall govern.
[remainder of the page left intentionally
blank]
48
IN WITNESS WHEREOF, the Company and the Grantee
have executed this Agreement as of the day and year first above written.
MFA FINANCIAL, INC.
By:
Name:
Title:
The Grantee hereby agrees and acknowledges that
(a) the Grantee will be bound by the terms and conditions of this Agreement and the Plan and (b) all determinations by the Committee
will be final and binding on all persons.
Name: Bryan Wulfsohn
49
Exhibit A
This Exhibit A sets forth the Performance Goals applicable to
the Phantom Shares granted pursuant to the Agreement to which this Exhibit A is attached. Unless otherwise specified in this Exhibit A,
all defined terms shall have the meanings set forth in the Agreement.
The Phantom Shares will vest based on
the Company’s total shareholder return for the TSR Performance Period and based on the Grantee’s continued service as set
forth in the Agreement. As further described below, the Absolute TSR Shares will be eligible to vest based on the Company’s
average total shareholder return for the Performance Period, and the Relative TSR Shares will be eligible to vest based on the Company’s
total shareholder return compared to the total shareholder return of the Peer Group Companies for the TSR Performance Period.
For purposes of this Exhibit A, TSR for the TSR Performance Period
shall be calculated as follows:
· “TSR” is equal to (x) the Average Final Price minus the
Average Initial Price, plus Dividends Paid on a share of common stock in respect of the TSR Performance Period, divided by (y) the
Average Initial Price.
· The “Average Initial Price” is equal to the average closing daily
price of a share of common stock during the last 20 trading days immediately prior to the first day of the TSR Performance Period.
· The “Average Final Price” is equal to the average closing daily
price of a share of common stock during the last 20 trading days in the TSR Performance Period.
· The “Dividends Paid” shall equal the cumulative dividends (including
any stock dividends) paid per share of common stock in respect of the TSR Performance Period. For this purpose, dividends declared, but
not yet paid, on a share within the 45-day period preceding the last day of the TSR Performance Period will be counted as Dividends Paid.
Notwithstanding the foregoing, if any dividends were included in Dividends Paid for purposes of calculating TSR for the year prior to
the year in which the TSR Performance Period commences, then such dividends will not be included in Dividends Paid for purposes of calculating
TSR for the TSR Performance Period.
Absolute TSR Shares
For purposes of the Absolute TSR Shares, the “Average TSR”
for the Performance Period is the TSR, divided by the number of full and partial years during the TSR Performance Period, and the “Target
TSR” is an 8% per annum simple cumulative return (pro-rated for partial years) over the TSR Performance Period.
The portion of the Absolute TSR Target Shares that will be eligible
to vest with respect to the Performance Period shall be determined by comparing the Average TSR of the Company to the Target TSR and may
range from zero up to a maximum vesting of 200% of the Absolute TSR Target Shares.
50
The number of Absolute TSR Shares that will be eligible to vest with
respect to the Performance Period shall equal the product of (i) the Absolute TSR Target Shares and (ii) the sum of (A) one
(1) plus (B) a fraction (which fraction can be a negative number), the numerator of which is the Company’s Average TSR
less Target TSR and the denominator of which is eight (8). For purposes of the preceding sentence, in the event that the Company’s
Average TSR is (x) less than zero, then the Company’s Average TSR shall be deemed to be zero, and (y) greater 16%, then
the Company’s Average TSR shall be deemed to be 16%.
Any Absolute TSR Shares that do not vest on the Vesting Date shall
be forfeited.
Vested Absolute TSR Shares and related Dividend Payments, if any, will
be settled as described in the Agreement.
Relative TSR Shares
At the end of each TSR Performance Period, the Company’s TSR
and the TSR of each of the Peer Group Companies will be ranked from highest to lowest. The “Relative TSR Vesting Percentage”
will be determined based on the Company’s TSR as compared to the TSR of the Peer Group Companies for the TSR Performance Period
as follows:
Company TSR Rank
Relative TSR Vesting Percentage
80th percentile or above
200%
50th percentile
100%
At or below 25th percentile
0%
If the Company’s TSR Rank is between the 25th percentile and
the 50th percentile or between the 50th percentile and the 80th percentile, the Relative TSR Vesting Percentage will be interpolated.
Notwithstanding the provisions set forth above, in the event that the
Company’s TSR is a negative number, the Relative TSR Vesting Percentage shall not exceed 100%.
The number of Relative TSR Shares that will be eligible to vest for
the TSR Performance Period will be determined by multiplying the Relative TSR Target Shares by the Relative TSR Vesting Percentage.
For the avoidance of doubt, in no event shall any Relative TSR Shares
vest if the Company’s Average TSR Rank is at or below the 25th percentile.
Not more than 200% of the Relative TSR Target Shares may vest based
on the Company’s TSR Rank.
Any Relative TSR Shares that do not vest on the Vesting Date shall
be forfeited.
Vested Relative TSR Shares and related Dividend Payments, if any, will
be settled as described in the Agreement.
51
Appendix 1 to Exhibit A
Relative TSR Peer Group Companies
[TO BE LISTED]
In the event of a merger, acquisition or business combination transaction
of a Peer Group Company during the TSR Performance Period in which such Peer Group Company is the surviving entity and remains publicly
traded, the surviving entity shall remain a Peer Group Company. Any entity involved in the transaction during the TSR Performance Period
that is not the surviving company shall no longer be a Peer Group Company.
In the event of a merger, acquisition or business combination transaction
of a Peer Group Company, a “going private” transaction or other event involving a Peer Group Company or the liquidation of
a Peer Group Company (other than a bankruptcy as described below), in each case during the TSR Performance Period and where the Peer Group
Company is not the surviving entity or is no longer publicly traded, such Peer Group Company shall no longer be a Peer Group Company.
Notwithstanding the foregoing, in the event of a bankruptcy of a Peer
Group Company during the TSR Performance Period where the Peer Group Company is not publicly traded at the end of the Performance Period,
such Peer Group Company shall remain a Peer Group Company but shall be deemed to be ranked last among all Peer Group Companies in the
Peer Group.
52
Exhibit E
Release
This Release of Claims (this
“Release”) is made as of _________________, by and between MFA FINANCIAL, INC. (“MFA”) and
________________ (the “Executive”).
(a) The
Executive, on behalf of himself, his agents, heirs, successors, assigns, executors and administrators, in consideration for the termination
payments and other consideration provided for under the Employment Agreement entered into by MFA and the Executive, as from time to time
amended in accordance with its terms (the “Employment Agreement”), hereby forever releases and discharges MFA, and
its successors, its affiliated entities, and, in such capacities, its past and present directors, employees, agents, attorneys, accountants,
representatives, plan fiduciaries, successors and assigns from any and all known and unknown causes of action, actions, judgments, liens,
indebtedness, damages, losses, claims, liabilities, and demands of whatsoever kind and character in any manner whatsoever arising on or
prior to the date of this Release, including but not limited to (i) any claim for breach of contract, breach of implied covenant,
breach of oral or written promise, wrongful termination, intentional infliction of emotional distress, defamation, interference with contract
relations or prospective economic advantage, negligence, misrepresentation or employment discrimination, and including without limitation
alleged violations of Title VII of the Civil Rights Act of 1964, as amended, prohibiting discrimination based on race, color, religion,
sex or national origin; the Employee Retirement Income Security Act of 1974 (“ERISA”); the Family and Medical Leave
Act; the Americans With Disabilities Act; the Age Discrimination in Employment Act; the Fair Labor Standards Act; the federal Worker Adjustment
and Retraining Notification Act; the federal Equal Pay Act; any federal False Claims Act; the Occupational Safety and Health Act; the
Fair Credit Reporting Act; the New York State Human Rights Law; the New York City Human Rights Law; the New York Labor Law; the New York
Executive Law; New York Equal Pay Law; New York Civil Rights Law; the New York Worker Adjustment and Retraining Notification Act; and
any other federal, state and local laws, ordinances and regulations; (ii) any and all liability that was or may have been alleged
against or imputed to MFA by the Executive or by anyone acting on his behalf; (iii) all claims for monetary or equitable relief,
employment or reemployment with MFA in any position, and any punitive, compensatory or liquidated damages; and (iv) all rights to
and claims for attorneys’ fees and costs except as otherwise provided in the Employment Agreement. The only claims that are not
being waived and released by the Executive under this Release are (i) claims for indemnification or D&O coverage or any claim
arising under, or preserved by, Section 5 of the Employment Agreement, (ii) claims that, cannot be waived as a matter of law
or public policy, (iii) claims based on any wrongful act or omission occurring after the date Executive signs this Release, (iv) claims
to vested benefits under any compensation or benefit plan, program or arrangement in which the Executive was participating as of the date
of termination of his employment, (v) claims seeking enforcement of this Release or the Employment Agreement, and (vi) claims
challenging the legality of this Release in a legal proceeding pursuant to the Older Workers Benefit Protection Act and the Age Discrimination
in Employment Act. The Executive acknowledges that the Executive has not made any claims or allegations related to discrimination, harassment
or sexual abuse and none of the termination payments and other consideration provided for under the Employment Agreement are related to
discrimination, harassment or sexual abuse.
53
(b) Except
as provided in Section (c) below, the Executive warrants, represents and certifies that he has not filed or instituted, and,
no person or agency has filed or instituted on his behalf and/or at his direction, any complaints, lawsuits, arbitration proceedings,
actions, causes of action, in law or equity, administrative charges, claims, controversies, demands, grievances and/or proceedings whatsoever
against any Releasee, in any forum. The Executive represents and warrants that he has not assigned any claim released herein.
(c) Nothing
in this Release or the Employment Agreement restricts or prohibits the Executive from initiating communications directly with, responding
to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation
to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity,
including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Department
of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General (collectively, the “Regulators”),
or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation. However,
to the maximum extent permitted by law, the Executive is waiving the Executive’s right to receive any individual monetary relief
from MFA or any others covered by the Release of Claims resulting from such claims or conduct, regardless of whether the Executive or
another party has filed them, and in the event the Executive obtains such monetary relief, MFA will be entitled to an offset for the payments
made pursuant to this Agreement. This Agreement does not limit the Executive’s right to receive an award from any Regulator that
provides awards for providing information relating to a potential violation of law. The Executive does not need the prior authorization
of MFA to engage in conduct protected by this paragraph, and the Executive does not need to notify MFA that the Executive has engaged
in such conduct.
Please take notice that federal
law provides criminal and civil immunity to federal and state claims for trade secret misappropriation to individuals who disclose a trade
secret to their attorney, a court, or a government official in certain, confidential circumstances that are set forth at 18 U.S.C. §§
1833(b)(1) and 1833(b)(2), related to the reporting or investigation of a suspected violation of the law, or in connection with a
lawsuit for retaliation for reporting a suspected violation of the law.
(d) BY
HIS SIGNATURE BELOW, THE EXECUTIVE ACKNOWLEDGES THAT:
(1) HE
HAS RECEIVED A COPY OF THIS RELEASE AND WAS OFFERED A PERIOD OF TWENTY-ONE (21) DAYS TO REVIEW AND CONSIDER IT;
(2) IF
HE SIGNS THIS RELEASE PRIOR TO THE EXPIRATION OF TWENTY-ONE DAYS, HE KNOWINGLY AND VOLUNTARILY WAIVES AND GIVES UP THIS RIGHT OF REVIEW;
(3) HE
HAS THE RIGHT TO REVOKE THIS RELEASE FOR A PERIOD OF SEVEN (7) DAYS AFTER HE SIGNS IT BY MAILING OR DELIVERING A WRITTEN NOTICE OF
REVOCATION TO THE COMPANY’S GENERAL COUNSEL, NO LATER THAN THE CLOSE OF BUSINESS ON THE SEVENTH DAY AFTER THE DAY ON WHICH HE SIGNED
THIS RELEASE;
54
(4) THIS
RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE SEVEN DAY REVOCATION PERIOD HAS EXPIRED WITHOUT THE RELEASE HAVING BEEN REVOKED
(THE “EFFECTIVE DATE”);
(5) THIS
RELEASE WILL BE FINAL AND BINDING AFTER THE EXPIRATION OF THE REVOCATION PERIOD REFERRED TO IN SECTION (d)(3).
(6) THE
COMPANY ADVISES THE EXECUTIVE TO CONSULT WITH AN ATTORNEY. THEREFORE, HE IS AWARE OF HIS RIGHT TO CONSULT AN ATTORNEY, HAS BEEN ADVISED
IN WRITING TO CONSULT WITH AN ATTORNEY, AND HAS HAD THE OPPORTUNITY TO CONSULT WITH AN ATTORNEY, IF DESIRED, PRIOR TO SIGNING THIS
RELEASE;
(7) NO
PROMISE OR INDUCEMENT FOR THIS RELEASE HAS BEEN MADE EXCEPT AS SET FORTH IN THIS RELEASE;
(8) HE
IS LEGALLY COMPETENT TO EXECUTE THIS RELEASE AND ACCEPT FULL RESPONSIBILITY FOR IT; AND
(9) HE
HAS CAREFULLY READ THIS RELEASE, ACKNOWLEDGES THAT HE HAS NOT RELIED ON ANY REPRESENTATION OR STATEMENT, WRITTEN OR ORAL, NOT SET FORTH
IN THIS DOCUMENT, AND WARRANTS AND REPRESENTS THAT HE IS SIGNING THIS RELEASE KNOWINGLY AND VOLUNTARILY.
IN WITNESS WHEREOF, the parties
have hereunto set their hands this __________ day of ___________________.
By:
Bryan
Wulfsohn
MFA Financial, Inc.
Name:
Title:
55
EX-10.3 — EXHIBIT 10.3
EX-10.3
Filename: tm2627083d1_ex10-3.htm · Sequence: 4
Exhibit 10.3
EXECUTION COPY
EMPLOYMENT AGREEMENT
THIS EMPLOYMENT AGREEMENT
(this “Agreement”) is entered into as of the second day of October, 2026 (the “Effective Date”),
by and between MFA Financial, Inc. (“MFA”), and Michael C. Roper (the “Executive”).
WITNESSETH:
WHEREAS, MFA and the Executive
entered into an agreement, effective as of February 11, 2024 (the “Former Agreement”);
WHEREAS, MFA and the Executive
desire to enter into an employment agreement that supersedes and replaces the Former Agreement in all respects as of the Effective Date
and sets forth the terms of the Executive’s employment with MFA; and
WHEREAS, the Executive wishes
to continue serving MFA, and MFA wishes to secure the continued exclusive services of the Executive, under the terms and conditions described
in this Agreement, which will be legally binding on the date the Agreement is executed by the parties hereto.
NOW THEREFORE, in consideration
of the foregoing premises and the mutual agreements herein contained, the parties hereto agree as follows:
1. Term
of Employment.
(a) MFA
hereby employs the Executive, and the Executive hereby accepts employment with MFA, in the positions and with the duties and responsibilities
as set forth in Section 2 below for the Term of Employment, subject to the terms and conditions of this Agreement. As of the Effective
Date, the Former Agreement is terminated.
(b) The
term of employment (the “Term of Employment”) under this Agreement shall commence on the Effective Date and continue
until December 31, 2027 (the “Initial Term”); provided that, the Term of Employment shall automatically renew
for periods of one-year (each an “Extension Term”) unless either party gives the other party written notice 31 days
prior to the end of the Initial Term or any Extension Term, as applicable, that the Term of Employment shall not be further extended.
If the last day of the Initial Term or any Extension Term occurs during a Garden Leave Period, the Term of Employment shall continue
through the end of such Garden Leave Period. The Term of Employment may also be terminated in accordance with Section 5 hereof.
The Company’s failure to renew the Term of Employment at the end of the Initial Term or any Extension Term, as applicable, shall
constitute termination without Cause (as defined below). The Executive’s failure to renew the Term of Employment at the end of
the Initial Term or any Extension Term shall not, by itself, constitute a termination for Good Reason (as defined below).
2. Position;
Duties and Responsibilities.
(a) During
the Term of Employment, the Executive shall be employed as Chief Financial Officer and Senior Vice President of MFA, reporting directly
and solely to the Chief Executive Officer of MFA (the “CEO”), with such authority, duties and day-to-day management
responsibilities as are customarily maintained and performed by persons holding such offices at similarly situated mortgage REITs and
such other duties as may be mutually agreed upon between the Executive and the CEO.
(b) During
the Term of Employment, the Executive shall, without additional compensation, also serve on the board of directors of, serve as an officer
of, and/or perform such executive and consulting services for, or on behalf of, such subsidiaries or affiliates of MFA as the Board of
Directors of MFA (the “Board of Directors”) or the CEO may, from time to time, request. MFA and such subsidiaries
and affiliates are hereinafter referred to, collectively, as the “Company.” For purposes of this Agreement, the term
“affiliate” shall have the meaning ascribed thereto in Rule 12b-2 under the Securities Exchange Act of 1934, as amended
(the “Act”).
(c) During
the Term of Employment, the Executive shall serve MFA faithfully, diligently and to the best of his ability and shall devote substantially
all of his business time and efforts to his employment and the performance of his duties under this Agreement. Nothing herein shall preclude
the Executive from engaging in charitable and community affairs and managing his personal, financial and legal affairs, so long as such
activities do not materially interfere with his carrying out his duties and responsibilities under this Agreement.
3. Compensation.
(a) Base
Salary. For the period beginning on the Effective Date and ending on December 31, 2026, the Executive shall be entitled to receive
an annualized base salary (the “Base Salary”) of $550,000, and effective as of January 1, 2027, the Executive
shall be entitled to receive a Base Salary of $575,000. The Compensation Committee of the Board of Directors (the “Compensation
Committee”) shall review the Executive’s Base Salary annually to determine whether increases or decreases are appropriate;
provided that, the Executive’s Base Salary may only be decreased if such decrease is part of an overall Company reduction of executive
base salaries and the applicable decrease (on a percentage basis) is substantially equivalent to that applicable to other senior executives
of MFA. For the avoidance of doubt, if the Executive’s annualized base salary is further increased during the Term of Employment,
such increased amount shall constitute the “Base Salary” for all purposes of this Agreement and any decrease of such Base
Salary shall be subject to the proviso in the preceding sentence.
(b) Performance
Bonus. For each twelve-month period beginning December 1 and ending November 30 during the Term of Employment (each, a
“Performance Period”), the Executive shall be eligible to receive an annual bonus (“Annual Bonus”).
For the 12-month Performance Period beginning December 1, 2025 and ending November 30, 2026, the Executive shall be eligible
to receive a discretionary annual bonus determined by the Compensation Committee. For the 12-month Performance Period beginning December 1,
2026, and the Performance Periods beginning each subsequent December 1 during the Term of Employment, the Executive shall be eligible
to receive an annual bonus (“Annual Bonus”) according to the terms set forth on the attached Exhibit A.
The Compensation Committee shall make all determinations with respect to the Annual Bonus in good faith and consistent with the attached
Exhibit A.
2
(c) Equity
Compensation. To the extent that the Executive is still employed by MFA and has not delivered or received a Notice of Termination
as of each applicable grant date, within the first five trading days of each calendar year during the Term of Employment, the Company
shall grant to the Executive a time-based restricted stock unit (“RSU”) award and a performance-based RSU award, each
of which shall be granted according to the terms set forth on the attached Exhibit B, the terms of the MFA Financial, Inc.
Equity Compensation Plan or any successor thereto (the “Equity Compensation Plan”) (which, for the avoidance of doubt,
shall not be inconsistent with the terms set forth on Exhibit B), and the terms set forth in the form time-based RSU award
agreement and the form performance-based RSU award agreement attached hereto as Exhibits C and D, respectively (the “Award
Agreements”). In the event of any inconsistency between the terms of this Agreement and the Award Agreements, the terms of
the Award Agreements shall govern. For the avoidance of doubt, each award granted to the Executive pursuant to the Equity Compensation
Plan prior to the Effective Date that is outstanding as of the Effective Date shall continue to be governed by the terms of the applicable
award agreement, as amended by Section 5(a)(iv), Section 5(b)(iii), Section 5(c)(v), and Section 5(f)(iii) of
this Agreement.
(d) Stock
Ownership Requirements. All shares of MFA stock distributed to the Executive by the Company under this Agreement or otherwise shall
be subject to the stock ownership guidelines in effect for executives from time to time, as determined by the Board of Directors. Unless
the stock ownership guidelines provide otherwise, vested shares of equity grants cannot be transferred or sold during the Executive’s
employment by the Company unless and until the value of the Executive’s stock holdings in MFA (including shares of restricted stock
and RSUs (with any RSUs that vest based on performance valued at target)) exceeds four times the Executive’s Base Salary; and following
the termination of Executive’s employment with the Company, vested shares of equity grants may not be sold or transferred to the
extent the value of the Executive’s stock holdings does not exceed four times the Executive’s Base Salary as of the date
of the Executive’s termination of employment (provided, however, that this sentence shall no longer apply following the six-month
anniversary of the Executive’s termination of employment). Notwithstanding the foregoing, the restrictions of this subsection (d) shall
not prevent Executive from selling shares of MFA stock to satisfy income tax and employment tax obligations relating to the vesting and
settlement of the equity grants to which the shares relate.
4. Employee
Benefit Programs and Fringe Benefits. The Executive shall be entitled to at least 25 days in the aggregate of vacation and paid time
off for each calendar year during the Term of Employment and shall be entitled to participate in all executive incentive and employee
benefit programs of MFA now or hereafter made available to MFA’s senior executives or salaried employees generally, as such programs
may be in effect from time to time. The Executive shall be entitled to sick leave in accordance with applicable law and MFA policies.
MFA shall reimburse the Executive for any and all necessary, customary and usual business expenses incurred by Executive in connection
with his employment in accordance with applicable MFA policies.
3
5. Termination
of Employment.
(a) Termination
Due to Disability. If the Executive’s employment is terminated during the Term of Employment by reason of the Executive’s
Disability, the Executive’s Term of Employment shall terminate automatically without further obligations to the Executive under
this Agreement except as provided in Section 5(g) below. In addition, and if the requirements of Section 5(j) are
met:
(i) The
Executive shall receive cash payments in an aggregate amount equal to the sum of (A) Executive’s then current Base Salary
and (B) the Executive’s Target Bonus (as defined in Exhibit A) for the Performance Period in which a Notice of
Termination is delivered (provided that, if Notice of Termination is delivered prior to December 1, 2026, then for purposes of this
Section 5(a), “Target Bonus” shall mean $750,000), with such amount to be paid in cash in equal ratable installments
in accordance with applicable MFA payroll practices over the 12 month period following such termination. Such installment payments shall
commence as soon as possible (without undue delay), but in any event within 60 days following the date of termination on account Disability,
and the first payment shall include any unpaid installments for the period prior to commencement. Notwithstanding the foregoing, in the
event that the Executive’s employment is terminated on account of Disability and such termination occurs within 24 months following
a Change of Control (as defined below), in lieu of payment in the form of installments, the sum of the amounts set forth in the preceding
clauses (A) and (B) shall be paid in a lump sum cash payment as soon as possible (without undue delay), but in any event within
60 days following the date of termination on account of Disability.
(ii) The
Executive shall receive any unpaid Annual Bonus (as defined in Exhibit A) for the Performance Period (as defined in Exhibit A)
immediately preceding the Executive’s date of termination, which shall be paid at the time set forth in Exhibit A.
(iii) The
Company shall reimburse the Executive for 100% of the COBRA premiums incurred by the Executive for the Executive and his eligible dependents
under the Company’s health care plan during the 18 month period following the Executive’s termination of employment. Such
reimbursement shall be provided on the payroll date immediately following the date on which the Executive remits the applicable premium
payment and shall commence within 60 days after the termination date; provided that the first payment shall include any reimbursements
that would have otherwise been payable during the period beginning on the Executive’s termination date and ending on the date of
the first reimbursement payment. Reimbursement payments shall be treated as taxable compensation to the Executive to the extent required
by law.
(iv) All
of the Executive’s outstanding equity-based awards (e.g., restricted stock, phantom shares, RSUs and stock options) shall be treated
in accordance with the following (whether granted before or after the Effective Date) and paid at the time set forth in the applicable
award agreement:
(A) Except
as otherwise provided in (C) below, all unvested awards shall immediately vest.
4
(B) All
vested options shall remain exercisable until the earlier of (x) 90 days following the date of such termination or (y) the
date on which each such option would have expired had the Executive’s employment not terminated.
(C) Any
equity award that is subject to vesting based on the achievement of performance goals shall vest in accordance with the terms and conditions
applicable to such award, determined as though the Executive remained actively employed through the end of the applicable performance
period; for the avoidance of doubt, if a Change of Control occurs during the applicable performance period and the Executive’s
date of termination occurs following such Change of Control, the Executive’s award shall become vested with respect to a number
of shares determined based on actual performance measured as of the date of the Change of Control, provided that, to the extent equitable,
each applicable performance goal shall be adjusted to account for the reduced performance period as set forth in the applicable award
agreement.
(b) Termination
Due to Death. If the Executive’s employment is terminated during the Term of Employment by reason of the Executive’s
death, the Executive’s Term of Employment shall terminate automatically without further obligations to the Executive, his legal
representative or his estate, as the case may be, under this Agreement except as provided in Section 5(g) below. In addition:
(i) The
Executive’s legal representative or his estate, as the case may be, shall receive a lump sum cash payment equal to the sum of (A) Executive’s
then current Base Salary and (B) the Executive’s Target Bonus for the Performance Period in which the Executive’s death
occurs (provided that, if such death occurs prior to December 1, 2026, then for purposes of this Section 5(b), “Target
Bonus” shall mean $750,000). Such payment shall be made as soon as possible (without undue delay), but in any event within 60 days
following the date of the Executive’s death.
(ii) The
Executive shall receive any unpaid Annual Bonus (as defined in Exhibit A) for the Performance Period (as defined in Exhibit A)
immediately preceding the Executive’s date of termination, which shall be paid at the time set forth in Exhibit A.
(iii) All
of the Executive’s outstanding equity-based awards (e.g., restricted stock, phantom shares, RSUs and stock options) shall be treated
in accordance with the following (whether granted before or after the Effective Date) and paid at the time set forth in the applicable
award agreement:
(A) Except
as otherwise provided in (C) below, all unvested awards shall immediately vest.
5
(B) All
vested options shall remain exercisable until the earlier of (x) 90 days following the date of such termination or (y) the
date on which each such option would have expired had the Executive’s employment not terminated.
(C) Any
equity award that is subject to vesting based on the achievement of performance goals shall vest in accordance with the terms and conditions
applicable to such award, determined as though the Executive remained actively employed through the end of the applicable performance
period; for the avoidance of doubt, if a Change of Control occurs during the applicable performance period and the Executive’s
date of termination occurs following such Change of Control, the Executive’s award shall become vested with respect to a number
of shares determined based on actual performance measured as of the date of the Change of Control, provided that, to the extent equitable,
each applicable performance goal shall be adjusted to account for the reduced performance period as set forth in the applicable award
agreement.
(c) Termination
By MFA Without Cause or By the Executive for Good Reason. In the event the Executive’s employment is terminated during the
Term of Employment by the Company without Cause or by the Executive for Good Reason (other than for Disability, as described in Section 5(a)),
the Executive’s Term of Employment shall terminate without further obligations to the Executive under this Agreement, except as
provided in Section 5(g) below. In addition and if the requirements of Section 5(j) are met:
(i) The
Executive shall be entitled to an amount (the “Severance Amount”) equal to the sum of (A) his then current Base
Salary and (B) the Executive’s Target Bonus for the Performance Period in which a Notice of Termination is delivered; provided
that, (A) if Notice of Termination is delivered prior to December 1, 2026, then for purposes of this Section 5(c)(i) and
Section 5(c)(ii), “Target Bonus” shall mean $750,000 and (B) for purposes of this Section 5(c)(i) and
Section (5)(c)(ii), Base Salary and Target Bonus shall be determined without regard to any changes giving rise to Good Reason pursuant
to Section 6(g)(iv). The Severance Amount shall be paid in cash in equal ratable installments in accordance with applicable MFA
payroll practices over the 12 month period following such termination (the “Severance Period”). The severance payments
shall commence within 60 days following the date of termination, and the first payment shall include any unpaid installments for the
period prior to commencement.
(ii) The
Executive shall receive a pro-rated portion of the Target Bonus, equal to the product of (A) the Target Bonus for the Performance
Period in which the Notice of Termination is provided, multiplied by (B) a fraction, the numerator of which is the number of days
during such Performance Period that the Executive is actively employed (excluding, for the avoidance of doubt and consistent with Section 5(e),
the Garden Leave Period), and the denominator of which is 365 (such payment, the “Pro-Rated Bonus”), which shall be
paid within 60 days following the Executive’s termination date.
6
(iii) The
Executive shall receive any unpaid Annual Bonus for the Performance Period immediately preceding the date on which the Notice of Termination
is provided (which, for the avoidance of doubt and consistent with Section 5(e) shall not include any Performance Period which
ends during the Garden Leave Period), which shall be paid at the time set forth in Exhibit A.
(iv) The
Company shall reimburse the Executive for 100% of the COBRA premiums incurred by the Executive for the Executive and his eligible dependents
under the Company’s health care plan during the 12 month period following the Executive’s termination of employment. Such
reimbursement shall be provided on the payroll date immediately following the date on which the Executive remits the applicable premium
payment and shall commence within 60 days after the termination date; provided that the first payment shall include any reimbursements
that would have otherwise been payable during the period beginning on the Executive’s termination date and ending on the date of
the first reimbursement payment. Reimbursement payments shall be treated as taxable compensation to the Executive to the extent required
by law.
(v) All
of the Executive’s outstanding equity-based awards (e.g., restricted stock, phantom shares, RSUs and stock options) shall be treated
in accordance with the following (whether granted before or after the Effective Date) and paid at the time set forth in the applicable
award agreement:
(A) Except
as otherwise provided in (C) below, all unvested awards shall immediately vest.
(B) All
vested options shall remain exercisable until the earlier of (I) 90 days following the date of such termination or (II) the
date on which each such option would have expired had the Executive’s employment not terminated.
(C) Any
equity award that is subject to vesting based on the achievement of performance goals shall vest in accordance with the terms and conditions
applicable to such award, determined as though the Executive remained actively employed through the end of the applicable performance
period. For the avoidance of doubt, nothing in this Section 5(c)(v)(C) requires vesting of any equity award if and to the extent
that the applicable performance goals are not achieved as of the end of the applicable performance period.
For the avoidance of doubt, a termination of
the Executive’s employment pursuant to this Section 5(c), Section 5(d), Section 5(f) or Section 5(k) below
shall not be a breach of this Agreement and does not relieve either party of its/his other obligations hereunder.
7
(d) Termination
by the Company for Cause or Voluntary Termination by the Executive. In the event the Executive’s employment is terminated during
the Term of Employment (i) by the Company for Cause, (ii) by the Executive on his own initiative for other than a Good Reason
and other than due to the Executive’s Disability, or (iii) due to the Executive’s failure to renew this Agreement at
the end of the Initial Term or any Extension Term, the Executive shall be entitled only to the amounts set forth in Section 5(g) below.
Notwithstanding any provision of this Agreement, if the Executive’s employment terminates pursuant to the preceding clause (ii),
the Executive’s last day of employment shall be the 90th day following the Company’s receipt of Notice of Termination by
the Executive.
(e) Garden
Leave. The Executive shall provide a Notice of Termination to the Company 90 days prior to any termination of the Executive’s
employment (whether for Good Reason or without Good Reason) during the Term of Employment, other than a termination during the period
described in Section 5(f), and the Company shall provide a Notice of Termination to the Executive 90 days prior to any termination
of the Executive’s employment without Cause during the Term of Employment, other than a termination during the period described
in Section 5(f). During this 90-day notice period (the “Garden Leave Period”), the Executive shall (i) continue
to be an employee of MFA and shall make himself available to provide such services directed by the Company that are reasonably consistent
with the Executive’s status as a senior executive of the Company and (ii) continue to be paid his Base Salary and to be eligible
to participate in the Company’s benefits programs, but shall not be eligible to: (A) earn any Annual Bonus with respect to
a Performance Period that ends on or after the date on which Notice of Termination is provided, (B) receive a Pro-Rated Bonus for
any portion of the Garden Leave Period, or (C) receive any award of RSUs during any Garden Leave Period. For the avoidance of doubt,
the preceding sentence shall not impair the Executive’s right to receive a Pro-Rated Bonus for any period of active employment
pursuant to Section 5(c)(ii) and Section 5(f)(ii). During the Garden Leave Period, the Company may require the Executive
to resign from any position with the Company and/or remove any or all of the Executive’s duties or responsibilities, which shall
not constitute Good Reason or otherwise be a violation of this Agreement. The Executive agrees that he will not commence employment with
any entity during or in connection with the commencement of the Garden Leave Period. During the Garden Leave Period, the Executive shall
take all steps reasonably requested by the Company to effect a successful transition of client and customer relationships to the person
or persons designated by the Company. For the avoidance of doubt, the Garden Leave Period shall not exceed 90 days.
(f) Termination
Related to Change of Control. In the event of the termination of the Executive’s employment during the Term of Employment
by the Company other than for Cause (and other than for Disability, as described in Section 5(a)) or by the Executive for Good Reason,
in either case within 24 months following a Change of Control, or within three months prior to a Change of Control if such termination
is initiated by, at the request or suggestion of, or with the agreement of, the counterparty to the Change of Control, the Executive’s
Term of Employment shall terminate without further obligations to the Executive under this Agreement, except as provided in Section 5(g) below.
In addition and if the requirements of Section 5(j) are met:
(i) MFA
shall immediately pay to Executive in a lump sum, but in all events within 60 days following the date of termination, an amount in cash
equal to two times the sum of (A) the Executive’s then current Base Salary and (B) the Executive’s Target Bonus
for the Performance Period in which a Notice of Termination is delivered; provided that, (A) if Notice of Termination is delivered
prior to December 1, 2026, then for purposes of this Section 5(f)(i) and Section 5(f)(ii), “Target Bonus”
shall mean $750,000 and (B) for purposes of this Section 5(f)(i) and Section (5)(f)(ii), Base Salary and Target Bonus
shall be determined without regard to any reductions giving rise to Good Reason pursuant to Section 6(g)(iv) or Section 6(g)(v);
8
(ii) The
Executive shall receive a Pro-Rated Bonus, which shall be paid within 60 days following the Executive’s termination date;
(iii) (A) All
of the Executive’s outstanding equity-based awards (e.g., restricted stock, phantom shares, RSUs and stock options), whether granted
before or after the Effective Date, shall immediately vest in full and shall be paid at the time set forth in the applicable award agreement;
and (B) any such options shall remain exercisable until the earlier of (I) 90 days following the date of such termination or
(II) the date on which each such option would have expired had the Executive’s employment not terminated; provided that, in
the case of any such award which is subject to vesting based on the achievement of performance goals, such award shall become vested
with respect to a number of shares determined based on actual performance measured as of the date of the Change of Control; provided
further that, to the extent equitable, each applicable performance goal shall be adjusted to account for the reduced performance period
as set forth in the applicable award agreement;
(iv) The
Company shall reimburse the Executive for 100% of the COBRA premiums incurred by the Executive for the Executive and his eligible dependents
under the Company’s health care plan during the 18 month period following the Executive’s termination of employment. Such
reimbursement shall be provided on the payroll date immediately following the date on which the Executive remits the applicable premium
payment and shall commence within 60 days after the termination date; provided that, the first payment shall include any reimbursements
that would have otherwise been payable during the period beginning on the Executive’s termination date and ending on the date of
the first reimbursement payment. Reimbursement payments shall be treated as taxable compensation to the Executive to the extent required
by law; and
(v) The
Executive shall receive any unpaid Annual Bonus for the Performance Period immediately preceding the Executive’s date of termination,
which shall be paid at the time set forth in Exhibit A.
For the avoidance of doubt, if the Executive
is eligible to receive payments and benefits pursuant to this Section 5(f), he shall not be eligible to receive any payments and
benefits pursuant to Section 5(a), 5(b) or 5(c).
9
(g) Other
Payments. Upon the termination of the Executive’s employment during the Term of Employment, in addition to the amounts payable
under any Section above and any accrued but unpaid Base Salary, the Executive shall be entitled to receive the following:
(i) any
vested deferred compensation (including any interest accrued on or appreciation in value of such deferred amounts) in accordance with
the applicable plan documents;
(ii) reimbursement
for reasonable business expenses incurred but not yet reimbursed by the Company; and
(iii) any
other vested benefits to which the Executive or his legal representative may be entitled under all applicable plans and programs of the
Company, as provided in Section 4 above.
(h) Payments
Subject to Section 409A and Other Applicable Law.
(i) This
Agreement and all payments hereunder (including payments pursuant to this Section 5) are intended to comply with or be exempt from
Section 409A of the Code and applicable Treasury regulations thereunder; provided that, MFA shall have no liability for any taxes
or penalties incurred by the Executive pursuant to Section 409A. Notwithstanding anything herein to the contrary, the Executive
shall not be entitled to any payment pursuant to this Section 5 prior to the earliest date permitted under Section 409A of
the Code, and applicable Treasury regulations thereunder. To the extent any payment pursuant to this Section 5 is required to be
delayed six months pursuant to the special rules of Section 409A of the Code related to “specified employees,”
each affected payment shall be delayed until six months after the Executive’s termination of employment, and, unless provided otherwise,
with the first such payment being a lump sum equal to the aggregate payments the Executive would have received during such six-month
period if no payment delay had been imposed. Any payments or distributions delayed in accordance with the prior sentence shall be paid
to the Executive on the first day of the seventh month following the Executive’s termination of employment. If the Executive dies
during the postponement period prior to payment, the amounts delayed shall be paid within 60 days after the date of the Executive’s
death.
(ii) Notwithstanding
any other provision contained herein, to the extent any payments or distributions due to the Executive upon termination of his employment
under this Agreement are subject to Section 409A of the Code, a termination of the Executive’s employment shall be interpreted
in a manner that is consistent with the definition of a “separation from service” under Section 409A of the Code and
the applicable Treasury regulations thereunder. Notwithstanding anything elsewhere to the contrary, the Executive shall have
no duties following any termination of his employment with MFA that are inconsistent with his having a “separation from service”
for purposes of Section 409A of the Code and any regulations thereunder.
10
(iii) To
the extent required by Section 409A of the Code on account of the terms of the Former Agreement, a portion of the installments provided
in Section 5(a)(i) or Section 5(c)(i) shall be paid in a lump sum no later than March 15 of the calendar year
following the calendar year in which the termination date occurs. With respect to the lump sum amounts payable in connection with a Change
of Control set forth in Section 5(a)(i) and Section 5(f)(i), such amounts shall be paid in installments as described in
Section 5(a)(i) and Section 5(c)(i) as though a Change of Control had not occurred, if such Change of Control does
not constitute a “change in control event” for purposes of Section 409A of the Code or if otherwise required by Section 409A
of the Code. For clarity, the provisions of this Section 5 shall not amend the payment timing of any equity award outstanding as
of the Effective Date, as determined in accordance with the terms of the applicable award agreement.
(iv) In
the case of any amounts that are payable to the Executive under this Agreement in the form of installment payments, the Executive’s
right to receive such payments shall be treated as a right to receive a series of separate payments under Treas. Reg. §1.409A-2(b)(2)(iii).
(v) Notwithstanding
anything herein to the contrary, in the event that the reimbursements provided pursuant to Section 5(a)(iii), Section 5(c)(iv) or
Section 5(f)(iv) would subject the Executive or the Company to adverse tax consequences under Section 105(h) of the
Code or any tax penalties, then the parties shall enter into an economically consistent arrangement that does not cause either party
to incur such adverse tax consequences or penalties.
(i) No
Mitigation; No Offset. In the event of any termination of the Executive’s employment under this Agreement, he shall be under
no obligation to seek other employment or otherwise in any way to mitigate the amount of any payment provided for in this Section 5,
and there shall be no offset against amounts due him under this Agreement on account of any remuneration attributable to any subsequent
employment that he may obtain.
(j) Release.
The Company’s obligation to make any payment or provide any benefit pursuant to this Section 5 (other than pursuant to Sections
5(b) and 5(g) above) shall be contingent upon, and is the consideration for, (i) the Executive executing and delivering
to the Company, within 60 days after termination of his employment, a general release (the “Release”), substantially
in the form annexed hereto as Exhibit E (with any revisions necessary to comply with applicable law as reasonably determined
by counsel to MFA and provided in writing to the Executive within five business days after the date of the termination of his employment),
and (ii) such release becoming irrevocable in accordance with its terms within 60 days after termination of employment. In
the event that any payment or benefit is subject to Section 409A of the Code and the 60-day period referred to in the immediately
preceding sentence spans two calendar years, any such payments or benefits required to be made hereunder during such 60-day period shall
be made in the second calendar year, the first payment of which shall include all payments that would otherwise have been made prior
thereto.
11
(k) Change
in Status following an Externalization Event. Notwithstanding anything in this Section 5 to the contrary, in the event that
the circumstances described in clauses (i) or (ii) below occur, then for purposes of this Agreement, the Executive’s
termination of employment shall not constitute a termination by the Company without Cause or a termination by the Executive for Good
Reason, and the Executive shall only be entitled to the amounts set forth in Section 5(g). For the avoidance of doubt, in the event
that the circumstances described in clauses (i) or (ii) below occur, the Executive shall not be eligible to receive the payments
and benefits described in Section 5(c) or Section 5(f).
(i) In
connection with the Executive’s termination of employment, MFA is managed by an external manager pursuant to a management and advisory
contract and such external manager has provided the Executive with an offer of employment (A) on economic terms that are at least
substantially equivalent in form and economic substance (and not in the aggregate) to those provided to the Executive immediately prior
to such termination of employment, and (B) on other terms that would not be deemed to trigger “Good Reason” under the
definition provided herein (an offer of employment that meets the requirements of (A) and (B), a “Qualifying Offer”);
or
(ii) A
Change of Control occurs and immediately following such Change of Control, MFA is managed by an external manager pursuant to a management
and advisory contract and such external manager has provided the Executive with a Qualifying Offer.
(l) Parachute
Payments.
(i) Notwithstanding
any other provisions of this Agreement to the contrary, in the event that it shall be determined that any payment or distribution in
the nature of compensation (within the meaning of Section 280G(b)(2) of the Code) to or for the benefit of the Executive, whether
paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise (the “Payments”),
would constitute an “excess parachute payment” within the meaning of Section 280G of the Code (after taking into consideration
any mitigating factors such as the value of any non-competition restrictions or similar factors), the Company shall reduce (but not below
zero) the aggregate present value of the Payments under the Agreement to the Reduced Amount (as defined below), if reducing the Payments
under this Agreement will provide the Executive with a greater net after-tax amount than would be the case if no such reduction was made
(for clarity, if not reducing the Payments will provide the Executive with a greater net after-tax amount, then no reduction shall occur).
The Payments shall be reduced as described in the preceding sentence only if (A) the net amount of the Payments, as so reduced (and
after subtracting the net amount of federal, state and local income and payroll taxes on the reduced Payments), is greater than or equal
to (B) the net amount of the Payments without such reduction (but after subtracting the net amount of federal, state and local income
and payroll taxes on the Payments and the amount of Excise Tax (as defined below) to which the Executive would be subject with respect
to the unreduced Payments). Only amounts payable under this Agreement shall be reduced pursuant to this Section 5(l), and any reduction
shall be made in accordance with Section 409A of the Code.
12
(ii) The
“Reduced Amount” shall be an amount expressed in present value that maximizes the aggregate present value of Payments
under this Agreement without causing any Payment under this Agreement to be subject to the Excise Tax, determined in accordance with
Section 280G(d)(4) of the Code. The term “Excise Tax” means the excise tax imposed under Section 4999
of the Code, together with any interest or penalties imposed with respect to such excise tax.
(iii) All
determinations to be made under this Section 5(l) shall be made by an independent registered public accounting firm or consulting
firm selected by the Company immediately prior to a change of control, which shall provide its determinations and any supporting calculations
both to the Company and the Executive within ten days of the change of control. Any such determination by such firm shall be binding
upon the Company and the Executive. All fees and expenses of the accounting or consulting firm in performing the determinations referred
to in this Section 5(l) shall be borne solely by the Company.
(m) Resignation
from Positions. Upon termination of the Executive’s employment with the Company for any reason, the Executive shall,
as may be requested by the Company, resign from any position he then holds as an officer, director or fiduciary of the Company or any
Company-related entity. In furtherance of the foregoing, the Executive shall execute and deliver to the Company any letters, documents
and other instruments necessary or appropriate to effect such resignation.
6. Definitions.
For purposes of this Agreement, the following terms shall be defined as set forth below:
(a) Business.
“Business” shall mean any business that is conducted by the Company during the Executive’s employment, or that is under
consideration by the Board of Directors with respect to which the Executive was materially involved or otherwise received Confidential
Information during the 12 months prior to the Executive’s termination of employment.
(b) Cause.
“Cause” shall mean the Executive’s (i) commission of a felony, a crime of moral turpitude or any crime
committed against MFA, other than traffic violations; (ii) engagement in willful misconduct, willful or gross negligence, or fraud,
embezzlement or misappropriation relating to significant amounts, in each case in connection with the performance of his duties under
this Agreement; (iii) failure to adhere to the lawful directions of the Board of Directors or the CEO that are reasonably consistent
with his duties and position provided for herein; (iv) breach in any material respect of any of the provisions of Section 7
of this Agreement; (v) material violation of the Company’s Code of Conduct or any other material written policy of the Company,
including without limitation, the Company’s nondiscrimination and harassment policy; or (vi) breach in any material respect
of the terms and provisions of this Agreement resulting in material and demonstrable economic injury to MFA. Notwithstanding the foregoing,
(i) the Executive shall be given written notice of any action or failure to act that is alleged to constitute Cause (a “Default”),
and if curable, an opportunity for 20 business days from the date of such notice in which to cure such Default, such period to be subject
to extension in the discretion of the CEO and (ii) regardless of whether the Executive is able to cure any Default, the Executive
shall not be deemed to have been terminated for Cause without (A) reasonable prior written notice to the Executive setting forth
the reasons for the decision to terminate the Executive for Cause, (B) an opportunity for the Executive, together with his counsel,
to be heard by the CEO and (C) delivery to the Executive of a Notice of Termination approved by the CEO, stating his good faith
opinion that the Executive has engaged in actions or conduct described in the preceding sentence, which notice specifies the particulars
of such action or conduct in reasonable detail; provided, however, MFA may suspend the Executive with pay until such time as his right
to appear before the CEO, as the case may be, has been exercised, so long as such appearance is within two weeks of the date of suspension.
For avoidance of doubt and notwithstanding the Executive’s cure rights, if any, if MFA reasonably determines that it is necessary
to place the Executive on administrative leave, or to relieve the Executive of some or all of the Executive’s duties so that MFA
may investigate any potential wrongdoing or misconduct, or pending resolution of any act, event or omission giving rise to Cause during
any applicable cure period, MFA’s doing so shall not be deemed to be either a breach by MFA of any provision of this Agreement
or a termination by MFA of the Executive’s employment without Cause nor shall such action constitute a basis for the Executive
to terminate the Executive’s employment for Good Reason.
13
(c) Change
of Control. A “Change of Control” shall mean the occurrence of any one of the following events:
(i) any
“person,” as such term is used in Sections 13(d) and 14(d) of the Act (other than MFA, any of its affiliates or
any trustee, fiduciary or other person or entity holding securities under any employee benefit plan or trust of MFA or any of its affiliates,
and other than the Executive) together with all “affiliates” and “associates” (as such terms are defined in Rule 12b-2
under the Act) of such person, shall become the “beneficial owner” (as such term is defined in Rule 13d-3 under the
Act), directly or indirectly, of securities of MFA representing 30% or more of either (A) the combined voting power of MFA’s
then outstanding securities having the right to vote in an election of the Board of Directors (“voting securities”),
or (B) the then outstanding shares of common stock of MFA (“Shares”) (in either such case other than as a result
of an acquisition of securities directly from MFA); or
(ii) persons
who, as of the Effective Date of this Agreement, constitute MFA’s Board of Directors (the “Incumbent Directors”)
cease for any reason, including, without limitation, as a result of a tender offer, proxy contest, merger or similar transaction, to
constitute at least a majority of the Board of Directors, provided that any person becoming a Director of MFA subsequent to the Effective
Date whose election or nomination for election was approved and/or ratified by a vote of at least a majority of the Incumbent Directors
shall, for purposes of this Agreement, be considered an Incumbent Director; or
14
(iii) consummation
of (A) any consolidation or merger of MFA or any subsidiary where the stockholders of MFA, immediately prior to the consolidation
or merger, would not, immediately after the consolidation or merger, beneficially own (as such term is defined in Rule 13d-3 under
the Act), directly or indirectly, shares representing in the aggregate 50% or more of the voting securities of the corporation issuing
cash or securities in the consolidation or merger (or of its ultimate parent corporation, if any), (B) any sale, lease, exchange
or other transfer (in one transaction or a series of transactions contemplated or arranged by any party as a single plan) of all or substantially
all of the assets of MFA or (C) any plan for the liquidation or dissolution of MFA.
Notwithstanding the foregoing, a “Change
of Control” shall not be deemed to have occurred for purposes of the foregoing clause (i) solely as the result of an acquisition
of securities by MFA which, by reducing the number of Shares or other voting securities outstanding, increases (x) the proportionate
number of Shares beneficially owned by any person to 30% or more of the Shares then outstanding or (y) the proportionate voting
power represented by the voting securities beneficially owned by any person to 30% or more of the combined voting power of all then outstanding
voting securities; provided, however, that, if any person referred to in clause (x) or (y) of this sentence shall thereafter
become the beneficial owner of any additional Shares or other voting securities (other than pursuant to a stock split, stock dividend,
or similar transaction), then a “Change of Control” shall be deemed to have occurred for purposes of this Section 6(c).
(d) Code.
“Code” shall mean the Internal Revenue Code of 1986, as amended.
(e) Competitor.
“Competitor” shall mean any entity or person that is engaged in the Business, including, without limitation, (i) any
mortgage REIT, (ii) any entity or person engaged in any element of acquiring mortgage backed securities (“MBS”),
single family residential mortgage loans (“Whole Loans”), credit risk transfer securities (“CRTs”)
or other products or instruments in which the Company invests, including any private or public investment firm or broker dealer whose
business strategy is based on or who engages in the trading, sales, investment or management of such securities, products or instruments,
(iii) any entity that manages or advises (including any external advisor) either (A) a mortgage REIT or (B) an entity
or person engaged in any element of acquiring MBS, Whole Loans, CRTs or other products or instruments in which the Company invests, including
any private or public investment firm or broker dealer whose business strategy is based on or who engages in the trading, sales, investment
or management of such securities, products or instruments, and (iv) any entity or person engaged in the management or sale of single
family residential real estate that is acquired as a result of foreclosure, short sale, deed-in-lieu or other actions undertaken by such
entity or person in respect of investments made by such entity or person in Whole Loans.
15
(f) Disability.
“Disability” shall mean the Executive’s inability for a period of six consecutive months, to render substantially
the services provided for in this Agreement with or without a reasonable accommodation by reason of mental or physical disability, whether
resulting from illness, accident or otherwise, other than by reason of chronic or persistent abuse of any substance (such as narcotics
or alcohol), provided that a Disability for purposes of Section 5(a) shall qualify as a Disability under Section 409A
of the Code to the extent required by Section 409A of the Code. Notwithstanding the foregoing, no circumstances or condition shall
constitute a Disability to the extent that, if it were, a 20% tax would be imposed under Section 409A of the Code; provided that,
in such a case, the event or condition shall continue to constitute a Disability to the maximum extent possible (e.g., if applicable,
in respect of vesting without an acceleration of distribution) without causing the imposition of such 20% tax. In addition, nothing herein
shall limit or restrict the payment of any amount subject to Section 409A of the Code upon an otherwise permitted payment event
under Section 409A of the Code, including upon a separation from service.
(g) Good
Reason. “Good Reason” shall mean:
(i) a
material diminution in the Executive’s title, duties or responsibilities (other than in connection with the Executive’s disability);
(ii) relocation
of the Executive’s place of employment without his consent outside the New York City metropolitan area;
(iii) the
failure of MFA to pay within 60 business days any material payment or benefits due from MFA;
(iv) the
material failure by MFA to honor any of its material obligations to the Executive; or
(v) solely
for purposes of Section 5(f), a reduction in any of: Base Salary, Target Bonus, TRSU Grant Date Value (as defined in Exhibit B
hereto) or PRSU Grant Date Value (as defined in Exhibit B hereto) from the level in effect immediately prior to such reduction or,
in the case of the RSUs, from the most recent annual grant received by the Executive prior to such reduction.
For Good Reason to exist, the Executive must
provide written notice of an event purportedly constituting Good Reason within 90 days of its occurrence, MFA must have failed to cure
such event within 15 days of such notice and the Executive must provide written notice of his decision to terminate employment, such
notice to be provided within 15 days of the expiration of such cure period. The effective date of such termination shall be
the end of the period of Garden Leave.
(h) Notice
of Termination. “Notice of Termination” means the written notice of termination of the Executive’s employment
delivered by, as applicable, the Executive or MFA.
(i) Restricted
Period. “Restricted Period” shall mean the period commencing on the Effective Date and ending on the first anniversary
of the Executive’s termination of employment for any reason; provided that, the Restricted Period shall be reduced by any applicable
Garden Leave Period that arises in connection with the Executive’s termination of employment or, if applicable, any period of notice
provided pursuant to Section 1(b).
16
7. Covenants.
(a) Confidentiality.
During the Term of Employment, and at all times thereafter, the Executive shall maintain the confidentiality of all confidential or proprietary
information of the Company, or of any other person or entity with which the Executive has been involved as a direct or indirect result
of his employment by, or performance of consulting or other services (including, without limitation, as a director, officer, advisor,
agent, consultant or other independent contractor) for, the Company (“Confidential Information”), and, except in furtherance
of his employment by the Company or as specifically required by law or by court order or as permitted by Section 7(g) or in
the course of carrying out his duties for the Company, he shall not directly or indirectly disclose any such information to any person
or entity; nor shall he use Confidential Information for any purpose except for the benefit of the Company. For purposes of this Agreement,
“Confidential Information” includes, without limitation: client or customer lists, identities, contacts, business
and financial information; investment strategies; pricing information or policies, fees or commission arrangements of the Company; marketing
plans, projections, presentations or strategies of the Company; financial and budget information of the Company; personnel information,
personnel lists, resumes, personnel data, organizational structure, compensation and performance evaluations; information regarding the
existence or terms of any agreement or relationship between the Company and any other party; and any other information of whatever nature,
which gives to the Company an opportunity to obtain an advantage over its competitors who or which do not have access to such information.
This restriction shall apply regardless of whether such Confidential Information is in written, graphic, recorded, photographic, data
or any machine readable form or is orally conveyed to, or memorized by, the Executive; provided, however, that this Section 7(a) shall
not apply to Confidential Information that is or becomes publicly known through no act or omission on the Executive’s part. Anything
to the contrary notwithstanding, nothing in this Agreement shall prevent the Executive from retaining papers and other materials of a
personal nature, including personal diaries, calendars and Rolodexes, information relating to his compensation or relating to reimbursement
of expenses, and copies of plans, programs and agreements relating to his employment.
17
(b) Non-Competition
and Non-Solicitation. The Executive acknowledges that during the Executive’s employment with the Company prior to and after
the Effective Date, (I) the Executive has had and will continue to have access to trade secrets and other Confidential Information
of the Company, which, if disclosed, would unfairly and inappropriately assist in competition against the Company; (II) in the course
of the Executive’s employment by a Competitor during the Restricted Period, there is significant risk that the Executive would
disclose or improperly use such trade secrets and Confidential Information; (III) the Company has substantial relationships with
its customers and the Executive has had and will continue to have access to these customers; (IV) the Executive has generated and
will continue to generate goodwill for the Company in the course of the Executive’s employment; and (V) the Executive’s
services are unique and irreplaceable. Therefore, in consideration of the Executive’s continued employment with the
Company, of the compensation and benefits provided to the Executive under this Agreement, of MFA’s agreement to make severance
benefits available pursuant to Section 5, and of the Executive’s being granted access to the customers, trade secrets and
other Confidential Information of the Company, the Executive agrees that the following restrictions on the Executive’s activities
during and after the Executive’s employment are necessary, appropriate and reasonable to protect the goodwill, Confidential Information
and other legitimate interests of the Company from unfair and inappropriate competition:
(i) During
the Restricted Period, the Executive will not, without the prior written consent of MFA, within the United States, manage, operate, control
or be connected as a stockholder (other than as a holder of shares publicly traded on a stock exchange or the NASDAQ National Market
System, provided that the Executive shall not own more than five percent of the outstanding shares of any publicly traded company) or
partner with, or serve as an officer, director, employee or consultant of, any Competitor. Notwithstanding the foregoing, nothing herein
shall prevent the Executive during the Restricted Period from providing services to or otherwise being associated with an entity that
is engaged in the Business so long as (A) the Executive’s services are not provided, directly or indirectly, within the division,
subsidiary, affiliate or business unit of the entity that engages in the Business and (B) the Executive has no responsibilities
regarding such Business.
(ii) During
the Restricted Period, the Executive will not, without the prior written consent of MFA, directly or indirectly (individually,
or through or on behalf of another entity as owner, partner, agent, employee, consultant, or in any other capacity), engage in any activity
intentionally to interfere with, disrupt, diminish or damage the business of the Company, or its relationship with any client, supplier
or other business relationship of the Company.
(iii) During
the Executive’s employment with the Company and during the period commencing on the Executive’s date of termination of employment
for any reason and ending on the second anniversary of the Executive’s termination of employment, the Executive will not, without
the prior written consent of MFA, directly or indirectly (individually, or through or on behalf of another entity as owner,
partner, agent, employee, consultant, or in any other capacity), (A) solicit, encourage, or engage in any activity to induce any
employee of MFA or its affiliates to terminate employment with MFA or its affiliates, or to become employed by, or to enter into a business
relationship with, any other person or entity; or (B) hire or retain any person who was an employee of MFA or its affiliates within
the six month period preceding such action; provided that, (x) this Section 7(b)(iii) shall not apply to any administrative
employee of MFA or its affiliates or any person who was an administrative employee of MFA or its affiliates and (y) any hiring or
solicitation pursuant to a general solicitation conducted by an entity that has hired or agreed to hire the Executive and that does not
directly or indirectly target current or former employees of MFA or its affiliates, or by a headhunter employed by such entity, which
in either case does not involve the Executive, shall not be a violation of this Section 7(b)(iii).
18
(c) MFA
Materials. The Executive acknowledges that all originals and copies of materials, records and documents generated by him or coming
into his possession during his employment by MFA are the sole property of MFA (“MFA Materials”). During his employment,
and at all times thereafter, the Executive shall not remove, or cause to be removed, from the premises of MFA, copies of any record,
file, memorandum, document, computer related information or equipment, or any other item relating to the business of MFA, except in furtherance
of his duties under this Agreement. When the Executive terminates his employment with MFA, or upon request of MFA at any time, the Executive
shall promptly deliver to MFA all originals and copies of MFA Materials in his possession or control and shall not retain any originals
or copies in any form. The Executive further agrees to delete or destroy any and all documents, files and/or backup files containing
MFA Materials on any computer or storage device owned by and/or within the care, custody or control of the Executive.
(d) No
Disparagement. Each of the Executive and MFA agrees that, except as required by applicable law or compelled by process of law or
as otherwise permitted pursuant to Section 7(g), during and after the Term of Employment they shall not make any derogatory, disparaging
or critical statement about the other party hereto or, further in the case of statements by the Executive about (i) MFA, its parent,
affiliates, or subsidiaries, if any; (ii) any product or service provided by MFA and its parent, affiliates or subsidiaries, if
any; or (iii) MFA’s and its parent’s, affiliates’ or subsidiaries’, if any, prospects for the future. Nothing
in this Section 7(d) shall (A) prohibit either MFA or the Executive from testifying truthfully in any legal or administrative
proceeding or from truthfully responding to any untrue statement by the other party or (B) prohibit the Executive from making truthful
statements in the course of carrying out his duties for MFA.
(e) Cooperation
with Respect to Litigation. During the Term of Employment and at all times thereafter, the Executive agrees to give prompt written
notice to MFA of any claim against the Company after becoming aware of such claim and (to the extent reasonably requested by MFA) to
reasonably cooperate, in good faith and to the best of his ability, with MFA in connection with any and all pending, potential or future
claims, investigations or actions which directly or indirectly relate to any action, event or activity about which the Executive may
have knowledge in connection with or as a result of his employment by the Company. Such cooperation will include all assistance that
MFA, its counsel or representatives may reasonably request, including reviewing documents, meeting with counsel, providing factual information
and material, and appearing or testifying as a witness; provided, however, that MFA will promptly reimburse the Executive for all reasonable
expenses, including travel, lodging and meals, incurred by him in fulfilling his obligations under this Section 7(e) and, except
as may be required by law or by court order, should the Executive then be employed by an entity other than MFA, such cooperation will
not materially interfere with the Executive’s then current employment.
(f) Remedies.
(i) The
Executive agrees that these restraints are necessary for the reasonable and proper protection of the Company and its trade secrets and
Confidential Information and that each and every one of the restraints is reasonable in respect to subject matter, length of time and
geographic area, and that these restraints, individually or in the aggregate, will not prevent the Executive from obtaining other suitable
employment during the period in which the Executive is bound by the restraints. The Executive agrees that, before providing
services, whether as an employee or consultant, to any entity during the Restricted Period, the Executive will provide a copy of this
Agreement to such entity and will certify in writing to MFA that he has done so. Notwithstanding the foregoing terms, nothing in this
Section 7 shall otherwise restrict or limit the Executive from providing services following the termination of the Executive’s
employment that are not expressly prohibited by the restrictions herein.
19
(ii) The
Executive acknowledges that each of these covenants has a unique, very substantial and immeasurable value to the Company, that the Executive
has sufficient assets and skills to provide a livelihood while such covenants remain in force and that, as a result of the foregoing,
in the event that the Executive breaches such covenants, monetary damages would be an insufficient remedy for the Company and equitable
enforcement of the covenant would be proper. The Executive therefore agrees that the Company, in addition to any other remedies
available to it, will be entitled to preliminary and permanent injunctive relief against any breach by the Executive of any of those
covenants, without the necessity of showing actual monetary damages or the posting of a bond or other security. The Executive
also agrees that, in addition to any other remedies available to the Company and notwithstanding any provision of this Agreement to the
contrary, in the event Executive breaches in any material respect any of his obligations under this Section 7, the Company may immediately
cease all payments under Sections 5(a), 5(b), 5(c) or 5(f) as applicable, all equity-based awards granted under this Agreement
may be immediately forfeited, and the Company may require that the Executive repay any after-tax amounts previously paid to the Executive
under Sections 5(a), 5(b) or 5(c) , as applicable, and any stock delivered or other amounts paid (each on an after-tax basis)
with respect to any equity-based awards granted under this Agreement.
(iii) The
Executive and MFA further agree that each restriction set forth in this Section 7 and each distinct portion and application of each
such restriction is intended to be separate and independent. If any such restriction, or any distinct and grammatically severable portion
thereof, is determined to be invalid or unenforceable, such restriction or portion may be severed only to the extent permitted by applicable
law, and the remaining restrictions and portions shall remain in full force and effect. Nothing in this Agreement shall be construed
to authorize a court to add to, rearrange, revise or otherwise rewrite any restriction, except to the extent permitted by applicable
law. The Executive further covenants that the Executive will not challenge the reasonableness or enforceability of any of the covenants
set forth in this Section 7, it being understood that the Executive shall not be considered to have challenged the enforceability
of this Section 7 by arguing that his conduct did not, in fact, violate the terms of this Section 7. The Executive further
covenants that he will reimburse MFA and its affiliates for all costs (including reasonable attorneys’ fees) incurred in connection
with any action to enforce any of the provisions of this Section 7 if either MFA and/or its affiliates prevails on any material
issue involved in such dispute or if the Executive challenges the reasonability or enforceability of any of the provisions of this Section 7.
It is also agreed that each of MFA’s affiliates will have the right to enforce all of the Executive’s obligations to that
affiliate under this Agreement, including without limitation pursuant to this Section 7.
20
(g) Permitted
Conduct.
(i) Nothing
in this Agreement, including the obligations set forth in this Section 7, restricts or prohibits the Executive from initiating communications
directly with, responding to any inquiries from, providing testimony before, providing confidential information to, reporting possible
violations of law or regulation to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority
or a government agency or entity, including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor
Relations Board, the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General (collectively,
the “Regulators”), or from making other disclosures that are protected under the whistleblower provisions of state
or federal law or regulation. The Executive does not need the prior authorization of the Company to engage in such communications with
the Regulators, respond to such inquiries from the Regulators, provide confidential information or documents to the Regulators, or make
any such reports or disclosures to the Regulators. The Executive is not required to notify the Company that he has engaged in such communications
with the Regulators.
(ii) The
Company hereby notifies the Executive that federal law provides criminal and civil immunity to federal and state claims for trade secret
misappropriation to individuals who disclose a trade secret to their attorney, a court, or a government official in certain, confidential
circumstances that are set forth at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related to the reporting or investigation
of a suspected violation of the law, or in connection with a lawsuit for retaliation for reporting a suspected violation of the law.
Nothing in this Agreement is intended to limit any rights under such federal law.
8. Indemnification.
MFA shall indemnify the Executive to the fullest extent permitted by Maryland law as amended from time to time in connection with the
Executive’s duties with MFA, against all costs, expenses, liabilities and losses (including, without limitation, attorneys’
fees, judgments, fines, penalties, ERISA excise taxes and amounts paid in settlement) actually and reasonably incurred by the Executive
in connection with an action, suit or proceeding. While the Executive is an officer of MFA, and for six years thereafter, MFA (or any
successor thereto) shall provide comprehensive coverage under its officers and directors insurance policy (or policies) on substantially
the same terms and levels that it provides to its senior executive officers, at MFA’s sole cost.
21
9. Clawback
Policy. The Executive agrees that all bonuses, equity compensation and other incentive compensation provided by the Company shall
be subject to any applicable clawback policy implemented by the Board of Directors from time to time.
10. Assignability;
Binding Nature. This Agreement shall inure to the benefit of MFA and the Executive and their respective successors, heirs (in the
case of the Executive) and assigns. No rights or obligations of MFA under this Agreement may be assigned or transferred by MFA except
that any such rights or obligations may be assigned or transferred pursuant to a merger or consolidation in which MFA is not the continuing
entity, or the sale or liquidation of all or substantially all of the assets of MFA, provided that the assignee or transferee is the
successor to all or substantially all of the assets of MFA and such assignee or transferee assumes the liabilities, obligations and duties
of MFA, as contained in this Agreement, either contractually or as a matter of law. This Agreement shall not be assignable by the Executive;
provided however that, in the event of the Executive’s death or a judicial determination of his incapacity, references to the Executive
in this Agreement shall be deemed, as appropriate, to be references to his heirs, executor(s) or other legal representative(s).
11. Representation.
MFA and the Executive each represent and warrant that it or he is fully authorized and empowered to enter into this Agreement and that
its or his entering into this Agreement and the performance of its or his obligations under this Agreement will not violate any agreement
to which it or he is a party.
12. Entire
Agreement. This Agreement contains the entire agreement between MFA and the Executive concerning the subject matter hereof and upon
the Effective Date supersedes all prior agreements, understandings, discussions, negotiations and undertakings, whether written or oral,
between them with respect thereto, including without limitation, the Former Agreement.
13. Amendment
or Waiver. This Agreement can only be changed, modified or amended in a writing that is signed by both the Executive and MFA and
that specifically identifies the provision(s) of this Agreement that are being changed, modified or amended. No waiver by either
MFA or the Executive at any time of any breach by the other party of any condition or provision of this Agreement shall be deemed a waiver
of a similar or dissimilar condition or provision at the same or at any prior or subsequent time. Any waiver must be in writing and signed
by the Executive or the Board of Directors, as the case may be.
14. Severability.
In the event that any provision or portion of this Agreement shall be determined to be invalid or unenforceable for any reason, in whole
or in part, the remaining provisions of this Agreement shall be unaffected thereby and shall remain in full force and effect to the fullest
extent permitted by law.
15. Reasonableness.
Except as otherwise provided in Section 7, to the extent that any provision or portion of this Agreement is determined to be unenforceable
by a court of law or equity, that provision or portion of this Agreement shall nevertheless be enforceable to the extent that such court
determines is reasonable.
16. Survivorship.
The respective rights and obligations of the parties hereunder shall survive any termination of this Agreement to the extent necessary
to the intended preservation of such rights and obligations. For the avoidance of doubt, the covenants in Section 7 of this Agreement
shall survive any termination or expiration of this Agreement and termination of the Executive’s employment for any reason.
22
17. Governing
Law. This Agreement, the rights and obligations of the parties hereto, and any claims or disputes relating thereto, shall be governed
by and construed in accordance with the laws of the State of Maryland (without regard to its choice of law provisions). Each
of the parties agrees that any dispute between the parties shall be resolved only in the courts of the State of Maryland or the United
States District Court for the District of Maryland and the appellate courts having jurisdiction of appeals in such courts. In
that context, and without limiting the generality of the foregoing, each of the parties hereto irrevocably and unconditionally (a) submits
for himself or itself in any proceeding relating to this Agreement or the Executive’s employment by MFA or any affiliate, or for
the recognition and enforcement of any judgment in respect thereof (a “Proceeding”), to the exclusive jurisdiction
of the courts of the State of Maryland, the court of the United States of America for the District of Maryland, and appellate courts
having jurisdiction of appeals from any of the foregoing, and agrees that all claims in respect of any such Proceeding shall be heard
and determined in such Maryland State court or, to the extent permitted by law, in such federal court; (b) consents that any such
Proceeding may and shall be brought in such courts and waives any objection that he or it may now or thereafter have to the venue or
jurisdiction of any such Proceeding in any such court or that such Proceeding was brought in an inconvenient court and agrees not to
plead or claim the same; (c) waives all right to trial by jury in any Proceeding (whether based on contract, tort or otherwise)
arising out of or relating to this Agreement or the Executive’s employment by MFA or any affiliate, or his or its performance under
or the enforcement of this Agreement; (d) agrees that service of process in any such Proceeding may be effected by mailing a copy
of such process by registered or certified mail (or any substantially similar form of mail), postage prepaid, to such party at his or
its address as provided in Section 19; and (e) agrees that nothing in this Agreement shall affect the right to effect service
of process in any other manner permitted by the laws of the State of Maryland.
18. Legal
Fees.
(a) MFA
shall pay directly all reasonable legal fees incurred by the Executive in connection with the negotiation, preparation and execution
of this Agreement up to $10,000.
(b) Subject
to Section 7(f), MFA shall reimburse the Executive (and his beneficiaries) any reasonable costs and expenses (including, without
limitation, reasonable attorneys’ fees and other reasonable costs of counsel) incurred by the Executive (or any of his beneficiaries)
in resolving any controversy, dispute or claim arising out of or relating to this Agreement (including, for the avoidance of doubt, with
respect to any equity grant described in this Agreement), if the Executive (or his beneficiaries) is the prevailing party with respect
to at least one material issue asserting a material breach of such Agreement by the Company.
19. Notices.
Any notice given to either party shall be in writing and shall be deemed to have been given when delivered (a) personally, (b) via
electronic mail with proof of delivery, (c) by an overnight courier with proof of delivery, or (d) via certified or registered
mail, postage prepaid, return receipt requested, in each case, duly addressed to the party concerned, if to MFA, at its principal executive
office (or, in the case of electronic mail, addressed to the General Counsel), and if to the Executive, at the address of the Executive
shown on MFA’s records (or, in the case of electronic mail, addressed to the Executive’s employment email address or personal
email address on file with MFA) or at such other address as such party may give notice of.
23
20. Headings.
The headings of the Sections contained in this Agreement are for convenience only and shall not be deemed to control or affect the meaning
or construction of any provision of this Agreement.
21. Counterparts.
This Agreement may be executed in two or more counterparts. Signatures delivered by facsimile (including by “pdf”)
shall be deemed effective for all purposes.
[remainder of the page left intentionally
blank]
24
IN WITNESS WHEREOF, the undersigned
have executed this Agreement as of the date first written above.
MFA FINANCIAL, INC.
By:
/s/
Craig L. Knutson
Name: Craig L. Knutson
Title: Chief Executive Officer
EXECUTIVE:
By:
/s/
Michael C. Roper
Name:
Michael C. Roper
25
Exhibit A
Annual Performance Bonus
The following summarizes the material terms of
the Annual Bonus for the Performance Period beginning December 1, 2026 and each subsequent Performance Period during the Term in
accordance with Section 3(b) of the Agreement to which this Exhibit A is attached. Unless otherwise specified in
this Exhibit A, all defined terms have the meanings set forth in the Agreement.
1. Performance
Period. The Annual Bonus shall be payable for each Performance Period. The Executive shall be eligible to receive the Annual Bonus
only if the Executive remains employed by the Company through the date on which the Annual Bonus is paid; provided that, the Executive
shall receive any unpaid Annual Bonus for the Performance Period immediately preceding the Executive’s date of termination of employment
(which, for the avoidance of doubt and consistent with Section 5(e) of the Agreement shall not include any Performance Period
which ends during the Garden Leave Period), if the Executive’s employment is terminated by the Company without Cause or by the
Executive for Good Reason, or if the Executive’s employment is terminated by death or Disability, subject to compliance with Section 5(j) of
the Agreement (except in the event of death). Any Annual Bonus shall be subject to achievement of the performance goals described herein.
The Executive shall not receive any unpaid Annual Bonus in the event the Executive’s employment is terminated by the Company for
Cause or by the Executive (other than for Good Reason as described above).
2. Target
Bonus. For each Performance Period, the Executive’s target annual bonus (the “Target Bonus”) shall be $850,000.
The Compensation Committee may increase or decrease the Executive’s Target Bonus for a Performance Period; provided that, the Executive’s
Target Bonus may only be decreased if such decrease is part of an overall Company reduction of executive target bonuses and the applicable
decrease (on a percentage basis) is substantially equivalent to that applicable to other senior executives of MFA. For the avoidance
of doubt, if the Executive’s Target Bonus is increased for any Performance Period, such increased amount shall constitute the “Target
Bonus” for all purposes of this Agreement and any decrease of such Target Bonus shall be subject to the proviso in the preceding
sentence.
3. Calculation
of Annual Bonus. The Executive is eligible to receive an Annual Bonus from zero to two times the Target Bonus for each Performance
Period, and the actual amount of the Annual Bonus payable to the Executive, if any, for each Performance Period, shall be determined
by the Compensation Committee in accordance with the following: (a) 75% of the Target Bonus shall be based on achievement of objective
performance goals established by the Compensation Committee, and (b) 25% of the Target Bonus shall be based on such factors as determined
by the Compensation Committee, including individual performance.
4. Payment
of Annual Bonus. The Annual Bonus shall be paid in cash between January 1 and March 15 following the end of the Performance
Period. All determinations with respect to the Annual Bonus, including the amount, if any, which is payable to the Executive for each
Performance Period, shall be made by the Compensation Committee, in good faith. Any such determinations shall be final and binding on
the Executive and MFA.
26
Exhibit B
Summary of the Company’s Long Term Incentive
Program
The following summarizes certain material components
of the Company’s Long Term Incentive Program as applicable to grants under Section 3(c) of the Agreement to which this
Exhibit B is attached. Notwithstanding any provision of the Agreement or this Exhibit B, all grants under Section 3(c) of
the Agreement shall be subject to, and consistent with, the terms and conditions of the Equity Compensation Plan and the Award Agreements.
Unless otherwise specified in this Exhibit B, all defined terms have the meanings set forth in the Agreement.
1. Annual
Grants.
To the extent that the Executive is still employed
by MFA on each applicable grant date and has not delivered or received a Notice of Termination, within the first five trading days of
each calendar year during the Term of Employment, the Executive shall receive grants of RSUs subject to time vesting (“TRSUs”)
and RSUs which vest based on the achievement of performance goals (“PRSUs”). The TRSU and PRSU grants shall be subject
to the terms of the applicable Award Agreements and the Equity Compensation Plan.
2. TRSUs
The annual grant of TRSUs will provide for a
grant of TRSUs with respect to a number shares of MFA common stock equal to a specified dollar value (the “TRSU Grant Date Value”)
divided by the closing price of MFA common stock on the date of grant, rounded to the nearest whole share. The TRSU Grant Date Value
shall be equal to $500,000; provided that, the Committee may increase or decrease such amount upon reasonable notice and consultation
with the Executive.
The TRSUs will become fully vested on the third
December 31 following the date of grant, provided that the Executive remains employed for the entire vesting period and subject
to vesting as set forth in the applicable Award Agreement, and as described in Sections 5(a), 5(b), 5(c) and 5(f) of the Agreement.
Any unvested TRSUs shall be forfeited as of the date of Executive’s termination of employment, except as provided in the applicable
Award Agreement, as described in Sections 5(a), 5(b), 5(c) and 5(f) of the Agreement.
Upon the settlement date set forth in the applicable
Award Agreement, the Executive will receive one share of common stock of MFA for each vested TRSU.
In the event that dividends are declared with
respect to the common stock of MFA during the period in which the TRSUs are outstanding, the Executive shall be credited with an amount,
per TRSU, equal to the amount of dividends declared and paid in respect of one share of common stock of MFA. Such credited amount
will be credited and paid in accordance with, and subject to the terms of, Exhibit C.
3. PRSUs
As further described below, 50% of each annual
grant of PRSUs (the “Absolute TSR PRSUs”) will vest based on MFA’s average total shareholder return (“Average
TSR”) for the three year performance period beginning on January 1 of the year of grant (the “TSR Performance
Period”), and 50% of each annual grant of PRSUs (the “Relative TSR PRSUs”) will vest based on MFA’s
TSR compared to the TSR of designated peer group companies, as set forth in the applicable Award Agreement, during the TSR Performance
Period.
27
Each annual grant of PRSUs will provide for a
target grant of Absolute TSR PRSUs (the “Absolute TSR Target Award”) and a target grant of Relative TSR PRSUs (the
“Relative TSR Target Award”).
The Absolute TSR Target Award shall be a number
of PRSUs equal to (a) divided by (b), where (a) is equal to 50% of the PRSU Grant Date Value (as defined below) and (b) is
equal to the grant date fair value per unit of one Absolute TSR PRSU. The Relative TSR Target Award shall be a number of PRSUs equal
to (a) divided by (b), where (a) is equal to 50% of the PRSU Grant Date Value and (b) is equal to the grant date fair
value per unit of one Relative TSR PRSU. The “PRSU Grant Date Value” shall be equal to $750,000, provided that, the Committee
may increase or decrease such amount upon reasonable notice and consultation with the Executive.
Each TSR Performance Period shall be the three-year
period beginning on January 1st of the calendar year in which the applicable grant of PRSUs is made.
The PRSUs will vest on the last day of the applicable
TSR Performance Period, to the extent that the total shareholder return performance goals described below are achieved, provided that
the Executive remains employed for the entire vesting period and subject to vesting as set forth in the applicable Award Agreement, as
described in Sections 5(a), 5(b), 5(c) and 5(f) of the Agreement. Any unvested PRSUs shall be forfeited as of the date of Executive’s
termination of employment, except as provided in the applicable Award Agreement, as described in Sections 5(a), 5(b), 5(c) and 5(f) of
the Agreement.
Upon the settlement date set forth in the applicable
Award Agreement, the Executive will receive one share of common stock of MFA for each vested PRSU. Notwithstanding anything to the contrary
in this Exhibit B, the fair market value of the shares of MFA common stock delivered, measured as of the last day of the TSR Performance
Period (or, if earlier, the date on which the PRSUs are settled pursuant to terms of the applicable Award Agreement), shall not exceed
400% of the fair market value of the target amount of PRSUs measured on the grant date (the “Maximum Cap”), and any
and all amounts otherwise payable pursuant to the applicable Award Agreement in excess of the Maximum Cap shall be forfeited, provided
that, payment with respect to the dividend equivalent rights described below for dividends declared and paid following the end of the
Performance Period shall not count against the Maximum Cap.
For purposes of the PRSUs, TSR of MFA and each
applicable peer group company for the vesting period shall be calculated as follows:
· “TSR”
is equal to (x) the Average Final Price minus the Average Initial Price, plus Dividends
Paid on common stock in respect of the TSR Performance Period, divided by (y) the Average
Initial Price.
28
· The
“Average Initial Price” is equal to the average of the daily closing price
of common stock during the last 20 trading days immediately prior to the first day of the
TSR Performance Period.
· The
“Average Final Price” is equal to the average of the daily closing price
of common stock during the last 20 trading days in the TSR Performance Period.
· The
“Dividends Paid” shall equal the cumulative dividends (including any stock
dividends) paid per share of common stock in respect of the TSR Performance Period. For this
purpose, dividends declared, but not yet paid, on a share within the 45 day period preceding
the applicable vesting date will be counted as Dividends Paid. Notwithstanding the foregoing,
if any dividends were included in Dividends Paid for purposes of calculating TSR for the
year prior to the year in which the TSR Performance Period commences, then such dividends
will not be included in Dividends Paid for purposes of calculating TSR for any subsequent
performance period.
Absolute TSR PRSUs
For purposes of the TSR PRSUs, the “Average
TSR” for the Performance Period is the TSR, divided by 3, and the “Target TSR” is an 8% per annum simple
cumulative return over the TSR Performance Period. MFA’s Average TSR will be compared to the Target TSR to determine whether and
to what extent the Absolute TSR PRSUs will vest.
The number of Absolute TSR PRSUs that will vest
at the end of the Performance Period shall be determined by comparing the MFA’s Average TSR to the Target TSR (8% per year), up
to a maximum vesting of 200% of the Absolute TSR Target Award (subject to the Maximum Cap described above). Any Absolute TSR PRSUs that
do not vest at the end of the TSR Performance Period shall be forfeited.
Example Calculations
Set forth below are examples addressing
vesting of Absolute TSR PRSUs. The examples below are intended to be used purely for illustrative purposes and assume that the Absolute
TSR Target Award for the applicable grant of Absolute TSR PRSUs is equal to 50,000, and assume that the Maximum Cap does not apply.
Example 1:
If MFA’s Average TSR over the
TSR Performance Period was 2%, then the portion of the Absolute TSR PRSUs that would be eligible to vest would be equal to: (2/8) of
the Absolute TSR Target Award, or 12,500 PRSUs.
Example 2:
If MFA’s Average TSR over the
TSR Performance Period was 12%, then the portion of the Absolute TSR PRSUs that would be eligible to vest would be equal to: (12/8) of
the Absolute TSR Target Award, or 75,000 PRSUs.
29
Example 3:
If MFA’s Average TSR over the
TSR Performance Period was 16%, then the portion of the Absolute TSR PRSUs that would be eligible to vest would be equal to (16/8) of
the Absolute TSR Target Award, or 100,000 PRSUs (maximum vesting).
Relative TSR PRSUs
At the end of each TSR Performance Period, MFA’s
TSR and the TSR of each of the designated peer group companies will be ranked from highest to lowest, and the “Relative TSR
Vesting Percentage” shall be determined based on MFA’s TSR as compared to the TSR of the designated peer group companies
for the TSR Performance Period as follows:
MFA’s
TSR Rank
Relative
TSR Vesting Percentage
80th
percentile or above
200%
50th
percentile
100%
25th
percentile or below
0%
If MFA’s TSR Rank is between the 25th percentile
and the 50th percentile, or between the 50th percentile and the 80th percentile, the Relative TSR Vesting Percentage will be interpolated.
Notwithstanding the provisions set forth above,
in the event that the MFA’s TSR is a negative number, the Relative TSR Vesting Percentage shall not exceed 100%.
The number of Relative TSR PRSUs that will vest
for the TSR Performance Period shall be determined by multiplying the Relative TSR Target Award by the Relative TSR Vesting Percentage.
For the avoidance of doubt, in no event shall
any Relative TSR PRSUs vest if MFA’s TSR Rank is at or below the 25th percentile.
The Executive shall not be eligible to receive
more than 200% of the Relative TSR Target Award based on MFA’s TSR Rank.
Example Calculations
Set forth below are examples addressing
vesting of Relative TSR PRSUs. The examples below are intended to be used purely for illustrative purposes and assume that the Relative
TSR Target Award for the applicable grant of Relative TSR PRSUs is equal to 50,000, MFA’s TSR is a positive number, and the Maximum
Cap does not apply.
30
Example 1:
If MFA’s TSR Rank at the end
of the TSR Performance Period was 15 out of 18, MFA would be in the 17th percentile. Because MFA’s TSR Rank would be below the
25th percentile, the Relative TSR Vesting Percentage would be equal to 0, so that none of the Relative TSR Target Award would become
vested. 100% of the Relative TSR Target Award for that TSR Performance Period would be forfeited.
Example 2:
If MFA’s TSR Rank at the end
of the TSR Performance Period was nine out of 18, MFA would be in the 50th percentile. The Relative TSR Vesting Percentage would be equal
to 100, so that 100% of the Relative TSR Target Award (50,000 PRSUs) would become vested.
Example 3:
If MFA’s TSR Rank at the end
of the TSR Performance Period was two out of 18, MFA would be in the 89th percentile. The Relative TSR Vesting Percentage would be equal
to 200, so that 200% of the Relative TSR Target Award (100,000 PRSUs) would become vested.
Dividend Equivalent Rights on PRSUs
In the event that dividends are declared with
respect to the common stock of MFA during the period beginning on the grant date of the PRSUs and ending on the date on which the PRSUs
are settled, then an amount equal to the dividends that the Executive would have received if the Executive had owned a number of shares
of MFA common stock equal to the number of outstanding PRSUs as of the date the dividend is declared shall be accrued in a bookkeeping
account. Accrued dividend amounts shall be credited and paid in accordance with, and subject to the terms of, Exhibit D. For the
avoidance of doubt, accrued dividend amounts shall only be payable to the extent that the underlying PRSUs vest and are distributed.
4. Withholding
Obligations
The parties hereto acknowledge and understand
that MFA or the Executive may require or elect (as the case may be) that the Executive satisfy any federal, state or local tax withholding
obligation with respect to TRSUs and PRSUs by withholding shares from the shares otherwise issuable to the Executive, provided that such
shares shall not exceed the minimum applicable tax withholding required by law, or such higher amount that does not result in adverse
accounting treatment for the Company, as approved in advance by the Compensation Committee.
5. Committee
Determinations
All determinations with respect to the TRSUs
and PRSUs shall be made by the Compensation Committee, in good faith and in compliance with this Exhibit B. Any such determinations
shall be final and binding on the Executive and MFA.
31
Exhibit C
Form TRSU Award
32
MFA FINANCIAL, INC.
EQUITY
COMPENSATION PLAN
PHANTOM SHARE AWARD AGREEMENT
(TIME
BASED VESTING)
AGREEMENT, dated as of the
____ of January, 20__ (the “Grant Date”), by and between MFA Financial, Inc., a Maryland corporation (the “Company”),
and Michael C. Roper (the “Grantee”).
WHEREAS, the Company maintains
the MFA Financial, Inc. Equity Compensation Plan, as it may be amended from time to time (the “Plan”) (capitalized terms
used but not defined herein shall have the respective meanings ascribed thereto by the Plan);
WHEREAS, the Grantee, as
an employee of the Company or a subsidiary of the Company, is an Eligible Person;
WHEREAS, the Company and
the Grantee entered into that certain Employment Agreement, entered into as of October 2, 2026 (as may be amended and/or restated
from time to time, the “Employment Agreement”); and
WHEREAS, the Committee has
determined that it is in the best interests of the Company and its stockholders to grant Phantom Shares to the Grantee subject to the
terms and conditions set forth below.
NOW, THEREFORE, IT IS
HEREBY AGREED AS FOLLOWS:
1. Grant
of Phantom Shares.
The Company hereby grants the Grantee [NUMBER]
Phantom Shares. The Phantom Shares are subject to the terms and conditions of this Agreement and are also subject to the provisions of
the Plan. The Plan is hereby incorporated by reference as though set forth herein in its entirety.
2. Vesting.
The Phantom Shares shall be subject to the terms
and conditions set forth in this Section 2.
(a) Except
as otherwise provided herein, 100% of the Phantom Shares shall vest on December 31, 20__, (the “Vesting Date”) provided
that the Grantee has not had a Termination of Service prior to such date.
(b) The
following terms shall apply in the event of Termination of Service:
(i) In
the event that, prior to the Vesting Date, the Grantee experiences a Termination of Service by the Company without Cause (as defined
in the Employment Agreement) or a Termination of Service by the Grantee for Good Reason (as defined in the Employment Agreement), then,
subject to Section 5(j) of the Employment Agreement relating to execution of a release, the Phantom Shares shall become fully
vested as of the date of the Grantee’s Termination of Service. For the avoidance of doubt, the vesting described in this Section 2(b)(i) shall
apply regardless of whether the Grantee’s Termination of Service occurs at any time prior to or following a Change of Control.
33
(ii) In
the event the Grantee experiences a Termination of Service on account of death or Disability (as defined in the Employment Agreement)
prior to the Vesting Date, then the Phantom Shares shall become fully vested as of the date of the Grantee’s Termination of Service;
provided that in the event of the Grantee’s Disability, such vesting shall be subject to Section 5(j) of the Employment
Agreement relating to execution of a release.
(iii) Notwithstanding
the foregoing provisions of this Section 2(b), if the circumstances described in clauses (A) or (B) below occur, then
for purposes of this Agreement, the Executive’s termination of employment shall not constitute a termination by the Company without
Cause or a termination by the Executive for Good Reason, and the Executive shall not be entitled to any vesting pursuant to this Section 2(b):
(A) In
connection with the Grantee’s Termination of Service with the Company, the Company is managed by an external manager pursuant to
a management and advisory contract and such external manager has provided the Grantee with an offer of employment (I) on economic
terms that are at least substantially equivalent in form and economic substance (and not in the aggregate) to those provided to the Grantee
immediately prior to such Termination of Service and (II) on terms that would not be deemed to trigger Good Reason (an offer of
employment that meets the requirements of (I) and (II), a “Qualifying Offer”).
(B) A
Change of Control occurs and immediately following such Change of Control, the Company is managed by an external manager pursuant to
a management and advisory contract and such external manager has provided the Grantee with a Qualifying Offer.
If the circumstances described in the preceding
clauses (A) or (B) occur and the Grantee accepts the external manager’s Qualifying Offer, then the Phantom Shares granted
pursuant to this Agreement shall not be forfeited upon the Grantee’s Termination of Service with the Company and shall remain outstanding
and continue to vest as long as the Grantee remains employed by the external manager. For the avoidance of doubt, upon the Grantee’s
termination of employment with the external manager, the Phantom Shares granted pursuant to this Agreement shall be treated in accordance
with the terms of this Agreement, applied as though the Grantee’s employment with the Company had terminated.
(c) Except
as otherwise provided in this Section 2 or as otherwise may be agreed to in writing between the Grantee and the Company, if the
Grantee experiences a Termination of Service for any reason, any unvested Phantom Shares shall, with no further action, be forfeited
and cease to be outstanding as of the Grantee’s Termination of Service.
34
3.
Settlement.
Each vested and outstanding Phantom Share shall
be settled in one share of Common Stock of the Company (a “Share”) within 60 days following the date on which such Phantom
Share vests as set forth in Section 2 above (the “Settlement Date”). To the extent payment described in this Section 3
is required to be delayed six months pursuant to the rules of Section 409A of the Code related to “specified employees,”
such payment shall not be made before the date which is six months after the date of Grantee’s Termination of Service. Any delayed
payment shall be made to the Grantee on the first day of the seventh month following the Grantee’s Termination of Service (or within
30 days following the Grantee’s death, if earlier).
4. Dividend
Equivalents.
In connection with the grant of the Phantom Shares
made hereby, the Grantee has the right to receive, with respect to each outstanding Phantom Share (whether or not vested) that has not
been forfeited in accordance with Section 2, cash in an amount equal to the cash dividend distributions declared on a Share to the
Company’s stockholders (each, a “Dividend Payment”) during the period from the Grant Date through the Settlement Date.
The Company shall make such cash payment to the Grantee within 15 days of the date on which the Dividend Payment is paid to the Company’s
stockholders, and in any event no later than December 31 of the year in which the Dividend Payment is paid.
5.
Miscellaneous.
(a) The
value of a Phantom Share may decrease depending upon the Fair Market Value of a Share from time to time. Neither the Company nor the
Committee, nor any other party associated with the Plan, shall be held liable for any decrease in the value of the Phantom Shares. If
the value of such Phantom Shares decrease, there will be a decrease in the underlying value of what is distributed to the Grantee under
the Plan and this Agreement.
(b) With
respect to this Agreement, (i) the Phantom Shares are bookkeeping entries and the Grantee shall not have any rights of a shareholder
with respect to Common Stock unless and until the Phantom Shares vest and are settled by the issuance of such Shares of Common Stock,
(ii) the obligations of the Company under the Plan are unsecured and constitute a commitment by the Company to make benefit payments
in the future, (iii) to the extent that any person acquires a right to receive payments from the Company under the Plan, such right
shall be no greater than the right of any general unsecured creditor of the Company, (iv) all payments under the Plan (including
distributions of Shares) shall be paid from the general funds of the Company and (v) no special or separate fund shall be established
or other segregation of assets made to assure such payments (except that the Company may in its discretion establish a bookkeeping reserve
to meet its obligations under the Plan). The award of Phantom Shares is intended to be an arrangement that is unfunded for tax purposes
and for purposes of Title I of the Employee Retirement Income Security Act of 1974, as amended.
(c) THIS
AGREEMENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF MARYLAND, WITHOUT REFERENCE TO PRINCIPLES OF CONFLICT OF LAWS. The captions of
this Agreement are not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified
except by a written agreement executed by the parties hereto or their respective successors and legal representatives. The invalidity
or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this
Agreement.
35
(d) The
Committee may construe and interpret this Agreement and establish, amend and revoke such rules, regulations and procedures for the administration
of this Agreement as it deems appropriate. In this connection, the Committee may correct any defect or supply any omission, or reconcile
any inconsistency in this Agreement or in any related agreements, in the manner and to the extent it shall deem necessary or expedient
to make the Plan fully effective. All decisions and determinations by the Committee in the exercise of this power shall be final and
binding upon the Company and the Grantee.
(e) All
notices hereunder shall be in writing and, if to the Company, shall be delivered to the Board or mailed to its principal office, addressed
to the attention of the Committee and, if to the Grantee, shall be delivered personally or mailed to the Grantee at the address appearing
in the records of the Company. Such addresses may be changed at any time by written notice to the other party given in accordance with
this Section 5(e).
(f) The
failure of the Grantee or the Company to insist upon strict compliance with any provision of this Agreement or the Plan, or to assert
any right the Grantee or the Company, respectively, may have under this Agreement or the Plan, shall not be deemed to be a waiver of
such provision or right or any other provision or right of this Agreement or the Plan.
(g) Nothing
in this Agreement shall (i) confer on the Grantee any right to continue in the service of the Company or its Subsidiaries or otherwise
confer any additional rights or benefits upon the Grantee with respect to the Grantee’s employment with the Company or (ii) interfere
in any way with the right of the Company or its Subsidiaries and its stockholders to terminate the Grantee’s service at any time.
(h) If
any change is made to the outstanding Common Stock or the capital structure of the Company, the Phantom Shares shall be adjusted in accordance
with the Plan.
(i) The
Phantom Shares and the rights relating thereto shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment,
pledge, encumbrance, attachment, garnishment, levy, execution, or other legal or equitable process, either voluntary or involuntary;
and any attempt to anticipate, alienate, sell, transfer, assign, pledge, encumber, attach or garnish, or levy or execute on the Phantom
Shares and the rights relating thereto shall be void.
(j) The
Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors
and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Grantee
and the Grantee’s beneficiaries, executors, administrators and the person(s) to whom the Phantom Shares may be transferred
by will or the laws of descent or distribution.
(k) The
Plan is discretionary and may be amended, suspended or discontinued by the Company at any time, in its discretion. The grant of the Phantom
Shares in this Agreement does not create any contractual right or other right to receive any Phantom Shares or other Grants in the future.
Future Grants, if any, will be at the sole discretion of the Company. Any amendment, suspension or discontinuation of the Plan shall
not constitute a change or impairment of the terms and conditions of the Grantee’s employment with the Company.
36
(l) The
issuance and transfer of Shares shall be subject to compliance by the Company and the Grantee with all applicable requirements of federal
and state securities laws and with all applicable requirements of any stock exchange on which the Shares may be listed. No shares of
Common Stock shall be issued or transferred unless and until any then applicable requirements of state and federal laws and regulatory
agencies have been fully complied with to the satisfaction of the Company and its counsel.
(m) The
Grantee shall be required to pay to the Company or make arrangements satisfactory to the Company regarding payment of any federal, state
or local taxes of any kind that are required by law to be withheld with respect to the Phantom Shares. Except as may be otherwise permitted
by the Committee, to satisfy such obligation, the Company shall withhold a number of Shares to be issued pursuant to this Agreement with
an aggregate Fair Market Value as of the date withholding is effected that would satisfy the withholding amount due; provided,
however, that no Shares shall be withheld with an aggregate value exceeding the minimum amount of tax required to be withheld
by law or such higher amount that does not result in adverse accounting treatment for the Company, as approved in advance by the Committee.
Notwithstanding anything contained in the Plan or this Agreement to the contrary, the Grantee’s satisfaction of any tax withholding
requirements imposed by the Committee shall be a condition precedent to the Company’s obligation as may otherwise be provided hereunder
to provide Shares to the Grantee, and the failure of the Grantee to satisfy such requirements with respect to this Grant shall cause
this Grant to be forfeited.
(n) The
Phantom Shares shall be subject to any applicable clawback policy implemented by the Board from time to time.
(o) The
Phantom Shares are intended to comply with Section 409A of the Code or an exemption thereunder and shall be construed and interpreted
in a manner that is consistent with the requirements for avoiding additional taxes or penalties under Section 409A of the Code and
administered in accordance with Section 27 of the Plan. Notwithstanding the foregoing, the Company makes no representations that
the payments and benefits provided under this Agreement comply with Section 409A of the Code and in no event shall the Company be
liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Grantee on account of non-compliance
with Section 409A of the Code. Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of
the Grantee’s execution of a release, directly or indirectly, result in the Grantee designating the calendar year of payment of
any amounts of deferred compensation subject to section 409A of the Code, and if a payment that is subject to execution of a release
could be made in more than one taxable year, payment shall be made in the later taxable year, to the extent required by Section 409A
of the Code.
37
(p) This
Agreement contains the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements,
written or oral, with respect thereto; provided that, for the avoidance of doubt, Section 7(f) of the Employment Agreement,
which provides for forfeiture of equity awards and repayment of any shares or other amounts received pursuant to equity awards in the
event that the Grantee breaches his obligations under Section 7 of the Employment Agreement, shall apply to the Phantom Shares and
any amounts paid to the Grantee pursuant to this Agreement, and is hereby incorporated by reference. In the event of any inconsistency
between the terms of this Agreement and the Employment Agreement, the terms of this Agreement shall govern.
[remainder of the page left intentionally
blank]
38
IN WITNESS WHEREOF, the Company
and the Grantee have executed this Agreement as of the day and year first above written.
MFA FINANCIAL, INC.
By:
Name:
Title:
The Grantee hereby agrees and acknowledges that
(a) the Grantee will be bound by the terms and conditions of this Agreement and the Plan and (b) all determinations by the
Committee will be final and binding on all persons.
Name: Michael C. Roper
39
Exhibit D
Form PRSU Award
40
MFA FINANCIAL, INC.
EQUITY
COMPENSATION PLAN
PHANTOM SHARE AWARD AGREEMENT
(PERFORMANCE
BASED VESTING)
AGREEMENT, dated as of the
____ day of January, 20__ (the “Grant Date”), by and between MFA Financial, Inc., a Maryland corporation (the “Company”),
and Michael C. Roper (the “Grantee”).
WHEREAS, the Company maintains
the MFA Financial, Inc. Equity Compensation Plan, as it may be amended from time to time (the “Plan”) (capitalized terms
used but not defined herein shall have the respective meanings ascribed thereto by the Plan);
WHEREAS, the Grantee, as
an employee of the Company or a subsidiary of the Company, is an Eligible Person;
WHEREAS, the Company and
the Grantee entered into that certain Employment Agreement, entered into as of October 2, 2026 (as may be amended and restated from
time to time, the “Employment Agreement”); and
WHEREAS, the Committee has
determined that it is in the best interests of the Company and its stockholders to grant Phantom Shares to the Grantee subject to the
terms and conditions set forth below.
NOW, THEREFORE, IT IS
HEREBY AGREED AS FOLLOWS:
1. Grant
of Phantom Shares.
(a) The
Phantom Shares are subject to the terms and conditions of this Agreement and are also subject to the provisions of the Plan. The Plan
is hereby incorporated by reference as though set forth herein in its entirety.
(b) The
target amount of Phantom Shares granted pursuant to this Agreement is [TARGET] Phantom Shares (the “Target Amount”); provided
that the Grantee has the opportunity to earn up to [200% OF TARGET] Phantom Shares (the “Maximum Amount”), subject to the
Maximum Cap described in Section 4(e), based upon achievement of performance goals and the terms and conditions described herein.
(i) With
respect to the Target Amount, [NUMBER] Phantom Shares (the “Absolute TSR Target Shares”), and with respect to the Maximum
Amount, [200% OF ABSOLUTE TSR TARGET SHARES] Phantom Shares will vest based on the Company’s total shareholder return for the TSR
Performance Period (as defined below) subject to the Grantee’s continued service with the Company through December 31, 20__
(the “Vesting Date”), except as provided in Section 2 below.
(ii) With
respect to the Target Amount, [NUMBER] Phantom Shares (the “Relative TSR Target Shares”), and with respect to the Maximum
Amount, [200% OF RELATIVE TSR TARGET SHARES] Phantom Shares will vest based on the Company’s total shareholder return compared
to the total shareholder return of the peer group companies listed on Appendix 1 to Exhibit A attached hereto (the
“Peer Group Companies”) for the TSR Performance Period subject to the Grantee’s continued service with the Company
through the Vesting Date except as provided in Section 2 below.
41
2. Vesting.
(a) Subject
to Section 2(b) and Section 2(c) and the Maximum Cap (as defined in Section 4(e)), the number of Phantom Shares
granted hereunder that shall vest on the Vesting Date, if any, shall be calculated in accordance with Exhibit A attached
hereto based upon the achievement of the performance goals set forth on Exhibit A (the “Performance Goals”) during
the period beginning on January 1, 20[ ] and ending on the Vesting Date (December 31, 20[ ]), or if earlier, a Change of Control
(such period, the “TSR Performance Period”); provided that, to the extent that any fractional Shares result, the number
of Phantom Shares eligible for settlement (as set forth in Section 4) shall be rounded up to the nearest whole share. Any Phantom
Shares granted hereunder that do not vest on the Vesting Date shall be forfeited.
(b) Except
as otherwise set forth in Section 2(c), the following terms shall apply in the event of a Termination of Service:
(i) If,
prior to the Vesting Date, the Grantee experiences a Termination of Service by the Company without Cause (as defined in the Employment
Agreement) or a Termination of Service by the Grantee for Good Reason (as defined in the Employment Agreement), then, subject to Section 5(j) of
the Employment Agreement relating to execution of a release, as of the Vesting Date, the Grantee shall vest in the number of Phantom
Shares that would have vested on the Vesting Date based upon achievement of the Performance Goals if the Grantee remained employed through
the Vesting Date.
(ii) If,
prior to the Vesting Date, the Grantee experiences a Termination of Service on account of the Grantee’s death or Disability (as
defined in the Employment Agreement), then the number of Phantom Shares that shall vest, if any, on the Vesting Date shall be the number
of Phantom Shares that would have vested on the Vesting Date based upon achievement of the Performance Goals if the Grantee remained
employed through the Vesting Date; provided that, such vesting shall be subject to Section 5(j) of the Employment Agreement
relating to execution of a release, if the Grantee experiences a Termination of Service on account of the Grantee’s Disability.
(iii) If
the Grantee experiences a Termination of Service by the Company for Cause, then all Phantom Shares granted pursuant to this Agreement,
whether or not vested, shall immediately be cancelled for no consideration, and the Grantee shall cease to have any rights under this
Agreement.
(c) If
a Change of Control occurs during the Performance Period, the number of Phantom Shares that vest pursuant to this Agreement shall be
calculated as described in this Section 2(c), subject to the Maximum Cap. Notwithstanding anything to the contrary, the Committee
may take such additional actions with respect to the Phantom Shares as it deems appropriate pursuant to the Plan.
42
(i) In
lieu of measuring performance as of the end of the Performance Period, the Committee shall calculate a “Change of Control Amount”
as of the closing date of the Change of Control (the “Change of Control Date”), determined in accordance with Exhibit A.
(ii) If
the Grantee continues in service through the Vesting Date, the Change of Control Amount shall vest on the Vesting Date.
(iii) If
the Grantee experiences a Termination of Service due to death or Disability upon or following the Change of Control and prior to the
Vesting Date, then upon such Termination of Service, the Grantee shall vest in the Change of Control Amount, subject in the case of the
Grantee’s Disability, to Section 5(j) of the Employment Agreement relating to execution of a release.
(iv) If
the Grantee experiences a Termination of Service by the Company without Cause or for Good Reason upon or following the Change of Control
and prior to the Vesting Date, then upon such Termination of Service, the Grantee shall vest in the Change of Control Amount, subject
to Section 5(j) of the Employment Agreement relating to execution of a release.
(v) If
the Grantee experiences a Termination of Service on account of the Grantee’s death or Disability, termination by the Company without
Cause or termination by the Grantee for Good Reason prior to the Change of Control Date, and a Change of Control occurs following the
such Termination of Service and prior to the Vesting Date, then as of the date of the Change of Control, the Grantee shall vest in the
Change of Control Amount, subject to Section 5(j) of the Employment Agreement relating to execution of a release.
(vi) For
the avoidance of doubt, if the Change of Control Date occurs after the Vesting Date but prior to settlement of the vested Phantom Shares,
the number of Phantom Shares that vest pursuant to this Agreement shall be determined in accordance with Exhibit A without regard
to the occurrence of the Change of Control.
(d) Notwithstanding
the foregoing provisions of this Section 2, if the circumstances described in clauses (i) or (ii) below occur, then for
purposes of this Agreement, the Grantee’s termination of employment shall not constitute a termination by the Company without Cause
or a termination by the Grantee for Good Reason, and the Grantee shall not be entitled to any vesting pursuant to this Section 2:
(i) In
connection with the Grantee’s Termination of Service with the Company, the Company is managed by an external manager pursuant to
a management and advisory contract and such external manager has provided the Grantee with an offer of employment (A) on economic
terms that are at least substantially equivalent in form and economic substance (and not in the aggregate) to those provided to the Grantee
immediately prior to such Termination of Service and (B) on terms that would not be deemed to trigger Good Reason (an offer of employment
that meets the requirements of (A) and (B), a “Qualifying Offer”).
(ii) A
Change of Control occurs and immediately following such Change of Control, the Company is managed by an external manager pursuant to
a management and advisory contract and such external manager has provided the Grantee with a Qualifying Offer.
43
If the circumstances described in the preceding
clauses (i) or (ii) occur and the Grantee accepts the external manager’s Qualifying Offer, then the Phantom Shares granted
pursuant to this Agreement shall not be forfeited upon the Grantee’s Termination of Service with the Company and shall remain outstanding
and continue to vest as long as the Grantee remains employed by the external manager. For the avoidance of doubt, upon the Grantee’s
termination of employment with the external manager, the Phantom Shares granted pursuant to this Agreement shall be treated in accordance
with the terms of this Agreement, applied as though the Grantee’s employment with the Company had terminated.
(e) Except
as otherwise provided in this Section 2, if the Grantee experiences a Termination of Service for any reason prior to the Vesting
Date, the Phantom Shares granted hereunder shall, with no further action, be forfeited and cease to be outstanding as of the Grantee’s
Termination of Service.
(f) Any
Phantom Shares granted hereunder that do not vest as of the Vesting Date shall, with no further action, be forfeited and cease to be
outstanding as of the Vesting Date.
3. Dividend Equivalents.
(a) With
respect to each outstanding Phantom Share granted hereunder that vests in accordance with Section 2 and Exhibit A (such shares
being the “Vested Phantom Shares”), the Grantee shall receive additional Phantom Shares (such additional Phantom Shares being
the “Dividend Phantom Shares”), which Dividend Phantom Shares will reflect the cash dividend distributions declared in the
ordinary course on a share (“Share”) of Common Stock of the Company (each, a “Dividend Payment”) during the period
beginning on the Grant Date and ending on the Vesting Date (or if earlier, the date on which the Phantom Shares are settled pursuant
to Section 4) (such period, the “Dividend Period”).
(b) Dividend
Payments shall be deemed to have been payable only with respect to Vested Phantom Shares and shall be made in the form of Dividend Phantom
Shares. The Dividend Phantom Shares shall settle in the form of additional Shares at the time the Phantom Shares granted hereunder are
settled pursuant to Section 4.
(c) The
number of Dividend Phantom Shares to be distributed as contemplated by subsections 3(a) and 3(b) shall be calculated as follows:
with respect to each Vested Phantom Share, the Company will, as of the date of any Dividend Payment during the Dividend Period, credit
to the Grantee an amount (per each Vested Phantom Share) equal to the amount of the cash dividend declared and paid in respect of one
Share. Such credited amount will be credited in the form of hypothetical additional Phantom Shares (such hypothetical Phantom Shares,
“DER Phantom Shares”), the number of which will be calculated (rounded up to the nearest whole share) based on the Fair Market
Value (i.e., closing market price) of a Share as of the payment date of the applicable cash dividend. Any and all DER Phantom Shares
credited to the Grantee in respect of the Dividend Period will be subject to compounding through the end of the Dividend Period (i.e.,
deemed reinvestment in Shares), such that they will be credited with additional hypothetical DER Phantom Shares to the extent of any
additional dividends declared during the Dividend Period and the number of which additional hypothetical DER Phantom Shares will also
be calculated (rounded up to the nearest whole share) based on the Fair Market Value of a Share as of the payment date of the applicable
cash dividend. The number of Dividend Phantom Shares to be received by the Grantee in respect of Vested Phantom Shares shall be the sum
of all DER Phantom Shares credited to the Grantee (inclusive of all additional DER Phantom Shares credited to the Grantee resulting from
compounding as contemplated in the preceding sentence).
44
(d) In
the event that dividends are declared with respect to the Common Stock of the Company during the period beginning on the Vesting Date
and ending on the date on which the Vested Phantom Shares are settled pursuant to Section 4, then an amount equal to the dividends
that the Grantee would have received if the Grantee had owned a number of Shares equal to the sum of the Vested Phantom Shares and any
Dividend Phantom Shares credited to the Grantee (as contemplated in Section 3(c) above) as of the date the dividend is declared
shall be paid to the Grantee in cash on the date such dividends are paid to holders of the Common Stock of the Company.
4. Settlement.
(a) Subject
to subsections (b), (c), (d) and (e) below, each vested and outstanding Phantom Share that vests pursuant to this Agreement
(which, for the avoidance of doubt, shall equal the sum of Vested Phantom Shares and Dividend Phantom Shares) shall be settled in one
Share on or about January 2, 20__1 (the “Settlement Date”).
(b) The
following terms shall apply in the event of a Termination of Service prior to the Settlement Date:
(i) In
the event that the Grantee’s Termination of Service occurs on or prior to the Vesting Date, each Phantom Share that vests pursuant
to this Agreement shall be settled in one Share in January 20__.2
(ii) In
the event that the Grantee’s Termination of Service occurs following the Vesting Date, then to the extent not previously settled
pursuant to Section 4(c) below, each Phantom Share that vested pursuant to this Agreement shall be settled in one Share within
30 days following such Termination of Service.
(iii) Notwithstanding
the preceding clauses (i) and (ii), in the event that the Grantee’s Termination of Service occurs on or prior to the Vesting
Date and within 24 months following a Change of Control that constitutes a “change in control event” for purposes of Section 409A
of the Code, each Phantom Share that becomes vested pursuant to this Agreement shall be settled in one Share within 60 days following
such Termination of Service.
(c) The
following terms shall apply in the event a Change of Control that constitutes a “change in control event” for purposes of
Section 409A of the Code occurs prior to the Settlement Date:
(i) Except
as otherwise provided in Section 4(b)(iii), in the event a Change of Control that constitutes a “change in control event”
for purposes of Section 409A of the Code occurs on or prior to the Vesting Date, each Phantom Share that becomes vested pursuant
to this Agreement shall be settled in one Share in January 20__3; and
1
Note to draft: To be January 2 immediately following the first anniversary of the Vesting Date.
2
Note to draft: To be January immediately following the Vesting Date.
3
Note to draft: To be January immediately following the Vesting Date.
45
(ii) In
the event a Change of Control that constitutes a “change in control event” for purposes of Section 409A of the Code
occurs following the Vesting Date, each Phantom Share that became vested pursuant to this Agreement shall be settled in one Share within
30 days following the date of the Change of Control.
(d) To
the extent any payment described in this Section 4 is required to be delayed six months pursuant to the rules of Section 409A
of the Code related to “specified employees,” such payment shall not be made before the date which is six months after the
date of Termination of Service. Any delayed payment shall be made to the Grantee on the first day of the seventh month following the
Grantee’s Termination of Service (or within 30 days following the Grantee’s death, if earlier).
(e) Notwithstanding
anything in this Agreement to the contrary, the Fair Market Value of the Shares delivered pursuant to this Agreement, measured as of
the last day of the Performance Period (or, if earlier, the date on which the Phantom Shares are settled pursuant to this Section 4)
shall not exceed 400% of the Fair Market Value of the Target Amount of Phantom Shares measured on the Grant Date (the “Maximum
Cap”), and any and all amounts otherwise payable pursuant to this Agreement in excess of the Maximum Cap shall be forfeited, provided
that, for the avoidance of doubt, payment with respect to the dividend equivalent rights described above for dividends declared and paid
following the Vesting Date shall not count against the Maximum Cap.
5. Miscellaneous.
(a) The value of a Phantom Share may decrease
depending upon the Fair Market Value of a Share from time to time. Neither the Company nor the Committee, nor any other party associated
with the Plan, shall be held liable for any decrease in the value of the Phantom Shares. If the value of such Phantom Shares decrease,
there will be a decrease in the underlying value of what is distributed to the Grantee under the Plan and this Agreement.
(b) With respect to this Agreement, (i) the
Phantom Shares are bookkeeping entries and the Grantee shall not have any rights of a shareholder with respect to Common Stock unless
and until the Phantom Shares vest and are settled by the issuance of such Shares of Common Stock, (ii) the obligations of the Company
under the Plan are unsecured and constitute a commitment by the Company to make benefit payments in the future, (iii) to the extent
that any person acquires a right to receive payments from the Company under the Plan, such right shall be no greater than the right of
any general unsecured creditor of the Company, (iv) all payments under the Plan (including distributions of Shares) shall be paid
from the general funds of the Company and (v) no special or separate fund shall be established or other segregation of assets made
to assure such payments (except that the Company may in its discretion establish a bookkeeping reserve to meet its obligations under
the Plan). The award of Phantom Shares is intended to be an arrangement that is unfunded for tax purposes and for purposes of Title I
of the Employee Retirement Income Security Act of 1974, as amended.
(c) THIS
AGREEMENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF MARYLAND, WITHOUT REFERENCE TO PRINCIPLES OF CONFLICT OF LAWS. The captions of
this Agreement are not part of the provisions hereof and shall have no force or effect. This Agreement may not be amended or modified
except by a written agreement executed by the parties hereto or their respective successors and legal representatives. The invalidity
or unenforceability of any provision of this Agreement shall not affect the validity or enforceability of any other provision of this
Agreement.
46
(d) The
Committee may construe and interpret this Agreement and establish, amend and revoke such rules, regulations and procedures for the administration
of this Agreement as it deems appropriate. In this connection, the Committee may correct any defect or supply any omission, or reconcile
any inconsistency in this Agreement or in any related agreements, in the manner and to the extent it shall deem necessary or expedient
to make the Plan fully effective. All decisions and determinations by the Committee in the exercise of this power shall be final and
binding upon the Company and the Grantee.
(e) All
notices hereunder shall be in writing and, if to the Company, shall be delivered to the Board or mailed to its principal office, addressed
to the attention of the Committee and, if to the Grantee, shall be delivered personally or mailed to the Grantee at the address appearing
in the records of the Company. Such addresses may be changed at any time by written notice to the other party given in accordance with
this Section 5(e).
(f) The
failure of the Grantee or the Company to insist upon strict compliance with any provision of this Agreement or the Plan, or to assert
any right the Grantee or the Company, respectively, may have under this Agreement or the Plan, shall not be deemed to be a waiver of
such provision or right or any other provision or right of this Agreement or the Plan.
(g) Nothing
in this Agreement shall (i) confer on the Grantee any right to continue in the service of the Company or its Subsidiaries or otherwise
confer any additional rights or benefits upon the Grantee with respect to the Grantee’s employment with the Company or (ii) interfere
in any way with the right of the Company or its Subsidiaries and its stockholders to terminate the Grantee’s service at any time.
(h) If
any change is made to the outstanding Common Stock or the capital structure of the Company, the Phantom Shares shall be adjusted in accordance
with the Plan.
(i) The
Phantom Shares and the rights relating thereto shall not be subject in any manner to anticipation, alienation, sale, transfer, assignment,
pledge, encumbrance, attachment, garnishment, levy, execution, or other legal or equitable process, either voluntary or involuntary;
and any attempt to anticipate, alienate, sell, transfer, assign, pledge, encumber, attach or garnish, or levy or execute on the Phantom
Shares and the rights relating thereto shall be void.
(j) The
Company may assign any of its rights under this Agreement. This Agreement will be binding upon and inure to the benefit of the successors
and assigns of the Company. Subject to the restrictions on transfer set forth herein, this Agreement will be binding upon the Grantee
and the Grantee’s beneficiaries, executors, administrators and the person(s) to whom the Phantom Shares may be transferred
by will or the laws of descent or distribution.
(k) The
Plan is discretionary and may be amended, suspended or discontinued by the Company at any time, in its discretion. The grant of the Phantom
Shares in this Agreement does not create any contractual right or other right to receive any Phantom Shares or other Grants in the future.
Future Grants, if any, will be at the sole discretion of the Company. Any amendment, suspension or discontinuation of the Plan shall
not constitute a change or impairment of the terms and conditions of the Grantee’s employment with the Company.
47
(l) The
issuance and transfer of Shares shall be subject to compliance by the Company and the Grantee with all applicable requirements of federal
and state securities laws and with all applicable requirements of any stock exchange on which the Shares may be listed. No shares of
Common Stock shall be issued or transferred unless and until any then applicable requirements of state and federal laws and regulatory
agencies have been fully complied with to the satisfaction of the Company and its counsel.
(m) The
Grantee shall be required to pay to the Company or make arrangements satisfactory to the Company regarding payment of any federal, state
or local taxes of any kind that are required by law to be withheld with respect to the Phantom Shares. Except as may be otherwise permitted
by the Committee, to satisfy such obligation, the Company shall withhold a number of Shares to be issued pursuant to this Agreement with
an aggregate Fair Market Value as of the date withholding is effected that would satisfy the withholding amount due; provided,
however, that no Shares shall be withheld with an aggregate value exceeding the minimum amount of tax required to be withheld
by law or such higher amount that does not result in adverse accounting treatment for the Company, as approved in advance by the Committee.
Notwithstanding anything contained in the Plan or this Agreement to the contrary, the Grantee’s satisfaction of any tax withholding
requirements imposed by the Committee shall be a condition precedent to the Company’s obligation as may otherwise be provided hereunder
to provide Shares to the Grantee, and the failure of the Grantee to satisfy such requirements with respect to this Grant shall cause
this Grant to be forfeited.
(n) The
Phantom Shares shall be subject to any applicable clawback policy implemented by the Board from time to time.
(o) The
Phantom Shares are intended to comply with Section 409A of the Code or an exemption thereunder and shall be construed and interpreted
in a manner that is consistent with the requirements for avoiding additional taxes or penalties under Section 409A of the Code and
administered in accordance with Section 27 of the Plan. Notwithstanding the foregoing, the Company makes no representations that
the payments and benefits provided under this Agreement comply with Section 409A of the Code and in no event shall the Company be
liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Grantee on account of non-compliance
with Section 409A of the Code. Notwithstanding any provision of this Agreement to the contrary, in no event shall the timing of
the Grantee’s execution of a release, directly or indirectly, result in the Grantee designating the calendar year of payment of
any amounts of deferred compensation subject to section 409A of the Code, and if a payment that is subject to execution of a release
could be made in more than one taxable year, payment shall be made in the later taxable year, to the extent required by Section 409A
of the Code.
(p) This
Agreement, including Exhibit A and Appendix 1 to Exhibit A, contains the entire agreement between the parties with respect
to the subject matter hereof and supersedes all prior agreements, written or oral, with respect thereto; provided that, for the
avoidance of doubt, Section 7(f) of the Employment Agreement, which provides for forfeiture of equity awards and repayment
of any shares or other amounts received pursuant to equity awards in the event that the Grantee breaches his obligations under Section 7
of the Employment Agreement, shall apply to the Phantom Shares and any amounts paid to the Grantee pursuant to this Agreement, and is
hereby incorporated by reference. In the event of any inconsistency between the terms of this Agreement and the Employment Agreement,
the terms of this Agreement shall govern.
[remainder of the page left intentionally
blank]
48
IN WITNESS WHEREOF, the Company and the Grantee
have executed this Agreement as of the day and year first above written.
MFA FINANCIAL, INC.
By:
Name:
Title:
The Grantee hereby agrees and acknowledges that
(a) the Grantee will be bound by the terms and conditions of this Agreement and the Plan and (b) all determinations by the
Committee will be final and binding on all persons.
Name:
Michael C. Roper
49
Exhibit A
This Exhibit A sets forth the Performance
Goals applicable to the Phantom Shares granted pursuant to the Agreement to which this Exhibit A is attached. Unless otherwise specified
in this Exhibit A, all defined terms shall have the meanings set forth in the Agreement.
The Phantom Shares will vest based on the Company’s
total shareholder return for the TSR Performance Period and based on the Grantee’s continued service as set forth in the Agreement.
As further described below, the Absolute TSR Shares will be eligible to vest based on the Company’s average total shareholder return
for the Performance Period, and the Relative TSR Shares will be eligible to vest based on the Company’s total shareholder return
compared to the total shareholder return of the Peer Group Companies for the TSR Performance Period.
For purposes of this Exhibit A, TSR for
the TSR Performance Period shall be calculated as follows:
· “TSR”
is equal to (x) the Average Final Price minus the Average Initial Price, plus Dividends
Paid on a share of common stock in respect of the TSR Performance Period, divided by (y) the
Average Initial Price.
· The
“Average Initial Price” is equal to the average closing daily price of a share
of common stock during the last 20 trading days immediately prior to the first day of the
TSR Performance Period.
· The
“Average Final Price” is equal to the average closing daily price of a share
of common stock during the last 20 trading days in the TSR Performance Period.
· The
“Dividends Paid” shall equal the cumulative dividends (including any stock dividends)
paid per share of common stock in respect of the TSR Performance Period. For this purpose,
dividends declared, but not yet paid, on a share within the 45-day period preceding the last
day of the TSR Performance Period will be counted as Dividends Paid. Notwithstanding the
foregoing, if any dividends were included in Dividends Paid for purposes of calculating TSR
for the year prior to the year in which the TSR Performance Period commences, then such dividends
will not be included in Dividends Paid for purposes of calculating TSR for the TSR Performance
Period.
Absolute TSR Shares
For purposes of the Absolute TSR Shares, the
“Average TSR” for the Performance Period is the TSR, divided by the number of full and partial years during the TSR Performance
Period, and the “Target TSR” is an 8% per annum simple cumulative return (pro-rated for partial years) over the TSR Performance
Period.
The portion of the Absolute TSR Target Shares
that will be eligible to vest with respect to the Performance Period shall be determined by comparing the Average TSR of the Company
to the Target TSR and may range from zero up to a maximum vesting of 200% of the Absolute TSR Target Shares.
50
The number of Absolute TSR Shares that will be
eligible to vest with respect to the Performance Period shall equal the product of (i) the Absolute TSR Target Shares and (ii) the
sum of (A) one (1) plus (B) a fraction (which fraction can be a negative number), the numerator of which is the Company’s
Average TSR less Target TSR and the denominator of which is eight (8). For purposes of the preceding sentence, in the event that the
Company’s Average TSR is (x) less than zero, then the Company’s Average TSR shall be deemed to be zero, and (y) greater
16%, then the Company’s Average TSR shall be deemed to be 16%.
Any Absolute TSR Shares that do not vest on the
Vesting Date shall be forfeited.
Vested Absolute TSR Shares and related Dividend
Payments, if any, will be settled as described in the Agreement.
Relative TSR Shares
At the end of each TSR Performance Period, the
Company’s TSR and the TSR of each of the Peer Group Companies will be ranked from highest to lowest. The “Relative TSR Vesting
Percentage” will be determined based on the Company’s TSR as compared to the TSR of the Peer Group Companies for the TSR
Performance Period as follows:
Company
TSR Rank
Relative
TSR Vesting Percentage
80th
percentile or above
200%
50th
percentile
100%
At
or below 25th percentile
0%
If the Company’s TSR Rank is between the
25th percentile and the 50th percentile or between the 50th percentile and the 80th percentile, the Relative TSR Vesting Percentage will
be interpolated.
Notwithstanding the provisions set forth above,
in the event that the Company’s TSR is a negative number, the Relative TSR Vesting Percentage shall not exceed 100%.
The number of Relative TSR Shares that will be
eligible to vest for the TSR Performance Period will be determined by multiplying the Relative TSR Target Shares by the Relative TSR
Vesting Percentage.
For the avoidance of doubt, in no event shall
any Relative TSR Shares vest if the Company’s Average TSR Rank is at or below the 25th percentile.
Not more than 200% of the Relative TSR Target
Shares may vest based on the Company’s TSR Rank.
Any Relative TSR Shares that do not vest on the
Vesting Date shall be forfeited.
Vested Relative TSR Shares and related Dividend
Payments, if any, will be settled as described in the Agreement.
51
Appendix 1 to Exhibit A
Relative TSR Peer Group Companies
[TO BE LISTED]
In the event of a merger, acquisition or business
combination transaction of a Peer Group Company during the TSR Performance Period in which such Peer Group Company is the surviving entity
and remains publicly traded, the surviving entity shall remain a Peer Group Company. Any entity involved in the transaction during the
TSR Performance Period that is not the surviving company shall no longer be a Peer Group Company.
In the event of a merger, acquisition or business
combination transaction of a Peer Group Company, a “going private” transaction or other event involving a Peer Group Company
or the liquidation of a Peer Group Company (other than a bankruptcy as described below), in each case during the TSR Performance Period
and where the Peer Group Company is not the surviving entity or is no longer publicly traded, such Peer Group Company shall no longer
be a Peer Group Company.
Notwithstanding the foregoing, in the event of
a bankruptcy of a Peer Group Company during the TSR Performance Period where the Peer Group Company is not publicly traded at the end
of the Performance Period, such Peer Group Company shall remain a Peer Group Company but shall be deemed to be ranked last among all
Peer Group Companies in the Peer Group.
52
Exhibit E
Release
This Release of Claims (this
“Release”) is made as of _________________, by and between MFA FINANCIAL, INC. (“MFA”) and
________________ (the “Executive”).
(a) The
Executive, on behalf of himself, his agents, heirs, successors, assigns, executors and administrators, in consideration for the termination
payments and other consideration provided for under the Employment Agreement entered into by MFA and the Executive, as from time to time
amended in accordance with its terms (the “Employment Agreement”), hereby forever releases and discharges MFA, and its successors,
its affiliated entities, and, in such capacities, its past and present directors, employees, agents, attorneys, accountants, representatives,
plan fiduciaries, successors and assigns from any and all known and unknown causes of action, actions, judgments, liens, indebtedness,
damages, losses, claims, liabilities, and demands of whatsoever kind and character in any manner whatsoever arising on or prior to the
date of this Release, including but not limited to (i) any claim for breach of contract, breach of implied covenant, breach of oral
or written promise, wrongful termination, intentional infliction of emotional distress, defamation, interference with contract relations
or prospective economic advantage, negligence, misrepresentation or employment discrimination, and including without limitation alleged
violations of Title VII of the Civil Rights Act of 1964, as amended, prohibiting discrimination based on race, color, religion, sex or
national origin; the Employee Retirement Income Security Act of 1974 (“ERISA”); the Family and Medical Leave Act; the Americans
With Disabilities Act; the Age Discrimination in Employment Act; the Fair Labor Standards Act; the federal Worker Adjustment and Retraining
Notification Act; the federal Equal Pay Act; any federal False Claims Act; the Occupational Safety and Health Act; the Fair Credit Reporting
Act; the New York State Human Rights Law; the New York City Human Rights Law; the New York Labor Law; the New York Executive Law; New
York Equal Pay Law; New York Civil Rights Law; the New York Worker Adjustment and Retraining Notification Act; and any other federal,
state and local laws, ordinances and regulations; (ii) any and all liability that was or may have been alleged against or imputed
to MFA by the Executive or by anyone acting on his behalf; (iii) all claims for monetary or equitable relief, employment or reemployment
with MFA in any position, and any punitive, compensatory or liquidated damages; and (iv) all rights to and claims for attorneys’
fees and costs except as otherwise provided in the Employment Agreement. The only claims that are not being waived and released by the
Executive under this Release are (i) claims for indemnification or D&O coverage or any claim arising under, or preserved by,
Section 5 of the Employment Agreement, (ii) claims that, cannot be waived as a matter of law or public policy, (iii) claims
based on any wrongful act or omission occurring after the date Executive signs this Release, (iv) claims to vested benefits under
any compensation or benefit plan, program or arrangement in which the Executive was participating as of the date of termination of his
employment, (v) claims seeking enforcement of this Release or the Employment Agreement, and (vi) claims challenging the legality
of this Release in a legal proceeding pursuant to the Older Workers Benefit Protection Act and the Age Discrimination in Employment Act.
The Executive acknowledges that the Executive has not made any claims or allegations related to discrimination, harassment or sexual
abuse and none of the termination payments and other consideration provided for under the Employment Agreement are related to discrimination,
harassment or sexual abuse.
53
(b) Except
as provided in Section (c) below, the Executive warrants, represents and certifies that he has not filed or instituted, and,
no person or agency has filed or instituted on his behalf and/or at his direction, any complaints, lawsuits, arbitration proceedings,
actions, causes of action, in law or equity, administrative charges, claims, controversies, demands, grievances and/or proceedings whatsoever
against any Releasee, in any forum. The Executive represents and warrants that he has not assigned any claim released herein.
(c) Nothing
in this Release or the Employment Agreement restricts or prohibits the Executive from initiating communications directly with, responding
to any inquiries from, providing testimony before, providing confidential information to, reporting possible violations of law or regulation
to, or from filing a claim or assisting with an investigation directly with a self-regulatory authority or a government agency or entity,
including the U.S. Equal Employment Opportunity Commission, the Department of Labor, the National Labor Relations Board, the Department
of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General (collectively, the “Regulators”),
or from making other disclosures that are protected under the whistleblower provisions of state or federal law or regulation. However,
to the maximum extent permitted by law, the Executive is waiving the Executive’s right to receive any individual monetary relief
from MFA or any others covered by the Release of Claims resulting from such claims or conduct, regardless of whether the Executive or
another party has filed them, and in the event the Executive obtains such monetary relief, MFA will be entitled to an offset for the
payments made pursuant to this Agreement. This Agreement does not limit the Executive’s right to receive an award from any Regulator
that provides awards for providing information relating to a potential violation of law. The Executive does not need the prior authorization
of MFA to engage in conduct protected by this paragraph, and the Executive does not need to notify MFA that the Executive has engaged
in such conduct.
Please take notice that federal
law provides criminal and civil immunity to federal and state claims for trade secret misappropriation to individuals who disclose a
trade secret to their attorney, a court, or a government official in certain, confidential circumstances that are set forth at 18 U.S.C.
§§ 1833(b)(1) and 1833(b)(2), related to the reporting or investigation of a suspected violation of the law, or in connection
with a lawsuit for retaliation for reporting a suspected violation of the law.
(d) BY
HIS SIGNATURE BELOW, THE EXECUTIVE ACKNOWLEDGES THAT:
(1) HE
HAS RECEIVED A COPY OF THIS RELEASE AND WAS OFFERED A PERIOD OF TWENTY-ONE (21) DAYS TO REVIEW AND CONSIDER IT;
(2) IF
HE SIGNS THIS RELEASE PRIOR TO THE EXPIRATION OF TWENTY-ONE DAYS, HE KNOWINGLY AND VOLUNTARILY WAIVES AND GIVES UP THIS RIGHT OF REVIEW;
(3) HE
HAS THE RIGHT TO REVOKE THIS RELEASE FOR A PERIOD OF SEVEN (7) DAYS AFTER HE SIGNS IT BY MAILING OR DELIVERING A WRITTEN NOTICE
OF REVOCATION TO THE COMPANY’S GENERAL COUNSEL, NO LATER THAN THE CLOSE OF BUSINESS ON THE SEVENTH DAY AFTER THE DAY ON WHICH HE
SIGNED THIS RELEASE;
54
(4) THIS
RELEASE SHALL NOT BECOME EFFECTIVE OR ENFORCEABLE UNTIL THE SEVEN DAY REVOCATION PERIOD HAS EXPIRED WITHOUT THE RELEASE HAVING BEEN REVOKED
(THE “EFFECTIVE DATE”);
(5) THIS
RELEASE WILL BE FINAL AND BINDING AFTER THE EXPIRATION OF THE REVOCATION PERIOD REFERRED TO IN SECTION (d)(3).
(6) THE
COMPANY ADVISES THE EXECUTIVE TO CONSULT WITH AN ATTORNEY. THEREFORE, HE IS AWARE OF HIS RIGHT TO CONSULT AN ATTORNEY, HAS BEEN ADVISED
IN WRITING TO CONSULT WITH AN ATTORNEY, AND HAS HAD THE OPPORTUNITY TO CONSULT WITH AN ATTORNEY, IF DESIRED, PRIOR TO SIGNING THIS
RELEASE;
(7) NO
PROMISE OR INDUCEMENT FOR THIS RELEASE HAS BEEN MADE EXCEPT AS SET FORTH IN THIS RELEASE;
(8) HE
IS LEGALLY COMPETENT TO EXECUTE THIS RELEASE AND ACCEPT FULL RESPONSIBILITY FOR IT; AND
(9) HE
HAS CAREFULLY READ THIS RELEASE, ACKNOWLEDGES THAT HE HAS NOT RELIED ON ANY REPRESENTATION OR STATEMENT, WRITTEN OR ORAL, NOT SET FORTH
IN THIS DOCUMENT, AND WARRANTS AND REPRESENTS THAT HE IS SIGNING THIS RELEASE KNOWINGLY AND VOLUNTARILY.
IN WITNESS WHEREOF, the parties
have hereunto set their hands this __________ day of ___________________.
By:
Michael C. Roper
MFA Financial, Inc.
Name:
Title:
55
EX-99.1 — EXHIBIT 99.1
EX-99.1
Filename: tm2627083d1_ex99-1.htm · Sequence: 5
Exhibit 99.1
MFA
FINANCIAL, INC.
12 East 49th
Street
8th Floor –
Suite 825
New York, New
York 10017
(212) 207-6400
PRESS RELEASE
FOR IMMEDIATE RELEASE
October 8, 2026
NEW YORK METRO
Investor Contact:
MFA Investor Relations
NYSE: MFA
212-207-6488
www.mfafinancial.com
MFA Financial, Inc.
Announces CEO
Succession Plan and Senior Leadership Appointment
Craig Knutson
to Retire as Chief Executive Officer Effective June 30, 2027; Will Remain on the Board of Directors Following Retirement
Bryan Wulfsohn
Appointed Chief Executive Officer Effective July 1, 2027; Will Join the Board of Directors Effective January 1, 2027
Andrew Kail to
join as Chief Investment Officer Effective January 1, 2027
NEW YORK –
MFA Financial, Inc. (NYSE: MFA) (“MFA” or the “Company”) today announced upcoming changes to its executive
leadership positions as part of the Company’s long-term succession planning. The leadership changes, which take effect in 2027,
are described below:
Chief Executive Officer
Craig L. Knutson,
67, MFA’s Chief Executive Officer, will retire from his position, effective June 30, 2027. To facilitate continuity and provide
the Company’s Board of Directors (the “Board”) and management with the benefit of Mr. Knutson’s long-time
institutional knowledge of the Company and its operational strategy, Mr. Knutson is expected to remain on the Board following his
retirement and will stand for reelection to the Board at MFA’s 2027 annual meeting of stockholders.
Bryan Wulfsohn,
MFA’s current President and Chief Investment Officer, will become President and Chief Executive Officer, effective July 1,
2027. Mr. Wulfsohn will also become a member of the Board effective January 1, 2027, increasing the size of the Board to eight
directors. Mr. Wulfsohn is a 16-year veteran of MFA with extensive experience managing the selection, oversight and funding of the
Company’s investment portfolios, and he has served as President since September 2024 and Chief Investment Officer or Co-Chief
Investment Officer since January 2019.
Laurie Goodman,
MFA’s Chair of the Board, said “On behalf of the Board and the entire MFA team, I would like to thank Craig for his
contributions to MFA and congratulate him on his upcoming retirement. The Board is deeply grateful to Craig for his leadership of MFA
since joining the Company in 2008 and in particular during the past nine years as CEO, and we are pleased that we will continue to benefit
from his insights as a director following his retirement. We also are thrilled to announce Bryan’s appointment as CEO. His appointment
is the culmination of a robust succession planning process and reflects the Board’s confidence in his leadership, intellect and
strategic vision for the Company.”
Mr. Knutson
said, “It has been a privilege working at MFA for the past 18 years and leading the Company for the past nine years. I look forward
to continuing to serve as a member of the Board and working with Bryan, my fellow directors and the MFA management team in the coming
months to help ensure a smooth transition. I have worked with Bryan for over 20 years, and I will retire knowing that MFA is in good
hands with him at the helm and am eager to see the Company thrive in the years ahead under Bryan’s leadership.”
Mr. Wulfsohn
commented, “I’m honored to be selected as the next CEO of MFA, and I appreciate the Board’s confidence in me for this
role. I am grateful to Craig for his mentorship and partnership over the years, and I look forward to leading a team whose expertise
and commitment I know firsthand. I’m excited for the future of the business and the opportunity to deliver strong returns for our
stockholders.”
Chief Investment Officer
MFA also announced
that Andrew P. Kail will join the Company as Senior Vice President and Chief Investment Officer, effective January 1, 2027. Mr. Kail,
a veteran of the mortgage finance industry for over 25 years, served most recently as Managing Director, Head of Residential Lending,
at Starwood Capital Group, a position he held from 2022 through earlier this year. Prior thereto, he was Director of Business
Development at Aspen Capital from 2019 to 2022. Earlier in his career Mr. Kail also held senior leadership positions in mortgage
finance with Fortress Investment Group, RBS Securities Inc. and Bear Stearns & Co., Inc.
Mr. Wulfsohn
said, “Craig and I have known Andrew for over 15 years, and he brings a wealth of skills, experiences and relationships to MFA
from his decades working in the mortgage finance industry on both the sell side and the buy side, including in asset management and operational
roles. We are excited to welcome him to MFA.”
About MFA Financial, Inc.
MFA Financial, Inc.
is a leading specialty finance company that invests in residential mortgage loans, residential mortgage-backed securities and other real
estate assets. Through its wholly owned subsidiary Lima One Capital, MFA also originates and services business purpose loans for real
estate investors. MFA has distributed over $5 billion in dividends to stockholders since its initial public offering in 1998.
MFA is an internally managed, publicly traded real estate investment trust.
Forward-Looking Statements
This press release contains, or may
be deemed to contain, “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of
1995, including with respect to the anticipated timing and effects of the leadership transition and appointments described herein. These
forward-looking statements are based on beliefs, assumptions and expectations of MFA’s future performance, taking into account
information currently available. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only
as of the date on which they are made. These types of statements are subject to various known and unknown risks, uncertainties, assumptions
and other factors, including those described in MFA’s Annual Report on Form 10-K for the year ended December 31, 2025,
and other reports that it may file from time to time with the Securities and Exchange Commission. These risks, uncertainties and other
factors could cause MFA’s actual results to differ materially from those projected, expressed or implied in any forward-looking
statements it makes. New risks and uncertainties arise over time, and it is not possible to predict those events or how they may affect
MFA. Except as required by law, MFA is not obligated to, and does not intend to, update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise.
GRAPHIC
GRAPHIC
Filename: tm2627083d1_img001.jpg · Sequence: 10
Binary file (4086 bytes)
Download tm2627083d1_img001.jpg
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 12
v3.26.3
Cover
Oct. 02, 2026
Document Information [Line Items]
Document Type
8-K
Amendment Flag
false
Document Period End Date
Oct. 02, 2026
Entity File Number
1-13991
Entity Registrant Name
MFA
FINANCIAL, INC.
Entity Central Index Key
0001055160
Entity Tax Identification Number
13-3974868
Entity Incorporation, State or Country Code
MD
Entity Address, Address Line One
12
East 49th Street
Entity Address, Address Line Two
11th
Floor – Suite 825
Entity Address, City or Town
New York
Entity Address, State or Province
NY
Entity Address, Postal Zip Code
10017
City Area Code
212
Local Phone Number
207-6400
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Entity Emerging Growth Company
false
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security
Common
Stock, par value $0.01 per share
Trading Symbol
MFA
Security Exchange Name
NYSE
Series B Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security
7.50%
Series B Cumulative Redeemable Preferred Stock, par value $0.01 per share
Trading Symbol
MFA/PB
Security Exchange Name
NYSE
Series C Preferred Stock [Member]
Document Information [Line Items]
Title of 12(b) Security
6.50%
Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, par value $0.01 per share
Trading Symbol
MFA/PC
Security Exchange Name
NYSE
Senior 8. 875 Percent Notes Due 2029 [Member]
Document Information [Line Items]
Title of 12(b) Security
8.875%
Senior Notes due 2029
Trading Symbol
MFAN
Security Exchange Name
NYSE
Senior 9. 000 Percent Notes Due 2029 [Member]
Document Information [Line Items]
Title of 12(b) Security
9.000%
Senior Notes due 2029
Trading Symbol
MFAO
Security Exchange Name
NYSE
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
+ References
No definition available.
+ Details
Name:
dei_DocumentInformationLineItems
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the state or province.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressStateOrProvince
Namespace Prefix:
dei_
Data Type:
dei:stateOrProvinceItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=MFA_Senior8.875PercentNotesDue2029Member
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type:
X
- Details
Name:
us-gaap_StatementClassOfStockAxis=MFA_Senior9.000PercentNotesDue2029Member
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: